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Abstract
Zearalenone (ZEN), a mycotoxin primarily produced by Fusarium fungi, occurs predominantly in cereal
grains. The European Commission asked EFSA for a scientiﬁc opinion on the risk to animal health
related to ZEN and its modiﬁed forms in feed. Modiﬁed forms of ZEN occurring in feed include phase I
metabolites a-zearalenol (a-ZEL), b-zearalenol (b-ZEL), a-zearalanol (a-ZAL), b-zearalanol (b-ZAL),
zearalanone (ZAN) and phase II conjugates. ZEN has oestrogenic activity and the oestrogenic activity
of the modiﬁed forms of ZEN differs considerably. For ZEN, the EFSA Panel on Contaminants in the
Food Chain (CONTAM) established no observed adverse effect levels (NOAELs) for pig (piglets and
gilts), poultry (chicken and fattening turkeys), sheep and ﬁsh (extrapolated from carp) and lowest
observed effect level (LOAEL) for dogs. No reference points could be established for cattle, ducks,
goats, horses, rabbits, mink and cats. For modiﬁed forms, no reference points could be established for
any animal species and relative potency factors previously established from rodents by the CONTAM
Panel in 2016 were used. The dietary exposure was estimated on 17,706 analytical results with high
proportions of left-censored data (ZEN about 60%, ZAN about 70%, others close to 100%). Samples
for ZEN were collected between 2001 and 2015 in 25 different European countries, whereas samples
for the modiﬁed forms were collected mostly between 2013 and 2015 from three Member States.
Based on exposure estimates, the risk of adverse health effects of feed containing ZEN was considered
extremely low for poultry and low for sheep, dog, pig and ﬁsh. The same conclusions also apply to the
sum of ZEN and its modiﬁed forms.
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Summary
Following a request from the European Commission, the EFSA Panel on Contaminants in the Food
Chain (CONTAM) assessed the risk to animal health related to the presence of zearalenone (ZEN) and
its modiﬁed forms in feed. The CONTAM Panel was asked to consider all relevant adverse health
effects, and in particular to address the co-occurrence of ZEN and its modiﬁed forms, and to estimate
the dietary exposure of different animal species.
Previous risk assessments from the European Food Safety Authority (EFSA) on ZEN in feed (2004),
ZEN in food (2011), modiﬁed forms of certain mycotoxins in food and feed (2014) and on the
appropriateness to set a group health-based guidance value for ZEN and its modiﬁed forms (2016)
have been used as a starting point for the present assessment.
ZEN is a phenolic resorcylic acid lactone mycotoxin produced by several Fusarium species,
particularly Fusarium graminearum. ZEN can be modiﬁed in plants, fungi and animals by phase I and
phase II metabolism. Modiﬁed forms of ZEN occurring in feed include its reduced phase I metabolites,
i.e. a-zearalenol and b-zearalenol (a-ZEL and b-ZEL), a-zearalanol and b-zearalanol (a-ZAL and b-ZAL),
zearalanone (ZAN) and its phase II derivatives, such as those conjugated with glucose, sulfate and glucuronic
acid. a-ZAL, one of the phase I metabolites of ZEN, is used as a growth promoter in non-European Union (EU)
countries under the name of Zeranol. It is banned in Europe, and therefore, it is included in ofﬁcial control
plans.
Analytical methods for ZEN and its modiﬁed forms in feed are well-established. However, while
methods reported in the scientiﬁc literature are widely based on the more sensitive liquid
chromatography–tandem mass spectrometry (LC–MS/MS), most of the routine analyses are still
performed by liquid chromatography-ﬂuorescence detector (LC-FLD) or liquid chromatography-
ultraviolet detector (LC-UV). Of note, calibrants for ZEN conjugates and reference materials for phase I
and phase II modiﬁed forms are not commercially available.
Wide interspecies differences in ZEN absorption, distribution, metabolism and excretion (ADME)
have been documented. Prehepatic, hepatic end extrahepatic ZEN metabolism has been reported; the
nature and the amount of the generated metabolites may affect the species-sensitivity to the toxin. In
farm and companion animals, reductive biotransformations largely prevail; the main ZEN metabolites
are a-ZAL, b-ZAL, with only very limited amounts of a-ZEL, b-ZEL, and other reductive metabolites
being produced; reduced metabolites retain or increase the oestrogenic potency of the parent
compound. Based on the levels measured in biological ﬂuids (plasma, urine or bile) of ZEN-treated
animals, the a-derivatives seem to prevail in pigs, dogs, and turkeys while the b-derivatives appear to
be more abundant in cattle, goats, horses, broiler chickens, and laying hens. Cytochrome P450 (CYP)-
mediated aromatic or aliphatic hydroxylation also occurs, but information in farm and companion
animals is limited. In orally exposed animals, ZEN and its metabolites are rapidly absorbed, distributed
to several organs and quickly excreted mainly via the biliary route as glucuronides; an active
enterohepatic circulation has been demonstrated. Excretion in milk and eggs has been documented for
ZEN and its metabolites.
There is scant information on the toxicokinetics of ZEN in cattle; rumen microbes extensively
metabolise ZEN to a-ZAL and b-ZAL, the latter being predominant also in biological ﬂuids. Little is
known on the toxicokinetics of ZEN in sheep; ZEN is almost completely biotransformed by ovine rumen
ﬂuid to a-ZAL, b-ZAL at similar proportions and both metabolites are present in urine of dosed animals
as both free and conjugated forms. No studies have been identiﬁed on ZEN administration to goats by
the oral route.
There is a large data set for ZEN toxicokinetics in pigs, including piglets, gilts, and sows. In all
porcine categories, the production of a-ZEL largely outweighed that of b-ZEL and other reductive
metabolites which were recovered, along with ZEN in blood, urine, and bile mostly in their
glucuronidated form. The modiﬁed forms ZEN-14-O-b-glucoside (ZEN14Glc), ZEN-16-O-b-glucoside
(ZEN16Glc) and ZEN-14-sulfate (ZEN14Sulf) were not detected in urine and faeces when administered
orally, suggesting a complete hydrolysis and thereby contribution to ZEN overall toxicity.
In poultry, ZEN is characterised by a low oral bioavailability and a rapid elimination. b-ZEL was
largely predominant over a-ZEL in broiler chickens and laying hens, while turkey poults tended to
biotransform ZEN more extensively and synthesise a relatively high amount of a-ZEL; in all cases,
glucuronidation was the main conjugation reaction.
In horses, a-ZEL and b-ZEL are the main ZEN metabolites, the latter being predominantly formed
over a-ZEL under in vivo conditions.
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Little is known about the toxicokinetics of ZEN in rabbits; ZEN, a-ZEL and b-ZEL were detected in
colonic chyme, faeces, bile and urine of rabbits orally dosed with ZEN.
There is scant information concerning ZEN toxicokinetics in ﬁsh. In rainbow trout, there is evidence
of a prevalent production of b-ZEL vs a-ZEL, while the reverse seems to occur in carp.
No information could be identiﬁed for toxicokinetics of cats and farmed mink. In orally exposed
dogs, measurable blood levels of ZEN, a- and b-ZEL were detected throughout the experiment, with a
clear prevalence of the a- over the b-derivative (up to 100%).
Little is known about the metabolic fate of modiﬁed forms, except for a-ZAL. In all species, a-ZAL is
oxidised to ZAN and isomerised to b-ZAL; the parent compound and the metabolites are mainly
glucuronidated.
The main biological activity of ZEN is its oestrogenicity, i.e. the ability to act like the endogenous
steroidal sex hormone 17-b-oestradiol. ZEN binds to oestrogenic receptors (ERs) and has a stronger
afﬁnity to ER-a than to ER-b. ZEN and its modiﬁed forms differ considerably in their oestrogenic
activity. Based on their ‘uterotrophic activity’ assessed in rodents, ZEN and its modiﬁed forms are
ranked as follows: a-ZEL > a-ZAL > ZEN  ZAN  b-ZAL > b-ZEL. ZEN can activate the pregnane X
receptor (PXR) and increase the transcription of a number of genes, including several CYPs.
Cattle appear to be more resistant to the adverse effects of ZEN than other farm animals because
they biotransform ZEN more into b-ZEL than a-ZEL.
The only one available dose–response experiment in dairy cows orally exposed to pure ZEN for
which a reduction in the size of corpora lutea was claimed but no effects level could be identiﬁed, was
too limited to identify adverse effects. Similar limitations were identiﬁed in a study on heifers at
relatively high exposure level where the conception rate tended to be decreased. No reference point
for risk characterisation could be derived in cattle.
Based on ovulation rates and lambing percentages, a lowest observed adverse effect level (LOAEL)
of 56 lg ZEN/kg body weight (bw) per day and a no observed adverse effect level (NOAEL) 28 lg
ZEN/kg bw per day was established for sheep. No data were available for deriving reference points for
risk characterisation for goats.
Pigs are generally regarded as being a very sensitive species to ZEN, the most sensitive being
prepubertal female piglets. Based on the appearance of the vulva and the uterus weight, a no
observed effect level (NOEL) of 10.4 lg ZEN/kg bw per day was established for piglets by the
CONTAM Panel in 2011 and retained in 2016. For sexually mature female pigs, a NOAEL of 40 lg/kg
bw per day was identiﬁed based on prolonged cycling.
Poultry responds to the presence of ZEN in feed only at rather high dietary concentrations and can
generally be regarded as resistant. Based on decreased number of lymphocytes and the vent swelling,
NOAELs of 7,500 and 9,100 lg/kg bw per day were identiﬁed for chickens and turkeys, respectively.
For other poultry species and categories data are scarce. Therefore, LOAELs/NOAELs could not be
derived.
The only available study performed in horses with the puriﬁed mycotoxin did not allow the
derivation of NOAEL or a LOAEL due to poor experimental design and the lack of a control group.
In rabbits, no oestrogenic effects at 100 lg/kg bw per day were observed. However, at 10 lg ZEN/kg
bw per day, a transient increase of catecholamine was observed. No NOAEL or LOAEL could be
established.
Very limited toxicity data for ZEN are available for ﬁsh. The CONTAM Panel estimated a NOAEL for
carp of 0.3 mg ZEN/kg feed to correspond to 9 lg ZEN/kg bw per day based on decreased number of
monocytes, increased number of granulocytes and increased lipid peroxidation in liver and gill and
altered the carbohydrate metabolism. No effect level to characterise the hazard of ZEN could be
established for other ﬁsh species.
Dogs are considered a sensitive species to ZEN. No NOAEL could be established. Based on
myometrium and endometrium lesions, aspect of uterine glands, blood haematology and biochemistry
a LOAEL of 25 lg ZEN/kg bw per day has been estimated for dogs (mature bitches).
No data could be identiﬁed concerning the effects of ZEN in cats.
For farmed mink, the available studies were not suitable for deriving reference point of hazard
characterisation since they were performed at doses hardly occurring in practice and the lowest tested
dose (1,000 lg/kg bw per day) already caused overt oestrogenic effects.
Very few experiments investigated the adverse effect of the modiﬁed forms of ZEN on livestock
species, horses, ﬁsh and dogs and none of them were suitable to derive a NOAEL or LOAEL.
The dietary exposure was estimated using a ﬁnal data set of 17,706 analytical results of ZEN and
modiﬁed forms occurrence in feed. Data were representing most of the feed commodities but for
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many commodities only a limited number of samples were analysed. Samples for ZEN were collected
between 2001 and 2015 in 25 different European countries, whereas samples on the modiﬁed forms
were collected mostly between 2013 and 2015 from three Member States. The percentage of left-
censored data (results below limit of detection and/or limit of quantiﬁcation) was high (ZEN about
60%; ZAN about 70%; a-ZEL, b-ZEL, a- ZAL and b-ZAL about 100%). The CONTAM Panel considered
it important to estimate the occurrence and the animal exposure to the total concentration of ZEN,
a-ZAL, b-ZAL, ZAN, a-ZEL, b-ZEL through feed.
Apart from ‘Cereal grains, their products and by-products’ and ‘Compound feed’, only a limited
number of quantiﬁed data were available for other feed groups, i.e. forages, land animal products,
legume seeds, minerals, oil and other seeds and tubers. The highest number of reported samples for
ZEN corresponded to the feed group ‘Cereal grains, their products and by-products’ (~ 67%) and
particularly for ‘Wheat’ (n = 6,499). Other food groups that were well represented were
‘Complementary/Complete feed’ (n = 2,625), ‘Maize and corn’ (n = 2,048) and ‘Barley’ (n = 1,596).
Although an important ingredient in commercial rabbit diets, no data were reported for lucerne meal.
The occurrence assessment for ZEN reported in the literature is consistent with data in the EFSA
database. Concerning the occurrence of modiﬁed forms, phase II conjugated forms have been often
reported in the recent literature, whereas no data have been received by EFSA. The co-occurrence of
ZEN and its phase I and phase II modiﬁed forms is mainly described in cereals and products thereof.
While milling may lead to a redistribution of ZEN and its modiﬁed forms in the ﬁnal fractions, with a
possible enrichment in middlings, there is no evidence of signiﬁcant degradation by processing.
Molar relative potency factors (RPFs) of the modiﬁed forms relative to ZEN were applied to
occurrence levels of the respective ZEN metabolites according to the Opinion of the EFSA CONTAM
Panel delivered in 2016.
Exposure to ZEN and its modiﬁed forms is primarily from consumption of contaminated cereal
grains and cereal by-products. Except for forage maize (and maize silage produced from it) and cereal
straw, levels in forages are generally low.
The mean lowest lower bound (LB) to highest upper bound (UB) exposures of dairy cows and beef
cattle to ZEN ranged from 0.06 to 5.1 lg/kg bw per day, and the P95 exposures ranged from 0.30 to
32.9 lg/kg bw per day. For sheep and goats, the calculated lowest LB to highest UB mean exposures
to ZEN were 0.18 and 1.78 lg/kg bw per day, respectively, while at the 95th percentile the range was
from 0.27 (LB) to 10.8 (UB) lg/kg bw per day. The calculated mean LB and UB exposures for pigs
were 0.81 and 1.35 lg/kg bw per day, respectively, while the 95th percentile exposures ranged from
2.50 (LB) to 7.88 (UB) lg/kg bw per day, respectively. For poultry, estimates of the mean exposure
ranged from 0.74 (LB) to 3.64 (UB) lg/kg bw per day. The equivalent range for the 95th percentile
estimates of exposure was 3.46 and 12.7 lg/kg bw per day, respectively. For horses, the LB and UB
mean exposure estimates to ZEN were 0.18 and 0.89 lg/kg bw per day, respectively, while for the
95th percentile the range LB to UB was 0.35 to 3.69 lg/kg bw per day. Based on assumed diet
compositions, the estimated mean LB and UB exposures for farmed salmonids and carp ranged from
0.08 to 0.50 lg/kg bw per day, respectively. At the 95th percentile, LB and UB estimates of exposure
were 0.49 and 1.78 lg/kg bw per day, respectively. The estimated mean exposure for farmed rabbits
and mink ranged from 0.31 (LB) to 1.11 (UB) lg/kg bw per day, while the equivalent range for the
95th percentile was from 0.85 to 1.41 lg/kg bw per day. For companion animals (cats and dogs), LB
and UB mean exposure to ZEN ranged from 0.22 to 0.33 lg/kg bw per day, respectively, while at the
95th percentile the range was from 0.75 (LB) to 0.80 (UB) lg/kg bw per day.
There was considerable variation between livestock groups in the percentage of the total exposure
(ZEN + a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL) that was accounted for by the sum of the modiﬁed
forms (a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL).
For many species, notably poultry, ZEN accounted for the total exposure (100%) because of lack of
data of ZEN modiﬁed forms.
At the LB exposure, the modiﬁed forms accounted for 0–39% of the total exposure at both the
mean and 95th percentile for cattle, goat, sheep, horses, pigs, ﬁsh, rabbits, cats, dogs and mink.
At the UB exposure, the modiﬁed forms accounted for 50% or more of the total exposure, both at
the mean and 95th percentile for dairy cows, beef cattle, lactating sheep, horses, weaned pigs and
rabbits. More than half of the UB mean exposure for fattening pigs, lactating sows, cats and dogs was
from the modiﬁed forms, but was < 50% at the 95th percentile.
The Panel noted that estimating the occurrence and exposure with such a high number of left
censored data leads to a very high uncertainty.
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Risk characterisation for ZEN, was performed comparing the chronic exposure values in diets at the
UB mean and UB 95th percentile concentrations for ZEN with identiﬁed reference points. For cattle,
horses, rabbit, goat, duck, mink and cats the health risk from the exposure to ZEN could not be
assessed as no NOAEL or LOAEL have been identiﬁed.
For poultry (chicken and fattening turkeys), the highest estimated chronic exposure of ZEN was less
than 0.06% of the NOAEL. The Panel concluded that the estimated risk for chronic adverse health
effects from feed containing ZEN was extremely low for poultry.
For sheep, the highest estimated chronic exposure of ZEN was less than 16% of the NOAEL. The
Panel concluded that the risk of adverse health effects of feed containing ZEN was low for sheep.
For dogs, only a LOAEL was available. The highest estimated chronic exposure of ZEN was less
than 3% of the LOAEL. The Panel concluded that the estimated risk for chronic adverse health effects
from feed containing ZEN was low for dog.
For ﬁsh, a NOAEL was only available for carp and was extrapolated to all ﬁsh species. The highest
estimated chronic exposure of ZEN was 24% of the NOAEL. The Panel concluded that the estimated
risk for chronic adverse health effects from feed containing ZEN was low for ﬁsh.
For piglets and gilts, the highest estimated chronic exposure (P95) of ZEN was 21% and 9% of the
NOAEL, respectively. The Panel concluded that the estimated risk for chronic adverse health effects
from feed containing ZEN was low for piglets and gilts.
Risk characterisation for the sum of ZEN and its modiﬁed forms, was performed comparing the
chronic exposure of the sum of ZEN and its modiﬁed forms corrected for molar RPFs with identiﬁed
reference points obtained for ZEN. For cattle, horses, rabbit, goat, duck, mink and cats the health risk
from the exposure to ZEN and its modiﬁed forms could not be assessed as no NOAEL or LOAEL have
been identiﬁed. The Panel noted that no data on levels of a-ZAL, b-ZAL, ZAN, a-ZEL or b-ZEL were
provided in species-speciﬁc compound feeds for poultry. However, considering the very high NOAELs
for these species, and the composition of their feed, the Panel considered the risk of health effects
from ZEN and its modiﬁed forms was extremely low for these species.
For sheep, the highest estimated chronic exposure of ZEN and modiﬁed forms was less than 25%
of the NOAEL. The Panel concluded that the risk of adverse health effects of feed containing ZEN and
its modiﬁed forms was low for sheep.
For dogs, only a LOAEL was available. For this species, the highest estimated chronic exposure of
ZEN and its modiﬁed forms were less than 5% of the LOAEL. The Panel concluded that the estimated
risk for chronic adverse health effect from consuming feed containing ZEN and its modiﬁed forms was
low for dog.
For ﬁsh, a NOAEL was only available for carp and was extrapolated to all ﬁsh species. The highest
estimated chronic exposure of ZEN and its modiﬁed forms was less than 30% of the NOAEL. The
Panel concluded that the estimated risk for chronic adverse health effect from feed containing ZEN and
its modiﬁed forms was low for ﬁsh.
For piglets and gilts, the highest estimated chronic exposure of ZEN and its modiﬁed forms were
59% and 12% of the NOAEL, respectively. The Panel concluded that the estimated risk for chronic
adverse health effects from feed containing ZEN and its modiﬁed forms was low for piglets and gilts.
The CONTAM Panel noted that there is a need for more data on the occurrence of modiﬁed forms
of ZEN in feed. In addition, there is a need of calibrants and reference materials for the development
of properly validated and sensitive routine analytical methods for ZEN modiﬁed forms in the feed
commodities and especially highly sensitive methods to identify the most potent form a-ZEL.
There is also a need for toxicological and toxicokinetic data on ZEN modiﬁed forms, particularly for
cattle, horses, rabbit, poultry, for companion animals and mink to ZEN, to reduce the uncertainties in
the animal risk assessment.
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1. Introduction
1.1. Background and Terms of Reference as provided by the European
Commission
BACKGROUND
Following a request from the European Commission, the risks to human and animal health related
to modiﬁed forms of the Fusarium toxins zearalenone, nivalenol, T-2 and HT-2 toxins and fumonisins
were evaluated in the scientiﬁc opinion on the risks for human health related to the presence of
modiﬁed forms of certain mycotoxins in food and feed,1 adopted by the EFSA Panel on Contaminants
in the Food Chain (CONTAM) on 25 November 2014.
The CONTAM Panel indicated in the recommendations that the animal health effects of zearalenone
need to be re-assessed in order to possibly set No observed adverse effect levels/lowest observed
effect levels (NOAELs/LOAELs) for zearalenone in order to be able to assess the risk for animal health
related to the presence of zearalenone and its modiﬁed forms in feed.
TERMS OF REFERENCE
In accordance with Art. 29 (1) (a) of Regulation (EC) No 178/2002, the Commission asks the
European Food Safety Authority (EFSA) for a scientiﬁc opinion on the risks for animal health related to
the presence of zearalenone and its modiﬁed forms in feed.
1.2. Interpretation of the Terms of Reference
The CONTAM Panel concluded that the terms of reference provided by the Commission were clear.
1.3. Additional information
1.3.1. Previous risk assessments
The Scientiﬁc Opinion related to zearalenone (ZEN) as an undesirable substance in animal feed
(EFSA, 2004) concluded that zearalenone exerts its toxic action by interacting with oestrogen receptors
(ERs) and causing an oestrogenic response in animals. Pigs were considered the most sensitive animal
species to zearalenone, with female pigs more sensitive than male pigs, followed by sheep, cattle and
poultry. The CONTAM Panel concluded that the calculation of animal exposure levels based on the
individual occurrence data of zearalenone in feed materials could not be carried out due to the
variability within the European Union (EU) member states feeding regimes for farm animals. No
NOAELs/LOAELs for zearalenone in animals were derived since the available data were considered
inadequate.
In the human ZEN risk assessment from EFSA in 2011, (EFSA CONTAM Panel, 2011), a tolerable
daily intake (TDI) of 0.25 lg/kg body weight (bw) per day was derived from a no observed effect level
(NOAEL) of 10 lg/kg bw for oestrogenic effects observed in immature gilts and applying an uncertainty
factor of 40 (4 for interspecies differences in toxicokinetics and 10 for inter-human variability). Lowest-
observed-effect-levels (LOELs) for ovary, uterus and vulva in female pigs ranged from 17 to 200 lg/kg
bw per day, with an overall no-observed-effect-level (NOEL) of 10.4 lg/kg bw per day.
The CONTAM Panel developed a Scientiﬁc Opinion on the risks for human and animal health related
to the presence of modiﬁed forms of certain mycotoxins in food and feed (EFSA CONTAM Panel,
2014). The toxicity for animals and humans of metabolites and masked or bound forms of fumonisins,
zearalenone, T-2 and HT-2 and nivalenol was evaluated. The EFSA occurrence database contained no
data on modiﬁed zearalenone; therefore occurrence was based on limited information reported in the
literature. An estimation of the human dietary exposure and animal feed exposure compared with the
exposure to the parent mycotoxins and assessments of the human and animal health risks was
performed. Risk characterisation was done by comparing exposure scenarios with reference doses for
the parent compounds. The CONTAM Panel identiﬁed several uncertainties and data gaps for modiﬁed
mycotoxins and recommended re-assessing the animal health effects of zearalenone and fumonisins in
order to set NOAELs/LOAELs for these compounds.
1 EFSA CONTAM Panel (2014). Scientiﬁc Opinion on the risks for human and animal health related to the presence of modiﬁed forms
of certain mycotoxins in food and feed. EFSA Journal 2014;12(12):3916, 107 pp. https://doi.org/10.2903/j.efsa.2014.3916.
Available online: www.efsa.europa.eu/efsajournal
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Recently, the CONTAM Panel assessed the appropriateness to set a group health based guidance
value for ZEN and modiﬁed forms. Different oestrogenic potencies are observed in vivo for ZEN and
modiﬁed forms. To account for these differences, molar potency factors relative to ZEN (relative
potency factors (RPFs) were calculated and applied to exposure estimates of the respective ZEN
metabolites (EFSA CONTAM Panel, 2016). The CONTAM Panel found it appropriate to set a group
human TDI of 0.25 lg/kg bw per day expressed as ZEN equivalents for ZEN and its modiﬁed forms.
1.3.2. Chemistry
Mycotoxins are secondary metabolites produced by ﬁlamentous fungi on food and feed
commodities, mainly grains. These low molecular weight compounds may exert a range of toxic
activities towards microorganisms, animals and humans.
Recent advances in the ﬁeld showed that not only parent compounds but also their modiﬁed forms
may occur simultaneously in raw cereals and products thereof. Deﬁnition and formation of modiﬁed
forms of mycotoxins have been recently addressed by the CONTAM Panel (EFSA CONTAM Panel, 2014,
2016). Although different nomenclature and numbering systems are in use in the literature dealing
with ZEN, the CONTAM Panel has followed the IUPAC numbering system in the deﬁnition of ZEN and
its modiﬁed forms as already done in previous opinions (EFSA CONTAM Panel, 2014, 2016).
In living organisms (i.e. plants, microbes, animals), the most relevant modiﬁcation of ZEN leads to
the formation of its main reduced metabolites a- and b-zearalenol (a- and b-ZEL) and, to a lesser
extent, to oxidised metabolites (Metzler et al., 2010). In addition, phase II metabolites are formed by
conjugation with polar groups, giving rise mainly to glucoside, glucuronide and sulfate conjugates (i.e.
ZEN-14-Glc, ZEN-14-Sulf) (Berthiller et al., 2013). While most of phase I metabolites are shared
between different living organisms, phase II conjugates may vary in plants, microbes, and animals.
Besides biological modiﬁcation, chemical modiﬁcation of ZEN may also occur in food and feed,
mainly due to non-thermal reaction, such as cis-isomerisation (K€oppen et al., 2012). Therefore,
modiﬁed forms of ZEN are deﬁned as conjugated forms or metabolites originated by in vivo
biotransformation (in plants, in fungi or in animals) or process degradation. Modiﬁed forms of ZEN
potentially occurring in feed of plant or animal origin are summarised in Figure 1.
Table 1: Relative potencies factors (RPFs) given on a molar basis for ZEN and its modiﬁed forms as
proposed by the CONTAM Panel (EFSA CONTAM Panel, 2016)
Compound Proposed RPF
ZEN 1.0
ZEN14Glc, ZEN16Glc, ZEN14Sulf 1.0
a-ZEL 60
a-ZEL14Glc and other a-ZELGlcs, a-ZELSulfs 60
b-ZEL 0.2
b-ZEL14Glc and other b-ZELGlcs, b-ZELSulfs 0.2
ZAN 1.5
ZANGlcs and ZANSulfs 1.5
a-ZAL 4.0
a -ZALGlcs, a-ZALSulfs 4.0
b-ZAL 2.0
b-ZALGlcs, b-ZALSulfs 2.0
cis-ZEN 1.0
cis-ZENGlcs and cis-ZENSulfs 1.0
cis-a-ZEL 8.0
cis-a-ZELGlcs and cis-a-ZELSulfs 8.0
cis-b-ZEL 1.0
cis-b-ZELGlcs and cis-b-ZELSulfs 1.0
ZEN: zearalenone; ZAN: zearalanone; ZAL: zearalanol; Glc: glucoside; Sulf: sulfate.
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Multiple abbreviations and numbering systems are used for zearalenone and its modiﬁed forms in
the scientiﬁc literature. For consistency with previous opinions, the CONTAM Panel has decided to use
for this opinion the system deﬁned in the Scientiﬁc Opinion on the risks for human and animal health
related to the presence of modiﬁed forms of certain mycotoxins in food and feed (EFSA CONTAM
Panel, 2014), as shown in Appendix A. Appendix A reports the main chemical information on
zearalenone and its modiﬁed forms potentially occurring in feed.
Parent compound
Zearalenone (ZEN) (C18H22O, CAS No. 17924-92-4, m.p. 164–165°C) is a white and crystalline
compound, insoluble in water, but soluble in aqueous alkali and various organic solvents such as
ethanol, acetone and ethyl acetate. It exhibits a typical ﬂuorescence at 460 nm when excited at
294 nm. ZEN is produced by fungi belonging to Fusarium spp., particularly Fusarium graminearum.
ZEN can be chemically classiﬁed as a macrocyclic b-resorcylic acid lactone (RAL), carrying a keto group
and an oleﬁnic double bond.
Phase I metabolites
ZEN may undergo phase I metabolism in living organisms (i.e. plants, fungi, animals), mainly
leading to the formation of reductive metabolites (Figure 1). The reduction of the keto group leads to
the stereoisomeric compounds a-zearalenol and b-zearalenol, while the reduction of the oleﬁnic double
bond leads to the alkane zearalanone (see Figure 2, Chemical structure and numbering system used
for zearalenone). When both the oleﬁnic double bond and the keto groups are reduced, the
stereoisomers a- and b-zearalanol are obtained.
Parent compound
ZEN
Biological modification Chemical modification
NON-THERMAL REACTION
cis-ZEN
FUNCTIONALIZATION
(Phase I metabolism)
CONJUGATION
(Phase II metabolism)
α-ZEL, β-ZEL, α-ZAL, 
β-ZAL; ZAN, cis-α- or cis-
β-ZEL, cis-α- or cis-β-ZAL
ZEN14Glc, ZEN16Glc, ZEN14Sulf, 
α-or β-ZEL14Glc, α- or β-ZAL14Glc; cis-ZEN14Glc; 
cis-ZEN16Glc, cis-ZEN14Sulf; cis-α- or cis-β-ZEL14Glc
Plant conjugates
Fungal conjugates
Animal conjugates
ZEN14Sulf 
ZEN14GlcA, 
α-or β-ZEL14GlcA 
Figure 1: Scheme of mycotoxin modiﬁcation and metabolism applied to ZEN
Zearalenone and its modiﬁed forms in feed
www.efsa.europa.eu/efsajournal 11 EFSA Journal 2017;15(7):4851
The main conjugated forms of ZEN and its phase I metabolites result from glucosylation and
sulfation. Conjugation mainly occurs at position 14 to a minor extent due to sterical hindrance, at
position 16.
Phase II metabolites
Conjugation of ZEN and phase I metabolites with more polar low molecular weight molecules such
as glucose or sulfate leads to the formation of modiﬁed forms that may escape routine mycotoxin
analysis. However, the parent compounds may be released upon hydrolysis in the gastrointestinal tract
of mammals.
For further details, see Scientiﬁc Opinion on the risks for human and animal health related to the
presence of modiﬁed forms of certain mycotoxins in food and feed (EFSA CONTAM Panel, 2014).
The phase II metabolites of ZEN-related compounds identiﬁed so far in plants and fungi are listed
in Table 1. Only metabolites completely characterised by spectroscopic methods [usually nuclear
magnetic resonance (NMR)] and/or conﬁrmed by chemical synthesis are included in the Table. The
structures of the others, which were tentatively identiﬁed, are discussed in the text.
Among the two regioisomeric monoglucosides identiﬁed for ZEN so far, ZEN-14-O-b-D-
glucopyranoside (ZEN14Glc) was ﬁrst identiﬁed and characterised as a transformation product of ZEN
by Rhizopus spp. (Kamimura, 1986), and later its formation was conﬁrmed in plant cell cultures and in
naturally infected cereals (see Section 3.2 Occurrence).
The regioisomeric ZEN-16-O-b-D-glucopyranoside (ZEN16Glc) was recently reported in cultures of
barley seedlings as well as in Brachypodium, and wheat suspension cultures (Kovalsky Paris et al.,
2014). In addition, plants can biotransform ZEN to a-ZEL and b-ZEL, which may undergo subsequent
glycosylation (Berthiller et al., 2006, 2009).
Fungal conjugation of ZEN with sulfate was ﬁrst described in cultures of four Fusarium spp.
(Plasencia and Mirocha, 1991), and recently conﬁrmed in cultures of Aspergillus oryzae strains and
Rhizopus species (Brodehl et al., 2014).
Glucuronidation is the main phase II biotransformation pathway of ZEN in animals. Glucuronides of
ZEN, and its phase I metabolites ZAN, a-ZEL, b-ZEL, a-ZAL and b-ZAL, can be found in urine and
tissues of animals fed with contaminated feed.
Chemical information on ZEN and its phase I and II metabolites are reported in Appendix A.
More details are reported in the Scientiﬁc Opinion on appropriateness to set a group health based
guidance value for zearalenone and modiﬁed forms (EFSA CONTAM Panel, 2016)
Formation of modiﬁed forms of ZEN in plants
ZEN may accumulate in plants, mainly cereals, upon fungal infection at the plant ﬂowering stage.
As a consequence of the plant–pathogen cross-talk, ZEN, as well as other Fusarium toxins, may
undergo modiﬁcation through the activation of phase I and phase II metabolic pathways.
The biochemical events as well as the genetic factors involved have been studied for deoxynivalenol
(DON) modiﬁcation in wheat and barley (Poppenberger et al., 2003; Berthiller et al., 2013; Kluger
et al., 2013), but little is known about the enzymatic pathway affecting ZEN metabolism in grains.
ZEN may undergo directly glucosylation and sulfation (phase II metabolism) to form ZEN14Glc,
ZEN16Glc, and ZEN14Sulf. In addition to direct conjugation, reductive phase I metabolism in plants
leads mainly to the formation of a- and b-ZEL, and at minor extent of ZAN, a- and b-ZAL. These phase
Figure 2: Chemical structure and numbering system used for zearalenone
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I metabolites may then be further modiﬁed to the corresponding phase II conjugated forms (see
Figure 3). Besides conjugated forms of the parent compounds, only a- and b-ZEL-glucosides have
been reported to occur in grains from the ﬁeld so far (Nathanail et al., 2015).
In addition, ZEN may undergo cis-isomerisation due to sunlight exposure. The isomeric parent
compound, namely cis-ZEN, may originate the correspondent phase I and phase II cis-forms
(Drzymala et al., 2015).
Although data from the literature indicate that factors such as plant genetic background, the
environment, and the agronomic factors may affect the ratio of modiﬁcation and the spectrum of
possible metabolites in plants, further studies are required to better understand the mechanism, and
to derive generalisation rules.
According to an in vitro study performed on Arabidopsis thaliana model system, phase II
metabolism may lead to the formation of glucosides, malonylglucosides, diglucosides and
pentosylhexosides (Berthiller et al., 2007). Therefore, it seems that ZEN follows a similar metabolic
pathway as other phenolic compounds, such as ﬂavonoids. However, these forms have never been
identiﬁed in grains from the ﬁeld or products thereof, so far.
Zearalenone and its modiﬁed forms in feed
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Figure 3: Modiﬁcation of ZEN in plants through phase I and phase II biotransformations
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Formation of modiﬁed forms of ZEN in animals and microorganisms
ZEN may be modiﬁed from microorganisms growing on food and feed commodities as well. In
particular, fungal and bacterial strains used for fermentation may conjugate ZEN, leading to the
formation of phase II metabolites. Among them, ZEN-14-Sulf has been often described (el-Sharkaway
et al., 1991; Jard et al., 2010). However, little is known about the metabolic processes, and the
biological factors affecting the formation of these conjugates.
The metabolic fate of ZEN in animals is described in Section 3.1.1.
1.3.3. Methods of analysis
The extraction of ZEN and its modiﬁed forms is mainly based on the same protocols already in use
for modiﬁed mycotoxins and extensively described in previous opinions (EFSA CONTAM Panel, 2014,
2016).
Concerning the analytical determination, ZEN and its modiﬁed forms can be easily detected by
ﬂuorescence (kex = 274 nm, kem = 440 nm) after a chromatographic separation. This approach is still
in use for feed, usually combined with sample puriﬁcation on immunoafﬁnity columns. However, in
recent years many protocols based on ultra high-performance liquid chromatography (HPLC) coupled
to mass spectrometry have been reported in literature (Berthiller et al., 2007, 2011; De Boevre et al.,
2012a, 2013). Commonly, C18 columns are used for a satisfactory chromatographic separation of the
analytes. Gradient elution based on acidiﬁed water–methanol or water-acetonitrile is applied. Although
13C-ZEN is commercially available, the use of the isotope dilution approach for correction of matrix
effects is still not frequently used. More often, liquid chromatography–tandem mass spectrometry
(LC–MS/MS) methods for feed may involve a sample clean up step on solid-phase extraction (SPE)
columns to decrease matrix effects. In the recent years, many methods based on multitoxin
approaches have been reported in the literature. Although able to detect the co-occurrence of different
mycotoxins, this approach requires a compromise in terms of sensitivity, accuracy, and recovery. For
this reason, limits of detection obtained for modiﬁed forms are often higher than those obtained for
the parent compounds. However, according to the analytical method in use, a broad range of
sensitivities is reported in the literature. Those based on mass spectrometry usually have limit of
detection (LOD) values in the range 0.05–10 lg/kg for both ZEN and its modiﬁed forms.
A different approach involves the enzymatic hydrolysis of the modiﬁed forms, and the subsequent
quantiﬁcation of the released parent compound. This indirect method has been often coupled to
ELISA-based techniques to return a total ZEN quantiﬁcation (as the sum of parent ZEN and ZEN
released from modiﬁed forms). Among tested enzymes, b-glucosidase, cellulase and cellobiase have
been used to cleave ZEN14Glc, obtaining an almost quantitative release of ZEN (Beloglazova et al.,
2013).
Certiﬁed reference materials and a certiﬁed calibrant for ZEN became available in 2003. They
consist of naturally contaminated maize ﬂour and blank maize ﬂour. Certiﬁed reference calibrant
solutions of ZEN, a-ZEL and b-ZEL in acetonitrile are commercially available, while ZAN, a-ZAL, and
b-ZAL are commercially available only as high purity standards (powder).To date, certiﬁed reference
materials and calibrants for conjugated forms (i.e. phase II metabolites) are not available on the
market.
1.3.4. Legislation
Directive 2002/32/EC on undesirable substances in animal feed stipulates that rules on feedingstuffs
are needed to ensure agricultural productivity and sustainability and to make it possible to ensure
public and animal health, animal welfare and the environment. Annex I of this Directive contains
maximum levels of a number of undesirable substances (chemical contaminants) that may be tolerated
in products intended for animal feed. ZEN is not regulated under this Directive.
Guidance values for ZEN have been recommended under Commission Recommendation 2016/1319/EC.2
The guidance values are shown in Table 2. Currently, modiﬁed forms of ZEN are not considered in the
legislation.
2 Commission Recommendation (EU) 2016/1319 of 29 July 2016 amending Recommendation 2006/576/EC as regards
deoxynivalenol, zearalenone and ochratoxin A in pet food. OJ L 208, 2.8.2016, p. 58–60.
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2. Data and methodologies
2.1. Feed occurrence data and methodologies
Following an European Commission mandate to EFSA, a call for annual collection of chemical
contaminant occurrence data in food and feed, including ZEN, was issued by the former EFSA Dietary
and Chemical Monitoring Unit (now DATA Unit)3 in December 2010 with a closing date of 1 October of
each year. European national authorities and similar bodies, research institutions, academia, food
business operators and other stakeholders were invited to submit analytical data on ZEN in feed. At
the time of receiving the request for the scientiﬁc opinion from the European Commission, no data on
the modiﬁed forms of ZEN were available in the EFSA Chemical Occurrence database. The EFSA
Evidence Management Unit (DATA Unit) invited European national authorities and similar bodies,
research institutions and other stakeholders to submit data on the following ZEN modiﬁed forms in
feed: ZEN-14-glucoside (ZEN14Glc), ZEN-14-sulfate (ZEN14Sulf), a-zearalenol (a-ZEL), b-zearalenol (b-ZEL),
zearalanone (ZAN), a-zearalanol (a-ZAL), b-zearalanol (b-ZAL), a-ZEL-14-glucoside (a-ZEL14Glc) and
b-ZEL-14-glucoside (b-ZEL14Glc). The data submissions to EFSA followed the requirements of the EFSA
Guidance on Standard Sample Description for Food and Feed (EFSA, 2010a); occurrence data were
managed following the EFSA standard operational procedures (SOPs) on ‘Data collection and
validation’ and ‘Data analysis and reporting’. By the end of July 2016, a total of 17,706 samples of feed
with analytical data on ZEN and its modiﬁed forms were available in the EFSA database. Data received
after that date were not included in the data set used to estimate dietary exposure.
Following the EFSA SOP on ‘Data analysis and reporting’ to guarantee an appropriate quality of the
data used in the exposure assessment the initial data set was carefully evaluated applying several data
cleaning and validation steps. Special attention was paid to different parameters such as ‘Sampling
strategy’, ‘Sampling year’, ‘Sampling country’, ‘Analytical methods’, and the ‘Reporting unit’. Feeds were
classiﬁed based on the catalogue of feed materials speciﬁed in the Commission Regulation (EU)
No 68/20134.
Analytical results were reported either in whole weight basis or 88% dry matter (DM). Before
estimating dietary exposure, all results were converted into mg/kg whole weight. For those samples
expressed on 88% DM basis, the moisture content was used to convert the analytical result into whole
Table 2: Guidance values for zearalenone in products intended for animal feed in the EU
(Commission Recommendation 2016/1319/EC)
Products intended for animal feed
Guidance value in mg/kg (ppm)
relative to a feedingstuff with a
moisture content of 12%
Feed materials(a)
– Cereals and cereal products(b) with the exception of maize by-products 2
– Maize by-products 3
Compound feed for:
– Piglets, gilts (young sows), puppies, kittens, dogs and cats for
reproduction
0.1
– Adult dogs and cats other than for reproduction 0.2
– Sows and fattening pigs 0.25
– Calves, dairy cattle, sheep (including lamb) and goats (including kids) 0.5
(a): Particular attention has to be paid to cereals and cereals products fed directly to the animals that their use in a daily ration
should not lead to the animal being exposed to a higher level of these mycotoxins than the corresponding levels of exposure
where only the complete feedingstuffs are used in a daily ration.
(b): The term ‘Cereals and cereal products’ includes not only the feed materials listed under heading 1 ‘Cereal grains and
products derived thereof’ of the list of feed materials referred to in part C of the Annex to Commission Regulation (EU)
No 68/2013 of 16 January 2013 on the Catalogue of feed materials (OJ L 29, 30.1.2013, p. 1) but also other feed materials
derived from cereals in particular cereal forages and roughages.
3 From 1 January 2014 onwards unit, title is Evidence Management Unit (DATA).
4 Commission Regulation (EU) No 68/2013 of 16 January 2013 on the Catalogue of feed materials Text with EEA relevance. OJ L
29, 16.1.2013, p. 1.
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weight; when the moisture content was missing, whenever possible imputation of the moisture content
from reported values was done (see Section 3.1.2).
In the analysis of ZEN occurrence data, the left-censored data, results below the LOD or below the
limit of quantiﬁcation [LOQ5] were treated by the substitution method as recommended in the
‘Principles and Methods for the Risk Assessment of Chemicals in Food’ (WHO/IPCS, 2009). The same
method is indicated in the EFSA scientiﬁc report ‘Management of left-censored data in dietary exposure
assessment of chemical substances’ (EFSA, 2010b). The guidance suggests that the lower bound (LB)
and upper bound (UB) approach should be used for chemicals likely to be present in the food (e.g.
naturally occurring contaminants, nutrients and mycotoxins). The LB is obtained by assigning a value
of zero (minimum possible value) to all samples reported as lower than the LOD (< LOD)/LOQ
(< LOQ). The UB is obtained by assigning the numerical value of LOD to values reported as < LOD and
LOQ to values reported as < LOQ (maximum possible value), depending on whether LOD or LOQ is
reported by the laboratory.
2.2. Feed consumption data and methodologies
ZEN and its modiﬁed forms are predominantly found in cereal crops, cereal grains and by-products
of cereal processing. These are widely used as feed for livestock; in the EU more than 93 million
tonnes of cereals and cereal by-products were used in the manufacture of compound feeds in 2014,
accounting for 60% of all feed materials used,6 almost all of which (> 95%) are grown or produced in
the EU. In addition, a further 51 million tonnes of cereal grains and by-products were fed in on-farm
mixes or as single ingredients. However, there are no industry data on the partition of these cereal
grains between livestock species (cattle, pigs, poultry, etc.).
Forages are important – and frequently the sole – feeds for ruminant livestock, and ZEN has been
widely identiﬁed in these feeds. A few studies have reported the presence of ZEN in pasture grasses
and grass silage (see Section 3.2.2), although levels are usually lower than have been reported in
maize and cereal silages and cereal straws, where ZEN has been regularly observed (See Section 3.2).
Estimating the exposure to ZEN and its modiﬁed forms requires estimates of feed intake, and in
this opinion two approaches have been adopted. For many livestock in the EU, part or all of the daily
ration is commonly provided in the form of manufactured compound feeds, and where data on levels
of ZEN and its modiﬁed forms in species-speciﬁc compound feeds7 are available, these have been used
to estimate exposure. Since compound feeds represent the complete diet for many livestock, this must
be the preferred method of calculating exposure. However, for some livestock categories information
on levels in compound feeds has not been given, or insufﬁcient data have been provided to allow
reliable estimates of exposure to be made, and for these data on individual feed materials have been
used, together with example diets (Appendix D) to estimate exposure. It should be stressed that these
do not represent ‘average’ diets, nor are the feeding systems ‘typical’ for all of Europe. Instead, they
are used to estimate levels of exposure to ZEN and its modiﬁed forms that might be indicative. They
are based on published guidelines on nutrition and feeding (AFRC, 1993; Caraba~no and Piquer, 1998;
NRC, 2007a,b; Leeson and Summers, 2008; McDonald et al., 2011; EFSA FEEDAP Panel, 2012; OECD,
2013), and expert knowledge of production systems in Europe. Details of the rations used feed intakes
and live weights assumed are given in Appendix D.
2.3. Toxicokinetic and toxicological data
Data were obtained from the scientiﬁc literature as described in Section 2.4.
2.4. Methodology for data collection and study appraisal
The CONTAM Panel considered the previous assessments on zearalenone and on modiﬁed fusarium
toxins (EFSA, 2004; EFSA CONTAM Panel, 2011, 2014, 2016) as comprehensive, covering all relevant
publications on ZEN and its modiﬁed forms, respectively, until those dates. All publications referenced
therein have been considered, wherever appropriate, also for the present evaluation.
5 The LOD can be deﬁned as the lowest concentration level that can be determined to be statistically different from a blank.
Similarly, the LOQ is the minimum concentration or mass of the analyte that can be quantiﬁed with acceptable accuracy and
precision (Keith et al., 1983). Keith LH et al., 1983. Principles of environmental analysis, Analytical Chemistry 55 (14), 2210–2218.
6 Source: FEFAC Feed and Food Statistical Yearbook 2014 Available online: www.fefac.eu
7 Complete and complementary feedingstuffs.
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In order to cover additional publications not considered in these previous assessments, a search for
literature was conducted for peer-reviewed original research published after the year 2000. Reviews
were also considered for the current risk assessment. In addition, when relevant papers were
identiﬁed during the risk assessment process (e.g. from other studies or reviews) they were also
considered for the assessment.
The search strategy was designed to identify scientiﬁc literature dealing with methods of analysis,
chemistry, occurrence in feed, animal exposure, toxicity, toxicokinetics and adverse effects in the
different animal species. An overview of the search terms is given in Appendix B, Section B.1.
Literature search was not restricted to publications in English language; however, literature in other
languages was only considered if an English abstract was available. A ﬁrst general literature search
was performed in December 2015 and has since been updated in May and December 2016 for the
adverse effects of ZEN and modiﬁed forms in farm and companion animals.
Web of Science8 and PubMed9 were identiﬁed as databases appropriate for retrieving literature for
the present evaluation. The references resulting from the literature search were imported and saved
using a software package (EndNote10), which allows effective management of references and citations.
The references obtained were screened using title and abstract to identify the relevant literature
and exclusion criteria are shown in Appendix B, Section B.2, and were subsequently reviewed by the
CONTAM working group (WG) zearalenone in feed, and has been used for the present assessment
based on expert judgement.
2.5. Use of molar RPFs for the ZEN modiﬁed forms
Molar RPFs of the modiﬁed forms relative to ZEN were applied to feed occurrence levels of the
respective ZEN metabolites (see Table 1) according to CONTAM Panel 2016 (EFSA CONTAM Panel,
2016). The CONTAM Panel noted that these molar (RPFs) were based on uterotrophic effects
measured for ZEN and its modiﬁed forms in rodent experiments and therefore did not take account of
other oestrogenic effects and other endpoints. Furthermore, applying these RPFs derived from mice to
different farm and companion animal species does not consider the species differences in the
toxicokinetics and toxicodynamics.
2.6. Methodologies for dietary exposure assessment in animals
Exposure to ZEN and its modiﬁed forms by livestock is a function of their concentration in their
diets and the amount of the diet consumed. In the absence of a comprehensive database on the
amounts or types of feed consumed by livestock in the EU, estimates of feed consumed for each of
the main categories of farmed livestock and companion animals are based on published guidelines on
nutrition (e.g. Caraba~no and Piquer, 1998; NRC, 2007a,b; Leeson and Summers, 2008; McDonald
et al., 2011; EFSA FEEDAP Panel, 2012; OECD, 2013), together with expert knowledge of production
systems in Europe.
For many farmed livestock and companion animals, their nutritional requirements are provided in
commercially manufactured complete (compound) feeds. Where sufﬁcient (reliable) data on the
concentrations of zearalenone and its modiﬁed forms in compound feeds have been provided, these
have been used to estimate exposure. However, where insufﬁcient compound feed data were
available, the CONTAM Panel identiﬁed example diets and feed inclusion rates, and used
concentrations of ZEN in individual feed materials to estimate P95 and mean exposure both LB and
UB. Details of the intakes and composition of diets used in estimating animal exposure to zearalenone
and its modiﬁed forms are given in Appendix D.
2.7. Methodology applied for risk assessment
The CONTAM Panel applied the general principles of the risk assessment process for chemicals in
food as described by WHO/IPCS (2009), which include hazard identiﬁcation and characterisation,
exposure assessment and risk characterisation. The principles described by WHO/IPCS (2009), EFSA
8 Web of Science (WoS), formally ISI Web of Knowledge, Thomson Reuters. Available at: http://thomsonreuters.com/thomson-
reuters-web-of-science/
9 PubMed, Entrez Global Query Cross-Database Search System, National Center for Biotechnology Information (NCBI), National
Library of Medicine (NLM), Department of the National Institutes of Health (NIH), United States Department of Health and
Human Services. Available at: http://www.ncbi.nlm.nih.gov/pubmed/
10 EndNote X5, Thomson Reuters. Available at: http://endnote.com/
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guidance pertaining to risk assessment have been applied for the present assessment. In addition, the
current risk assessment was used for internal testing of the draft Guidance on Uncertainty in EFSA
Scientiﬁc assessment (EFSA Scientiﬁc Committee, 2016). For details on the speciﬁc EFSA guidance
applied, see Appendix C.
3. Assessment
3.1. Hazard identiﬁcation and characterisation
3.1.1. Toxicokinetics
The information concerning the toxicokinetics of ZEN, as well as its modiﬁed forms, in several
animal species has been covered by previous EFSA opinions (EFSA, 2004; EFSA CONTAM Panel, 2011,
2016). The main kinetic pathways in mammalian species are shown in Figure 4.
The main ZEN metabolites and enzymes involved in their generation in animals are reported in
Figures 5 and 6.
Figure 4: Principal pathways and metabolism of ZEN and its modiﬁed forms in some mammalian
species (adapted from D€anicke and Winkler, 2015)
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Major phase I reductive metabolism (bold arrow) is mediated by 3a- and 3b-hydroxysteroid
dehydrogenases (HSDs); minor phase I oxidative metabolism (dotted arrows) is mediated by CYP
isoforms leading to catechol formation.
Figure 5: The main metabolites of ZEN formed in animals
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Only new studies published since the above EFSA evaluations or relevant topics not previously
covered will be reported below.
3.1.1.1. Absorption
Due to its lipophilicity, which is reﬂected by a relatively high log partition coefﬁcient between
octanol and water (log Kow), ZEN is rapidly absorbed at the enteric level following oral exposure
(Kuiper-Goodman et al., 1987); as an example, bioavailability of approximately 80–85% has been
estimated following a single oral dose in piglets of 10 mg/kg bw (Biehl et al., 1993). It is reasonable to
assume that also the reduced ZEN metabolites may easily cross biological membranes as it has been
demonstrated in the Caco-2 cell model (Pfeiffer et al., 2011). In an epithelial cell model, both ZEN and
the reduced metabolites a-ZEL and b-ZEL have been reported to interact with ABCC efﬂux proteins
(Videmann et al., 2009), the expression of which shows wide variation in veterinary species (Schrickx
and Fink-Gremmels, 2008).
ZEN and most of its metabolites will be absorbed and re-absorbed after being released by enteric
hydrolysis.
3.1.1.2. Distribution
Most of the information concerning tissue distribution is related to the parent compound (ZEN) and
has been derived from residue studies related to the transfer (carry-over) (see Section 3.1.1.6). The
apparent volume of distribution is large and includes target tissues of ZEN toxic action like uterus,
ovarian follicles and testes (Kuiper-Goodman et al., 1987). In a recent review, D€anicke and Winkler
(2015) summarised the available experimental feed studies performed with ZEN in food producing
species (lactating cows, fattening cattle, pigs, rabbits and avian species) taking into consideration liver,
muscle, kidney and fat. Despite the wide range of dosages and duration of the exposure, in general a
very limited amount of ZEN was found in liver followed by kidney, fat and muscle; the few available
reports also indicate that the modiﬁed forms (ZEN metabolites) are present in lower concentrations
than the parent compound.
3.1.1.3. Metabolism
In vitro studies
Prehepatic ZEN biotransformations are mediated by rumen and enteric microorganisms, but may
also occur in enteric cells. Microorganisms of the chyme are major players in both extraction from feed
and metabolism of ZEN and its modiﬁed forms at the gastro-intestinal level.
The rumen microbiota plays a key role in ZEN biotransformation (D€anicke et al., 2004). Several
in vitro studies (reviewed by D€anicke and Winkler, 2015) indicate that reductive reactions largely
Figure 6: Main phase II metabolism involves the phenolic ring, and leads to the formation of sulfate
or glucuronic acid conjugates, catalysed by sulfotransferases (SULTs) or uridine diphosphate
glucuronosyltransferases (UGTs), respectively
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predominate, with the generation mainly of b-ZEL and a-ZEL. Such conclusions have been supported
by in vivo studies on ﬁstulated cows (D€anicke et al., 2005b). The reduction of ZEN to a-ZEL has been
demonstrated using porcine chyme collected from the distal part of the enteric tract (Kollarczik et al.,
1994). On the other hand, hydrolytic reactions carried out by enteric and presumably rumen
microorganisms are involved in the release of ZEN from its modiﬁed forms. As detailed in the latest
EFSA evaluation (EFSA CONTAM Panel, 2016) few studies have been performed on the hydrolysis of
ZEN glucoside (ZEN14G). Gareis et al. (1990) obtained indications for the complete hydrolysis in a pig,
with ZEN and a-ZEL being detected in faeces and urine. In vitro studies with human faeces point to
the ability of human enteric microﬂora to hydrolyse ZEN glucosides (Dall’Erta et al., 2013; Kovalsky
Paris et al., 2014).
As mentioned above, metabolism also occurs in enteric cells. Although data concerning target
species are seemingly scant, caprine duodenal and jejunal preparations were found able to metabolise
ZEN to a-ZEL and b-ZEL (Dong et al., 2010a). More recently, in vitro studies performed with Caco-2
cells indicate that enteric cells are fully competent in carrying out both phase I and phase II RAL
biotransformations, generating reduced, glucuronidated, and sulfated metabolites (in various
proportions) of ZEN, ZAN, a-ZEL, b-ZEL as well as a-ZAL and b-ZAL (Pfeiffer et al., 2011).
After prehepatic metabolism, ZEN undergoes extensive liver phase I and phase II
biotransformations, which have been described in previous EFSA opinions (EFSA, 2004; EFSA CONTAM
Panel, 2011, 2016) and may be summarised as follows: Phase I biotransformations are mainly
reductive in nature and involve the NAD(P)H-mediated sequential reduction of the C6 keto group,
yielding a-ZEL and its stereoisomer b-ZEL, followed by a further reductive step at C11–C12 double
bond with the formation of a-ZAL and b-ZAL, respectively. It is generally accepted that a- and
b-hydroxysteroid dehydrogenases (HSDs) are the major enzymes performing tissue ZEN reduction in
mammalian species; such enzymes play a key role in steroid hormone homeostasis as they participate
both in the synthesis of testosterone, oestradiol, and progesterone and in the conversion of the more
hormonally active keto-derivatives (–CO) into the less active reduced (–COH) derivatives (Penning
et al., 2004). Wide species-related quantitative differences in the synthesis of the above metabolites as
well as in the subcellular (microsomal or cytosolic) localisation and the cofactor requirement (NADPH
vs NADH) of the reductive reactions have been demonstrated. In addition, the amount and the ratio of
the in vitro generated metabolites (especially a-ZAL and b-ZAL) have been reported to vary according
to the ZEN concentrations (Malekinejad et al., 2005a,b). Results from in vitro experiments indicate that
pig liver preparations convert ZEN predominantly to a-ZEL, while b-ZEL seems to prevail in chicken
preparations. Also in primary cultures of equine hepatocytes, ZEN was mostly metabolised to a-ZEL
(Malekinejad, 2013). In addition, the ability of liver microsomes in biotransforming ZEN to a-ZEL and
b-ZEL seems to be maximal in pig and sheep subfractions compared to cattle, chickens, and rats. As
regards poultry, in vitro investigations with liver post-mitochondrial fractions indicate a general greater
synthesis of the a- vs the b-derivative; however, wide interspecies variations also occurred in avian
species, with quails being identiﬁed as high b-reducers, guinea-fowls, ducks and chickens as weak
b-reducers, and geese as weak a- and b-reducers (Kolf-Clauw et al., 2007).
More recent in vitro studies conﬁrm the occurrence of a CYP-mediated ZEN hydroxylation, but little is
known about the generation of CYP-mediated ZEN hydroxylated derivatives in domestic animal species.
In rat and human liver microsomes, aromatic hydroxylation occurs mainly at C13 and C15, resulting in
the formation of 13- and 15-OH catechol ZEN derivatives (Fleck et al., 2012). Similar to
catecholoestrogens formed by the CYP1B-mediated oxidation of 17b-estradiol (E2), they might be further
oxidised to quinones which subsequently enter a futile cycle with the generation of reactive oxygen
species and DNA damage. Aliphatic hydroxylation of ZEN and a-ZEL at various C positions has also been
reported in vitro, with dog and rabbit liver microsomes seemingly more active than human, rat and
murine preparations. It should be noted that the oestrogenic potency of such hydroxylated derivatives is
one order of magnitude lower than ZEN (EFSA CONTAM Panel, 2011, Hildebrand et al., 2012). As far as
aromatic hydroxylation is concerned, upon the incubation of 50 lM ZEN with steer, pig, human, mouse
and rat liver microsomes, a higher quantity of catechol- (mainly C15 hydroxylated) vs. aliphatic
hydroxylated metabolites was detected in all species but mice. When expressed per nmoles of CYP, the
amount of catechol metabolites was in the order steer< pig < human < mouse < rat, which correlates
well with the extent of the oxidative damage measured in the same preparations as the formation of
8-oxo-7,8-dihydro-20-deoxyguanosine using calf thymus DNA (Fleck et al., 2012). As in the case of E2,
catechol derivatives of ZEN may be detoxiﬁed by catechol-O-methyltransferase (COMT). However, in vitro
investigations performed with liver cytosols from mammalian species, including steers and piglets
indicate that ZEN catechol-derivatives are poor substrates of COMT (Fleck et al., 2012). These catechols
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are actually able to inhibit the COMT activity toward 2-OH-E2, the major E2 catechol metabolite (Pfeiffer
et al., 2013).
It is worth noting that, in addition to enteric metabolism, further extrahepatic ZEN metabolism has
been reported. For example, porcine cumulus oocyte cells and granulosa cells express both 3a-and 3b-
HSD; similarly, as in liver, a-ZEL was produced to a higher extent than b-ZEL after the incubation of
GCs with ZEN (Malekinejad et al., 2006), indicating that ZEN-derived oestrogenic metabolites may be
generated also in target tissues. The metabolic conversion of ZEN into a- and/or b-ZEL has been
documented in caprine brain, lung, and kidney microsomal and cytosolic subfractions (Dong et al.,
2010a). Rat erythrocytes were also found able to convert ZEN, mostly into its a-reduced derivative
(Chang and Lin, 1984).
ZEN itself as well as all its reduced forms are subjected to phase II reactions resulting in the
formation of polar derivatives almost devoid of oestrogenic activity. Conjugation is mainly accomplished
by uridine diphospho glucuronosyltransferases (UGTs), each hydroxyl group being theoretically prone
to form glucuronides which may subsequently undergo biliary or urinary excretion. In the former case,
an active enterohepatic cycling is reported to occur. Again, there are well-known species related
differences in the extent of glucuronidation of ZAN and ZEN and its reduced metabolites, as well as in
the preferred route of elimination (biliary vs urinary) and in the glucuronidation position (EFSA
CONTAM Panel 2011, 2016). Pig liver microsomes exhibited the maximal in vitro glucuronidating
capacity towards ZEN, a-ZEL or b-ZEL, followed by sheep, cattle, rat and chicken subfractions
(Malekinejad et al., 2006). No information is available about the contribution of different UGT families
to the glucuronidation of ZEN and its metabolites in farm animal species.
There is general consensus that sulfation presents an additional conjugation route for ZEN and all
its reduced metabolites. According to Metzler et al. (2010), however, there is a paucity of data
concerning both the structures and the enzymology of such sulfate derivatives.
Overall, due to the well- known differences in the oestrogenic activity of ZEN metabolites, the
species-dependent metabolic proﬁle may have a considerable impact on the sensitivity to the
mycotoxin.
In vivo studies
The metabolite proﬁle of ZEN in blood, bile or urine of food producing species after oral exposure
has recently been reviewed in food producing species (D€anicke and Winkler, 2015). The proportion of
the reduced metabolites seems to vary according to both the extent and the duration of the exposure.
The majority of the experiments has been carried out in pigs and conﬁrms the results of the vitro
studies in that a-ZEL is largely prevailing over b-ZEL in all examined biological ﬂuids. In partial contrast
with the outcome of the in vitro studies, a much higher proportion of b-ZEL compared to a-ZEL was
detected in bile and urine samples from ZEN-exposed bovines, while in broilers a-ZEL seems to be
preferentially formed, with a blood a-ZEL/b-ZEL ratio up to 10 and even much higher in turkeys.
Evidence of a higher production of a-ZEL vs b-ZEL has also been provided for the canine species
(Gajezcka et al., 2013). Data are lacking concerning the occurrence of aromatic and/or aliphatic ZEN
hydroxylated derivatives in biological ﬂuids of farm and companion animals.
Modiﬁed forms
Due to its legal application as a growth-promoter in certain non-EU countries, the metabolic fate of
Zeranol (a-ZAL) has been investigated in several species, including rats, humans, pigs, dogs, cattle,
and rabbits (Migdalof et al., 1983; Bories and Suarez, 1989; Bories et al., 1991; Kleinova et al., 2002).
In all species, the main hepatic phase I biotransformations consist in the oxidation of the C7-secondary
alcoholic group to the corresponding –CO derivative, referred to as ZAN, as well as in the generation
of the diastereoisomer b-ZAL, also known as taleranol, resulting from the aldo-ketoreductase-mediated
reduction of the same alcoholic group. Phase II biotransformation yields both glucurono- and
sulfoconjugates, which are produced under in vitro and in vivo conditions (Bories et al., 1991; Pfeiffer
et al., 2010; Binder et al., 2017).
The metabolic fate of ZEN14Glc, ZEN16Glc, and ZEN14Sulf has been recently studied in pigs orally
dosed with such modiﬁed forms; the lack of the recovery of any of such plant metabolites in urine or
faeces points to their complete hydrolysis occurring in the gastrointestinal tract (Binder et al., 2017)
and hence to a substantial contribution to ZEN overall toxicity.
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3.1.1.4. Excretion
In most species, ZEN and its reductive metabolites are predominantly excreted via the faecal route
mainly as glucuronides due to an extensive biliary excretion; the occurrence of a remarkable
enterohepatic cycling may explain the relatively long persistence of the mycotoxin and its derivatives in
the body, particularly in pigs (EFSA CONTAM Panel, 2011, 2016); in rabbits and humans the rate of
urinary excretion seems higher than in the other species (Kuiper-Goodman et al., 1987).
No new information could be identiﬁed concerning the placental transfer of zearalenone and its
metabolites which has been demonstrated in rats (i.v. administration) and pigs.
Both ZEN and its metabolites are reported to be excreted in ovine, bovine and porcine milk
(Dacasto et al., 1995; EFSA, 2004; D€anicke et al., 2014; Flores-Flores et al., 2015).
Studies with [14C]ZEN or the unlabeled compound in laying hens have demonstrated the
progressive accumulation of ZEN and lipophilic metabolites in egg yolk (summarised in EFSA, 2004).
Further details about the carry over rate of ZEN and its metabolites can be found in
Section 3.1.1.6.
3.1.1.5. Species related toxicokinetics
The main TK parameters in various species are shown in Table 3. No speciﬁc toxicokinetic studies
could be retrieved for sheep, rabbit, ﬁsh, cats, dogs and farmed mink.
Ruminants
Cattle
• Exposure to ZEN
As detailed in the EFSA 2011 evaluation (EFSA CONTAM Panel, 2011), in vitro studies indicate that
ZEN was preferentially converted into b-ZEL rather than a-ZEL by bovine liver preparations.
In vivo experiments were carried out to study rumen metabolism, administering ZEN contaminated
diets to ﬁstulated cows. In line with the in vitro ﬁndings, approximately 89% of the totally ingested
ZEN (0.1 mg ZEN/kg diet) were recovered at the proximal duodenum as ZEN (30%), a-ZEL (30%) and
b-ZEL (40%), respectively, a-ZAL, b-ZAL and ZAN being not detectable (D€anicke et al., 2005b). Feed
intake level may inﬂuence the rate and the extent of ZEN conversion into its metabolites. In ﬁstulated
cows fed DM amounts increasing from 5.6 to 20.5 kg with a constant dietary ZEN concentration of
0.062 mg/kg, ZEN reduction to b-ZEL, the main rumen metabolite, decreased with increasing feed,
and consequently ZEN, intake; this was matched by a linear increase in the ﬂow of ZEN at the
duodenum (Seeling et al., 2005). These results indicate that high yielding dairy cows, characterised by
a high level of feed intake, might be more exposed systemically to ZEN than to b-ZEL, although the
toxicological implications of this ﬁnding remains unclear.
There is scant information on the in vivo toxicokinetics and bioavailability of ZEN or its modiﬁed
forms in cattle. Prelusky et al. (1990) investigated the blood kinetics of ZEN, a-ZEL and b-ZEL after a
single or repeated oral administration. In a cow fed a contaminated diet for 21 days (545 mg
ZEN/days corresponding to ~ 24 mg/kg diet at 88% DM and ~ 1,030 lg/kg bw), a Cmax of 3 ng/mL
was observed after a period of 62 h (tmax); after oral administration of a single dose of 1.8 g ZEN
(~ 80 mg/kg diet at 88% DM; ~ 3,400 lg/kg bw) or 6 g ZEN (~ 265 mg/kg diet at 88% DM;
~ 11,300 lg/kg bw) per animal, Cmax values of 9 and 13 ng/mL, respectively, were recorded with a
unique (tmax) of 12 h. These data indicate that maximum plasma concentrations after oral ZEN
administration in cattle are reached later when compared to other species. Tmax in bile is even reached
much later, pointing at the role of the enterohepatic cycling of ZEN metabolites.
In another study, a single oral ZEN dose of 10 mg resulted in an approximate peak concentration
Cmax = 3 ng ZAL (not further speciﬁed which isoform)/mL estimated from the graphic data
presentation. The so-estimated Cmax corresponded to a tmax of 96 h while Cmax of 150 ng a-ZEL/mL
was detected much earlier (tmax = 24 h) (Kennedy et al., 1998).
11
• Exposure to modiﬁed forms
The incubation of a-ZAL with rumen microﬂora resulted in the formation of ZAN, while the reverse
occurred upon the incubation of ZAN with bovine faecal matter, suggesting a reversible oxidation-
reduction reaction (a-ZAL!  ZAN) carried out by microbial dehydrogenases (Baldwin et al., 1983).
11 Figures extrapolated from published graphs.
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The NAD+- and NADP+- mediated in vitro biotransformation of a-ZAL was investigated in bovine
liver, muscle, and uterine microsomes. The main metabolite was in all cases ZAN, but the oxidative
activity of extrahepatic fractions was negligible (Ingerowski and Stan, 1979).
Five gallbladder cannulated cattle (unspeciﬁed breed and gender, live weight ~ 300 kg) were each
administered 10 mg a-ZEL or b-ZEL and bile samples were collected just before dosing and once daily
for the following 14 days, and analyzed for the presence of a-ZEL and a-ZAL with a GC/MS method
after deconjugation. In a-ZEL-treated animals there was a constant rise in biliary a-ZAL, reaching a
plateau at 10 days (~ 30 ng/mL), which was matched by a slow decline in a-ZEL. By contrast, no
a-ZAL but measurable amounts of a-ZEL could be detected in bile samples from b-ZEL-treated cattle
(Kennedy et al., 1998).
The in vivo metabolism of a-ZAL and of ZEN was investigated in Simmenthal heifers (1.5–2 years of
age, average body weight around 400 kg) fed ‘uncontaminated’ oats or ZEN-contaminated oats for
84 days, corresponding to a daily intake of 158 lg or 2,740 lg ZEN, respectively. Heifers from a third
group were implanted with two 25 mg a-ZAL pellets, one at the beginning of the trial and the other
after 42 days. Urine were collected every 5-days and ZEN and its metabolites were determined by
LC–MS/MS. Traces (< 0.5 lg/L) of ZEN and b-ZEL was found in urine specimens from control animals
administered with the ‘uncontaminated’ diet. In ZEN-treated heifers, there was a predominant
excretion of b-ZEL (range 20–65 lg/L) compared to its a-epimer (range 3–5 lg/L) in a ratio of
approximately 8:1. Urine were also found to contain ZEN (range 5–8 lg/L), as well as both a-ZAL
(Zeranol, range 2–3 lg/L) and b-ZAL (taleranol, range 2–3 lg/L), the two latter in a ratio 1:1. A
completely different picture was found in the urine of Zeranol implanted heifers, with low but
measurable levels of both a-ZAL (Zeranol, range 2–5 lg/L) and b-ZAL (taleranol, range 2–5 lg/L).
Although the ratio between the two epimers was the same as that measured in ZEN exposed animals
(1:1), only traces of a-ZEL and no measurable levels of b-ZEL could be found (Kleinova et al., 2002).
Sheep
• Exposure to ZEN
In vitro experiments revealed that approximately 90% of ZEN was degraded by sheep rumen ﬂuid
to a-ZEL and b-ZEL at similar proportions, whereby protozoa appeared to be more active than bacteria
(Kiessling et al., 1984).
Ovine liver preparations were able to biotransform ZEN to both a- and b-ZEL (EFSA CONTAM Panel,
2011). The a-derivative seemed to prevail over the b-one, especially when NADPH instead of NADH
was used as the cofactor (Olsen and Kiessling, 1983).
A study was conducted on two adult Romney ewes (live weight 30–35 kg) using radiolabelled ZEN.
One ewe received 5 mg 13C-ZEN via the oral route, the other 1 mg 13C-ZEN via the intravenous (i.v.)
route. Based on the results of analytical investigations (GC–MS) performed on urine samples, dosed
sheep were able to biotransform ZEN to a-ZEL, b-ZEL, a-ZAL and b-ZAL both in their free and conjugated
forms (glucuronides and presumably some sulfates); b-ZEL and a-ZEL were the predominating forms
while ZEN, a-ZAL and b-ZAL were less abundant. Interestingly, since the formation of a-ZAL and b-ZAL
was observed also in the intravenously treated animal, the authors conclude that rumen metabolism did
not seem to be a prerequisite for the formation of such metabolites (Miles et al., 1996).
• Exposure to modiﬁed forms
The incubation of either lamb liver microsomal or cytosolic fractions with a-ZAL (Zeranol) resulted in
the NAD+-mediated formation of ZAN and of small amounts of b-ZAL; the latter was almost entirely
due to the NADH-dependent reduction of ZAN (Pompa et al., 1988)
Goats
• Exposure to ZEN
After incubating caprine hepatic cell preparations with ZEN, a-ZEL was proved to be predominantly
formed by the cytosolic and postmitochondrial fractions while b-ZEL turned out to be the main product
of the microsomal fraction (Dong et al., 2010a). Corresponding cell preparations of rumen and
intestinal tissues were also reported to biotransform ZEN mostly to a-ZEL. As expressed per mg
protein, the amount of a-ZEL generated by tissues others than liver was approximately 1/8–1/3
compared to liver preparations. Nevertheless, the contribution of extrahepatic tissues should be
considered as comparable to that of the liver given the large mass of gastrointestinal tissues in
ruminants (Dong et al., 2010a).
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There is no study available about administering ZEN via the oral route. Toxicokinetics of ZEN was
evaluated in male and female Shiba goats aged 2.5–6 years whereby 1.2 mg/kg bw were administered
intravenously. The estimated distribution and terminal elimination half-lives were 3.15 and 28.58 h,
respectively. Analysis of urine revealed the presence of mostly glucuronidated/sulfated ZEN, a-ZEL and
b-ZEL with the latter being the predominant metabolite. Faecal metabolites were largely in the
unconjugated form (Dong et al., 2010b).
• Exposure to modiﬁed forms
No data available.
Pigs
• Exposure to ZEN
Pigs were found to have a ZEN metabolising enteric microbial activity. After incubating ZEN
anaerobically with porcine chyme collected from caecum, colon and rectum, a-ZEL was detected as the
only known metabolite, besides another unknown one. However, in incubations with chyme from
duodenum and jejunum no ZEN metabolites could be detected (Kollarczik et al., 1994).
Several studies have addressed the in vitro metabolic fate of ZEN in cell subfractions, concluding
that the formation of a-ZEL was largely outweighing that of b-ZEL and that glucuronidation was by far
the most common phase II reaction not only in liver but also in extrahepatic tissues (EFSA, 2004; EFSA
CONTAM Panel, 2011, 2016).
In vivo experiments support the in vitro ﬁndings and suggest that the formation of a-ZEL prevails in
pigs. ZEN and b-ZEL are also found in various biological specimens at varying proportions while the
other reductive ZEN-metabolites are of minor importance. The proportions of ZEN, a-ZEL and b-ZEL
were shown to depend on the age of the pigs and the matrix investigated (for review see D€anicke and
Winkler, 2015).
Toxicokinetics of ZEN in pigs was recently reviewed (D€anicke and Winkler, 2015) and is further
elaborated in Table 3.
The terminal elimination half-lives (Table 3) decreased markedly after interrupting the enterohepatic
cycling of ZEN metabolites by various techniques; this provides a rationale for their excretion via the
bile and subsequent reabsorption in the intestine.
Different methods and kinetic models estimated the bioavailability of ZEN for pigs to vary between
80% and 87%. Bioavailability, however, also depends on consideration of the AUCs of the metabolites
generated from ZEN. For example, bioavailability was estimated to be 78% when only ZEN data were
used for calculation but was 87% when a-ZEL was considered additionally (Table 3).
• Exposure to modiﬁed forms
In vitro studies with radiolabelled a-ZAL (Zeranol) showed that both glucuronidated and sulfated
derivatives were formed by pig hepatic subfractions (Bories et al., 1991). The metabolic fate and
disposition of implanted [3H] a-ZAL were studied in one male and one female pig. Results indicate that
a-ZAL is extensively metabolised to ZAN, which, in turn may be reduced to b-ZAL or back to a-ZAL.
Both free and conjugated a-ZAL (Zeranol) and metabolites were excreted via the urinary and the
biliary route, mainly as glucurono-derivatives and were recovered from liver extracts (Bories et al.,
1992).
Excretion kinetics of ZEN (10 lg/kg bw per day), equimolar doses of ZEN14Glc, ZEN16Glc,
ZEN14Sulf administered as an oral bolus was examined in male piglets in a cross-over design (Binder
et al., 2017). None of the three modiﬁed forms was detectable in urine or faeces suggesting a
complete hydrolysis. ZEN and its modiﬁed forms were excreted in faces as ZEN and a-ZEL, while in
urine additionally ZEN-14-glucuronide was detected. The total recoveries with the excreta varied
between 19% and 48% of the administered doses of ZEN and its modiﬁed forms.
Poultry
• Exposure to ZEN and modiﬁed forms
A number of in vitro ﬁndings indicate that, similar to cattle, b-ZEL is produced to a much larger
extent than a-ZEL in liver subfractions from laying hens, with no apparent detection of zearalanols
(Malekinejad et al., 2006; Zinedine et al., 2007). Further in vitro investigations carried out with liver
postmitochondrial fractions from different avian species revealed that at low ZEN concentrations
(16 lM) a relatively higher amount of a-ZEL was generated. A high b-reducing activity was found in
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quails, while guinea-fowls, ducks and chickens were classiﬁed as weak b-reducers and geese as weak
a- and b-reducers (Kolf-Clauw et al., 2008).
The systemic ZEN availability of orally administered ZEN (0.3 mg/kg bw) could not be determined
because ZEN and metabolite levels remained undetectable in blood (Osselaere et al., 2013). The low
ZEN bioavailability is supported by earlier experiments testing biological effects of increasing ZEN
dosages which were administered intramuscularly (i.m.) or orally (p.o.) (Chi et al., 1980a,b). The
weight of the oviduct was enhanced dose-dependently following i.m. administration but inconsistently
and less markedly in response to the p.o. route. The relative oestrogenic effect of i.m. administered
ZEN was determined at 1.37% compared to oestradiol. Based on the published data by Chi et al.
(1980b), the calculated ratio between mean oviduct weights recorded after p.o. or i.m. administration
of 800 mg ZEN/kg bw suggests that approximately 86% of p.o. dosed ZEN was without effect. This
might be a reﬂection of an efﬁcient biliary and/or renal elimination processes.
In a recent study (Devreese et al., 2015), six turkey poults, six broiler chickens and six laying hens
were administered ZEN (3 mg/kg bw) by oral gavage or by the i.v route. Blood samples were taken at
different intervals up to 3 h after dosing and plasma levels of ZEN and its metabolites were
determined by LC–MS/MS. ZEN, as well a- and b-ZELs could be measured in plasma samples and only
traces of zearalanols and ZAN were detected. In all birds, upon oral administration ZEN was rapidly
absorbed, with Tmax and MAT values of ~ 0.30 a.m. and rapidly eliminated as well (T1/2 el of ~ 0.30 a.m.).
The bioavailability was low (up to 10% based on comparison with IV treated animals), pointing to a
low absorption and/or the occurrence of a remarkable pre-systemic metabolism. It is noteworthy that,
turkey poults exhibited high Vd values (10.65  1.05 L/kg) which were about two- and threefold-
higher with respect to broiler chickens and laying hens, respectively, indicating an extensive tissue
distribution. The results of the kinetic studies on plasma a-ZEL/b-ZEL are in line with in vitro studies
indicating the higher production of b-ZEL vs a-ZEL in most avian species but the turkey. After p.o.
administration, turkey poults were more efﬁcient in biotransforming ZEN to a-ZEL, with an a-ZEL/b-ZEL
plasma ratio of 0.749 compared to 0.153 in broiler chickens and 0.027 in laying hens. The lack of
signiﬁcant differences of a-ZEL/b-ZEL plasma ratio between IV treated birds further supports the
occurrence of a notable pre-systemic metabolism in poultry (Devreese et al., 2015). The dietary
administration of 800 mg ZEN/kg to turkey poults for 2 weeks also resulted in the prevalent presence
of a-ZEL in plasma, b-ZEL being barely detectable (Olsen et al., 1986).
Horse
• Exposure to ZEN and modiﬁed forms
In vitro studies performed with primary cultures of equine hepatocytes and liver subfractions
indicate that ZEN is extensively biotransformed to its reduced metabolites, a-ZEL being formed to a
greater extent (two- to threefold) than b-ZEL. Both the parent compound and the main metabolite
(a-ZEL) were entirely glucuronidated at low concentrations, while at higher concentrations ZEN
conjugation was prevailing (Malekinejad, 2013).
A kinetic study was conducted in six fertile Haﬂinger mares (463  36 kg) offered a naturally
contaminated diet containing 10 mg DON/kg and 1 mg ZEN/kg (approximately 0.003 mg/kg bw) for
18 days, starting from the day of ovulation (Songsermsakul et al., 2013). Blood and urine specimens
were collected at days 1 and 10, faecal samples at days 2 and 11. Results revealed a prolonged
absorption, Tmax being reached 8–12 h from the beginning of the administration. At day 10, the main
plasma metabolite was b-ZEL with a ratio a-ZEL/b-ZEL of about 1:20; both ZEN and its metabolites
were nearly 100% present as glucuronides. In the 10-day urine samples, ZEN as well as a-ZEL were
mainly detected, with a a-ZEL/b-ZEL ratio of 1.4:1; lower but measurable amounts of a-ZAL, b-ZAL
and ZAN were also present. A similar excretion pattern was observed in faeces, in which the a-ZEL/b-
ZEL ratio rose to 2:1. In plasma and urine, ZEN and its metabolites were detected nearly 100% as
glucuronides, while the conjugation degree in faeces amounted to only 4–15%. It is concluded that
a-ZEL and b-ZEL are the main ZEN metabolites in horse, the latter being predominantly formed over
a-ZEL under in vivo conditions.
In an in vivo screening, 24 blood samples of a total of 49 blood samples collected from patients
sent to a Horse Clinic for orthopaedic reasons, were positive for ZEN with a median concentration of
0.11 ng/mL (0.02–0.38 ng/mL), 3 samples were positive for a-ZEL with a median of 0.19 ng/mL
(0.14–0.28 ng/mL), and 37 samples were positive for b-ZEL with a median of 1.24 ng/mL
(0.28–7.65 ng/mL). The concentrations of ZAN, a-ZAL and b-ZAL were lower than the corresponding
LOD. b-ZEL was demonstrated as the main ZEN metabolite (Schumann et al., 2016).
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Rabbits
• Exposure to ZEN
In fattening rabbits which were fed diets with increasing concentrations of supplemented ZEN up to
0.297 mg/kg, a dose-dependent increase of total (free plus conjugated) ZEN, a-ZEL and b-ZEL was
detected in colonic chyme, faeces, bile and urine while a-ZAL concentrations were lower than the LODs
of 10–50 ng/g. Neither muscle, liver nor kidneys were detected positive for the analysed ZEN residues
in their total forms (free plus conjugated) (Uebersch€ar, 1999).
• Exposure to modiﬁed forms
The kinetics of a single oral dose of [3H]zeranol (8 mg/kg) was studied in New Zealand rabbits
(Migdalof et al., 1983). The maximum blood radioactivity was reached 8 h after the bolus and
decreased thereafter with a terminal elimination half-life of approximately 26 h. Within 120 h after the
bolus, approximately 65% and 17.1% of the administered radioactivity were recovered in urine and
faeces, respectively.
Fish
• Exposure to ZEN
In vitro studies conducted with rainbow trout liver subfractions point to a predominant production
of b-ZEL vs a-ZEL (Malekinejad et al., 2012).
ZEN and a-ZEL were detected in muscles of carp at mean concentrations of 0.13–0.22 and
0.05–0.16 ng/g dry weight, respectively, 12 h after the last feeding for 4 weeks while ZAN, a-ZAL and
b-ZAL as well as b-ZEL were lower than the LOQs (Pietsch et al., 2015a). Interestingly, residue
concentrations appeared not to be related to the dietary ZEN concentration which increased from the
control diet (no added ZEN), to 0.332, 0.621 and 0.797 mg ZEN/kg diet.
Samples of rainbow trout muscle, liver, intestines and ovaries and of the corresponding system
water and feed were taken from three commercial Polish ﬁsh farms. ZEN was not detected in the
muscle but trace ZEN levels were detected in the liver (< LOD of 2 lg/kg). It is worth to note that the
highest feed concentration of 81.8 lg/kg was associated to the highest ZEN concentration of 7.1 lg/kg
determined in the ovaries (Wozny et al., 2013). However, the HPLC method employed did not include
any ZEN metabolite.
• Exposure to modiﬁed forms
No information on the toxicokinetics of ZEN modiﬁed forms in ﬁsh was identiﬁed.
Farmed mink
No information on the toxicokinetics of ZEN or its modiﬁed forms could be identiﬁed.
Companion animals
• Exposure to ZEN
No studies have been identiﬁed concerning the toxicokinetics of ZEN in cats. Very limited
information is available for dogs. In an experiment involving prepubertal female Beagle dogs receiving
a daily dose 0, 50 or 75 lg ZEN/kg bw for 42 days (Gajezcka et al., 2013), blood samples taken at
weekly intervals revealed the presence of ZEN, a- and b-ZEL throughout the experiment, with a clear
prevalence of the a- over the b-derivative (up to 100%).
• Exposure to modiﬁed forms
There are no studies on the toxicokinetics of ZEN modiﬁed forms in cats.
The kinetics of a single oral dose of [3H] a-ZAL (8 mg/kg) was studied in Beagle dogs (Migdalof
et al., 1983). Radioactivity rapidly increased after bolus administration and reached a maximum
concentration after 4 h from where it declined rapidly and was not detectable after 24 h. Due to a lack
of sufﬁcient data, an estimation of the terminal half-life was not attempted. Approximately 8.2% and
76.1% of the administered radioactivity were recovered with urine and faeces, respectively, within
120 h. Both a-ZAL and ZAN, the main identiﬁed metabolite, underwent glucuronidation. Biliary
excretion was largely predominant over urinary excretion.
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Conclusions
In most species, ZEN is generally well absorbed, but its bioavailability is relatively low due to an
extensive presystemic metabolism which takes place at rumen, enteric, and hepatic level. Reductive
reactions largely predominate. They are mediated by a- and b-HSD, yielding a- and b-ZEL and to a
much lesser extent a- and b-ZAL; the a-derivatives display a remarkably higher oestrogenic potency.
In vitro and in vivo studies have demonstrated wide interspecies differences in the generation of
a- and b-derivatives, which have been correlated with the species-mediated sensitivity to the
mycotoxin. The extensive rumen and/or enteric metabolism underwent by ZEN largely accounts for the
discrepancies observed in some species (e.g. poultry, goats, horses) between the results from in vitro
investigations and those derived from in vivo studies. Based on the levels measured in biological ﬂuids
(plasma, urine, or bile) of ZEN treated animals, the a-derivatives seem to prevail in pigs, dogs, and
turkeys while the b-derivatives appear to be more abundant in cattle, goats, horses, broiler chickens,
and laying hens. Other minor metabolic routes for ZEN include cytochrome P450 (CYP)-mediated
aromatic and aliphatic hydroxylation, although data concerning the occurrence of hydroxylated
derivatives in organs or biological ﬂuids from the examined species could not be identiﬁed.
Little is known about the metabolic fate of modiﬁed forms, except for a-ZAL, which is used as
growth-promoter in non-EU countries under the name of Zeranol. In all species, a-ZAL is oxidised to
ZAN and isomerised to b-ZAL; the parent compound and the metabolites are mainly glucuronidated.
Reduced metabolites but also ZEN and ZAN are subjected to glucuronidation and, to a lesser
extent, sulfation. In most species the resulting conjugates are mainly excreted via the biliary route. An
active enterohepatic circulation is reported particularly in the pig, thereby prolonging the persistence of
ZEN and its metabolites in the body. Scant information is available about ZEN toxicokinetics in ﬁsh and
dogs and no information is available for cats and farmed mink.
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Table 3: Parameters of toxicokinetics of ZEN in various species
Species/
category
Dose
(mg/kg bw)
Toxin
source
Route of
administration
tmax
(h)
t1/2 el
(h)
Bio-
availability
(%)(a)
Analytes
considered for
evaluation
Experimental
disruption of
enterohepatic
cycling
Reference
Pig 5 [3H]ZEN i.v. 86.6 Total ZENs No Biehl et al. (1993)
10 [3H]ZEN p.o. 2–3 86.6 80–85(b) Total ZENs No
5 [3H]ZEN i.v. 3.34 Total ZENs Yes
0.079 ZEN p.o. 0.5 ZEN No Olsen et al. (1985))
4.5 a-ZEL
1 ZEN i.v. 2.63 ZEN No D€anicke et al. (2005a)
2.94 a-ZEL
1 ZEN i.v. 1.1 ZEN Yes
3.04 a-ZEL
1 ZEN p.o. 0.7 5.3 78 ZEN No D€anicke and Winkler (2015)
2.7 4.37 a-ZEL
87 ZEN+ a-ZEL
Broiler 5 [3H]ZEN p.o. 4–8 89 Total ZENs No Mirocha et al. (1982)
0.3 ZEN i.v. 0.52 ZEN No Osselaere et al. (2013)
3 ZEN i.v. 0.29 ZEN No Devreese et al. (2015)
3 ZEN p.o. 0.35 0.34 8.34 ZEN No
3 ZEN i.v. 0.03 a-ZEL No
3 ZEN p.o. 0.63 a-ZEL No
3 ZEN i.v. 0.07 b-ZEL No
3 ZEN p.o. 0.61 b-ZEL No
Laying hen 10 [14C]ZEN p.o. 2–4 Total ZENs No Dailey et al. (1980)
3 ZEN i.v. 0.46 ZEN No Devreese et al. (2015)
3 ZEN p.o. 0.32 0.36 10.28 ZEN No
3 ZEN i.v. 0.03 a-ZEL No
3 ZEN p.o. 0.27 a-ZEL No
3 ZEN i.v. 0.03 b-ZEL No
3 ZEN p.o. 0.42 b-ZEL No
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Species/
category
Dose
(mg/kg bw)
Toxin
source
Route of
administration
tmax
(h)
t1/2 el
(h)
Bio-
availability
(%)(a)
Analytes
considered for
evaluation
Experimental
disruption of
enterohepatic
cycling
Reference
Turkey 3 ZEN i.v. 0.38 ZEN No Devreese et al. (2015)
3 ZEN p.o. 0.97 0.35 6.87 ZEN No
3 ZEN i.v. a-ZEL No
3 ZEN p.o. a-ZEL No
3 ZEN i.v. b-ZEL No
3 ZEN p.o. b-ZEL No
Cow ~ 3.4 ZEN p.o. 12 ZEN No Prelusky et al. (1990)
~ 11.3 ZEN p.o. 12 ZEN No
Goat 1.2 ZEN i.v. 28.58 Total ZENs No Dong et al. (2010a,b)
Horse ~ 0.003 ZEN p.o. 8–12 ZEN No Songsermsakul et al. (2013)
Rat 1 ZEN i.v. 0.6 ZEN No Shin et al. (2009)
2 ZEN i.v. 1.9 ZEN No
4 ZEN i.v. 1.8 ZEN No
8 ZEN i.v. 2.8 ZEN No
8 ZEN p.o. 16.8 2.7 ZEN No
8 ZEN p.o. 7.0 1.1 ZEN Yes
bw: body weight; i.v.: intravenous; p.o.: per os; tmax: time at maximum plasma/serum concentration; t1/2 el: plasma/serum elimination half-life; ZEN: zearalenone; ZEL: zearalenol.
Note: reported terminal plasma/serum elimination half-lives (t1/2 el) might depend on models used for evaluation of the kinetics.
(a): Based on area under the curve (AUC) method.
(b): Based on comparisons of cumulative faecal and urinary excretions after i.v. and p.o. ZEN administration.
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3.1.1.6. Transfer into feed from animal origin
Transfer of ZEN and its modiﬁed forms from feed to animal tissues which is subsequently used as
animal feed, needs to be considered both from a quantitative and a qualitative (types of metabolites
transferred to animal tissue) point of view. A quantitative evaluation is possible by calculating transfer
or carry-over factors as the ratio between the concentrations of ZEN and its modiﬁed forms in animal
tissue and in feed. A recent review suggested that ZEN, a-ZEL and b-ZEL accounted for the majority of
total ZEN residues in farm animals (D€anicke and Winkler, 2015). Moreover, it seems that ZEN and
a-ZEL are the main metabolites in pigs and poultry while b-ZEL contributed signiﬁcantly to the total
residue levels in bovine tissues, including milk. The calculated transfer factors varied from 0.004 to
0.295 in livers from various animal species, from 0.008 to 0.05 in bovine milk, from 0 to 0.021 in
porcine muscle and up to 0.0007 in kidneys of turkey. Adipose tissue from various animal species and
eggs were virtually free from toxin residues after experimental oral exposure to ZEN (D€anicke and
Winkler, 2015). It becomes generally clear from experimental data that the ZEN metabolite pattern in
animal tissues is different from that usually found in plant derived feedstuffs (see Section 3.2). Survey
data on the occurrence of modiﬁed ZEN forms in market-collected foodstuffs of animal origin
principally support the experimental ﬁndings.
The occurrence of ZEN was reported up to 12.5 lg/kg in cow’s milk from Egypt, USA, UK, and
China (Flores-Flores et al., 2015). Lower amount of ZAN (up to 0.37 lg/L), a-ZAL (3.03 lg/L), and
a-ZEL (0.073 lg/kg) were reported in cow’s milk samples collected in China as well (Xia et al., 2009;
Huang et al., 2014).
The co-occurrence of ZEN and its modiﬁed forms a- and b-ZEL in cow’s milk production was
reported by Meucci et al. (2011). Target compounds were found in a range of 0.01–0.04 lg/L for ZEN,
0.15–0.76 lg/L for a-ZEL, and 3.5–10.8 lg/L for b-ZEL. The same authors reported the (co)occurrence
of ZEN and a- and b-ZEL in meat-based products (n = 44) as well. Products based on calf, rabbit,
horse, lamb, turkey, ham, and chicken were considered.
Although the food commodities were intended for human consumption the residues reported give
indication which patterns of ZEN and modiﬁed forms could be expected in the feedstuffs of animal
origin. While ZEN, b-ZEL and b-ZAL were not detected, a-ZEL was found in 27% of the samples, with
a mean concentration ranging between 1.1 and 8.5 lg/kg and a maximum concentration of 30.5 lg/kg
in calf meat. The authors reported the occurrence of a-ZAL in one sample, at a concentration of
950 lg/kg (Meucci et al., 2011).
In summary, the occurrence of ZEN and its modiﬁed forms in food and feed from animal origin is
poorly addressed in the literature, with few tissue-speciﬁc information from ﬁeld studies. However,
data obtained from the literature are in agreement with those received by EFSA and used for
calculating the exposure. Although distribution would suggest that conjugated forms are present in the
tissues, the CONTAM Panel did not identify additional information on the occurrence of conjugated
forms of ZEN in products of animal origin.
Conclusions
Taken together, the experimental data on the transfer of ZEN from contaminated feedstuffs into
animal tissues suggest that animal derived feedstuffs are unlikely to contribute quantitatively to the
exposure of animals to zearalenone and its modiﬁed forms.
However, in contrast to feedstuffs of plant origin the pattern of modiﬁed ZEN forms in feedstuffs of
animal origin includes especially a-ZEL and b-ZEL besides ZEN. In evaluating the risk, the higher
proportions of the oestrogenic more potent a-ZEL and the target animal species fed with higher
proportions of feedstuffs of animal origin, such as dogs and cats, ﬁsh and farmed mink need to be
considered.
3.1.2. Mode of action
The mode of action of ZEN has been recently reviewed by the CONTAM Panel (EFSA, 2004; EFSA
CONTAM Panel 2011, 2016).
3.1.2.1. Oestrogenic activity
The dominating biological activity of ZEN is its oestrogenic activity, i.e. the ability to act like the
endogenous steroidal sex hormone 17 b-oestradiol (E2). Indeed, numerous in vivo and in vitro studies
have indicated that ZEN binds to ERs, generating an oestrogen-like response (EFSA, 2004; EFSA
CONTAM Panel 2011, 2016). Zebraﬁsh was also used as a model ﬁsh species to investigate the
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oestrogenic effect of ZEN and its modiﬁed forms (Chen et al., 2010; Johns et al., 2011; Schwartz
et al., 2013).
ZEN passively crosses the cell membrane and binds to oestrogenic receptors (ERs). The receptor-
zearalenone complex is rapidly transferred to the nucleus, where it binds to oestrogen-responsive
elements, thereby activating gene transcription (EFSA, 2004). Two subtypes of ERs, i.e. ER-a and ER-
b, are known to be expressed in mammalian tissues. ER- a is commonly assumed to be the dominant
ER in the uterus. ER-a and ER-b exhibit different binding afﬁnities for oestrogenic compounds (EFSA
CONTAM Panel, 2016). Generally, ZEN has a stronger afﬁnity to ER-a than to ER-b (EFSA CONTAM
Panel, 2011).
Besides its binding to ERs, the endocrine effects of ZEN involve other mechanisms. Indeed, ZEN
and its reduced metabolites are competitive substrates for 3a -HSD and 3b -HSD, two enzymes
involved in the synthesis of steroids (Fink-Gremmels and Malekinejad, 2007).
A landmark effect of oestrogenic compounds is the induction of uterine growth in immature or
ovariectomised female animals; the ‘uterotrophic activity’ is a common in vivo assay using mice or rats
which measures the increase in wet weight of the uterus (Thigpen et al., 1987). ZEN and its modiﬁed
forms differ considerably in their oestrogenic activity (EFSA CONTAM Panel, 2016). Based on their
‘uterotrophic activity’ assessed in rodents, ZEN and its modiﬁed forms are classiﬁed as follows
a-ZEL > a-ZAL > ZEN  ZAN  b-ZAL > b-ZEL (EFSA CONTAM Panel, 2016).
Relative binding afﬁnity of ZEN and its modiﬁed form, especially a-ZEL, to ERs varied for different
species (for example, pig > rat > chicken – see Metzler et al., 2010). Moreover, the expression levels of
the two ER types differ between species. However, in most ER-binding assays using cytosolic ER, the
proportion of ER-a and ER-b is not known.
3.1.2.2. Effects on transcription factors other than ER
ZEN can activate the pregnane X receptor (PXR), a human xenobiotic receptor member of ligand
activated nuclear transcription factors (Ding et al., 2006). ZEN activates PXR) by displacing its
co-repressor N-CoR and by recruiting the co-activators SRC-1, PBP and GRIP1. PXR regulates the
expression of various genes involved in the metabolism of endobiotics and xenobiotics, such as the
CYP3A4, the major human CYP. PXR is also involved in the transcriptional regulation of glutathione-S-
transferases, sulfotransferases and UDP glucuronosyl transferases as well as organic anion transporters
and ATP-binding cassette (ABC) efﬂux transporters (reviewed in EFSA CONTAM Panel, 2011). In primary
cultures of human hepatocytes, ZEN at concentrations as low as 0.1 lM, activates, in addition to PXR,
constitutive androstane receptor (CAR) and aryl hydrocarbon receptor (AhR) mRNA levels. Some of the
phase I target genes are also activated, mainly CYP3A4, CYP2B6 and CYP1A1 and to a lesser extent
CYP3A5 and CYP2C9 (Fink-Gremmels and Malekinejad, 2007; EFSA CONTAM Panel, 2011).
The interaction of ZEN and its modiﬁed forms, with the human androgen receptor (hAR) was also
studied (Molina-Molina et al., 2014). Their ability to antagonise hAR-mediated reporter gene expression
elicited by a model synthetic androgen (R1881) was examined in androgen-sensitive PALM cells. The
study demonstrates that ZEN and its modiﬁed forms possess hAR-mediated antagonistic activity in
PALM cells, in which ZAN, a-ZAL, and b-ZAL were the most effective hAR antagonists.
The genotoxicity of ZEN was evaluated by EFSA (EFSA CONTAM Panel, 2011, 2016). ZEN was
negative in bacterial mutation studies; it was found clastogenic and aneugenic in a variety of cell
culture systems as well as in vivo (EFSA CONTAM Panel, 2011, 2016).
3.1.2.3. Effect of ZEN and modiﬁed forms on proliferation and apoptosis
ZEN caused a concentration-dependent, proliferation-stimulating effect on T47D and MCF-7 cell
lines similar to that elicited by natural oestrogen compounds. This pro-proliferative effect was
associated with the presence ERs. Of note, while lower concentrations of ZEN induce proliferation,
higher concentrations triggered a decrease in cell viability (Kowalska et al., 2016). It has been
proposed that a-ZAL promotes breast cancer cell growth by stimulating aromatase activation and
increasing oestrogen biosynthesis in adipose tissue. Indeed, 2–50 nM a-ZAL (Zeranol) was able to
signiﬁcantly increased aromatase activity, aromatase mRNA expression and oestrogen production in
primary cultured human breast preadipocytes (Zhong et al., 2016). The ability of ZEN to stimulate cell
proliferation has been documented by its ability to activate cyclin-dependent kinases in MCF-7 cells.
ZEN increases the cyclin D1 protein levels and activates cyclin-dependent kinase (Cdk)-2 resulting in
the hyperphosphorylation of retinoblastoma gene product. This activation of Cdk-2 also leads to an
increased rate of G1 to S phase transitions and mitosis (Fink-Gremmels, 2008b).
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ZEN has been shown to induce apoptosis in leukemic cell lines and PBMC via modulation of pro-
and anti-apoptotic proteins Bax and Bcl-2, as well as changes in the mitochondrial potential and
induction of cytochrome C release (Banjerdpongchai et al., 2010). In addition ZEN was able to activate
both the extrinsic and intrinsic apoptotic pathways in primary rat Sertoli cells (Xu et al., 2016).
3.1.3. Adverse effects in livestock, ﬁsh, horses and companion animals
Generally, there are three types of studies which might be used for evaluation of effects of ZEN and
modiﬁed forms on animals:
• controlled experiments using pure ZEN and its modiﬁed forms
• controlled feeding experiments with naturally contaminated feedstuffs and feed contaminated
with fungal material
• ﬁeld studies and epidemiological observations
Controlled experiments using pure ZEN and modiﬁed forms added to feed with zero- or low levels
of natural contamination of ZEN and other oestrogenic compounds are the most appropriate way for
toxicity testing. However, adding the toxins to the diet might bear the disadvantage that the
toxicokinetics and bioavailability might differ from that of naturally contaminated feedstuffs due to
varying forms of binding to the feed matrix.
Controlled feeding experiments with naturally contaminated feedstuffs have the advantage that the
effects of ZEN and modiﬁed forms can be determined more according to practical conditions, although
the inﬂuence of co-occurring mycotoxins (e.g. DON) cannot be excluded.
Field studies are usually poorly controllable but might provide information on a larger number of
animals suspected to be exposed to ZEN and modiﬁed forms. However, as oestrogenic effects might
be induced by other oestrogen-like substances such as phytoestrogens and xenoestrogens, ﬁeld
studies need to be evaluated carefully, especially with regard to the extent of differential diagnosis.
Many of these studies were already reported in the previous EFSA opinion related to the presence of
ZEN in feed (EFSA, 2004) and are not addressed in the present section. However, some of these ﬁeld
studies are considered relevant to other sections of the present opinion (e.g. Section 3.1.1
Toxicokinetics).
All types of studies were regarded in earlier evaluations on the effects of ZEN on farm animals by
EFSA (EFSA, 2004; EFSA CONTAM Panel 2011, 2014, 2016), FAO/WHO (2000), the SCF (2000) and
other reviews (Seeling and D€anicke, 2005; Zinedine et al., 2007; Fink-Gremmels, 2008a). The current
TDI for humans is actually based on oestrogenic effects in pig (EFSA CONTAM Panel, 2011, 2016).
The EFSA (2004) opinion did not set NOAELs or LOAELs for pigs and other livestock due to
limitations in the availability, reliability and consistency of the data available at that time. The present
assessment takes account of all the evidence available to the CONTAM Panel, and considers the issues
of reliability and consistency as part of the uncertainty.
3.1.3.1. Adverse effects in livestock – evaluation of different types of studies
Ruminants
Cattle
• Zearalenone
a) Controlled experiments using pure ZEN
Only two experiments were performed using pure ZEN in cattle. These studies were evaluated by
EFSA in the opinion on ZEN as an undesiderable substance in animal feed (EFSA, 2004). Brieﬂy, the ﬁrst
one involved the oral administration only of a relatively high ZEN dose to virgin heifers (250 mg puriﬁed
ZEN per head corresponding to a mean exposure of 1,456 lg/kg bw per days for 66 days) and resulted in
a slightly decreased conception rate (62% compared to 87% found in the untreated control group)
(Weaver et al., 1986a). Another experiment performed by these authors with cows revealed no adverse
effects on progesterone levels after oral treatment with daily ZEN doses of 31.25, 62.5, 125.0, 250.0, and
500.0 mg ZEN/cow corresponding to calculated exposures of 48, 96, 192, 385 and 769 lg/kg bw per day
and associated dietary concentrations of 1.4, 2.8, 5.7, 11.4 and 22.7 mg/kg for an observation period of
two oestrus cycles. However, upon clinical examinations corpora lutea appeared to be smaller (neither
actual measurements nor statistics were reported) in all groups treated with ZEN independent of dose
(Weaver et al., 1986b). Based on the available information, no NOAEL/LOAEL could be derived.
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b) Controlled feeding experiments with naturally contaminated feedstuffs and feed contaminated
with fungal material
Studies with heifers on the effects of feeding ZEN contaminated oats (1.25 mg ZEN/kg feed) were
evaluated by EFSA (2004). These experiments revealed no relevant effects on oestrus cycle or
histology of reproductive organs.
Feeding and balance experiments with dairy cows revealed no overt signs of hyperoestrogenism or
reproductive disorders when naturally contaminated cereals were used as ZEN vehicles. In these
experiments, the diets contained ZEN concentrations of 0.055 mg/kg (Seeling and D€anicke, 2005;
Seeling et al., 2005), 0.02–0.58 mg/kg (Winkler et al., 2014), 0.062–0.099 mg/kg (Keese et al., 2008a,b)
at a DM content of 88%.
• Modiﬁed forms
No data on the adverse effects of ZEN modiﬁed forms suitable to derive effect levels to characterise
the hazard in cattle were identiﬁed.
Sheep
• Zearalenone
Sensitivity of sheep to ZEN has previously been evaluated by FAO/WHO (2000) and EFSA (2004).
Based on the experiments by Smith et al. (1990), signiﬁcant linear dose–response relationships -
covering daily doses of 1.5, 3, 6, 12 and 24 mg/ewe equivalent to calculated exposures of 28, 56, 111,
224 and 444 lg/kg bw per day and dietary concentrations of 0.8, 1.6, 3.2, 6.4 and 12.6 mg/kg - were
described for a number of reproductive traits such as cycle length, duration of oestrus, number of
ovulations per ewe, as well as ovary and uterus weight. Based on the deviation from the normal
duration of the cycle length, a LOAEL of 56 lg ZEN /kg bw per day was identiﬁed while the NOAEL
corresponded to an exposure of 28 lg ZEN/kg bw per day.
• Modiﬁed forms
No data on the adverse effects of ZEN modiﬁed forms in sheep were identiﬁed.
Goat
• Zearalenone
No data concerning oral exposure to ZEN were identiﬁed. Intravenous application of a single ZEN
bolus of 2.4 mg/kg bw resulted in hepatocyte swelling and lymphocytic inﬁltration of the liver, the
kidney pelvic and of the endometrium 48 h post injection (Dong et al., 2010a,b). No lesions were
found in the gastrointestinal tract and the ovaries. From this experiment no critical effect levels can be
derived.
• Modiﬁed forms
No data on the adverse effects of ZEN modiﬁed forms in goat were identiﬁed.
Conclusion on ruminants
In sheep, based on the depressed ovulation rates and lower lambing percentages a LOAEL of 56 lg/kg
bw per day was identiﬁed while the NOAEL corresponded to an exposure of 28 lg/kg bw per day. These
exposure levels corresponded to dietary ZEN concentrations of 3 and 1.5 mg/kg feed, respectively.
Data suitable to derive reference points for risk characterisation for goats could not be identiﬁed
from the literature.
When exposed to ZEN, cattle appear quite resistant but neither a LOAEL nor a NOAEL could be
derived. The only one available dose–response experiment in dairy cows orally exposed to pure ZEN
for which a reduction in the size of corpora lutea was claimed but no effects level could be identiﬁed,
was too limited to identify adverse effects. Similar limitations were identiﬁed in a study on heifers at
relatively high exposure level where the conception rate tended to be decreased.
No data were available for evaluating dose related effects of ZEN modiﬁed forms in ruminant
species.
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Pigs
Zearalenone
EFSA evaluated ZEN in feed in 2004 and concluded that female pigs were the most sensitive
animals, but that the hormonal effects varied with age groups and cycling (EFSA, 2004). Furthermore,
EFSA stated that there was a large variation in the outcome from trials with pigs, that seemed to be
related to the use of naturally contaminated feed versus pure toxin and that a reference point of
hazard characterisation of ZEN in pig feed could not be established.
In 2011, the CONTAM Panel concluded that ovaries, vulva and uterus were the most sensitive
tissues, and that the LOAEL in these tissues in mature and immature gilts ranged from 17 to 200 lg/kg
bw per day, with the overall NOEL from relevant pig studies being 10.4 lg/kg bw per day (EFSA
CONTAM Panel, 2011).
EFSA also reviewed several studies on pigs and gilts exposed to ZEN in 2016 (EFSA CONTAM Panel,
2016), including prepubertal gilts (Teixeira et al., 2011; Gajezcka et al., 2012; Jiang et al., 2012; Oliver
et al., 2012; Schoevers et al., 2012; Chen et al., 2015a,b; Gonkowski et al., 2015; Jakimiuk et al.,
2015; Obremski and Poniatowska-Broniek, 2015; Obremski et al., 2015a,b; Pistol et al., 2015). The
CONTAM Panel concluded that the observed minor alterations in intestinal lymphoid tissue at doses
below the NOEL (10.4 lg/kg bw per day) used to derive the TDI of 0.25 lg/kg bw per day (EFSA
CONTAM Panel, 2011) were without evidence of adversity. Furthermore, only one dose was used in
these studies and no dose-effect relations could be established (EFSA CONTAM Panel, 2016).
a) Controlled experiments using pure ZEN
The pivotal study in the SCF evaluation (SCF, 2000) a was a study where sexually mature gilts were
given 0, 1, 5 or 10 mg ZEN/kg feed on days 5 to 20 of oestrus, corresponding to 0, 40, 200 or
400 lg/kg bw per day (Edwards et al., 1987a). The feeding was performed in summer and winter but,
since there were no differences between the seasons, the results were pooled to give 24–25 animals/
dose. The inter-oestrus interval increased from 21.0  0.3 days to 29.2  2.9 days in the medium-
dose group and 32.7  3.3 days in the high-dose group. Increased plasma concentrations of
progesterone and prolonged maintenance of corpora lutea was also observed in pigs with a prolonged
interoestrus interval. No effect on any parameter was observed in pigs given the lowest dose of 40 lg /kg
bw per day and this was used as a NOAEL in the risk assessment by the SCF.
In their risk assessment of ZEN in food in 2011, EFSA reviewed feeding studies of the effects of
ZEN in pigs published since the opinion of ZEN in feed from 2004. The review included several feeding
studies where pure ZEN was given to female prepubertal pigs, of which several reported effects on
uterus and ovaries at levels similar to what was reported in mature gilts by Edwards et al. (1987a)
(Obremski et al., 2003; Wasowicz et al., 2005; Zwierzchowski et al., 2005; Jakimiuk et al., 2010a,b).
The pivotal study in this assessment was, however, a study based on naturally infected maize (D€oll
et al., 2003, see below section b).
Male piglets (n = 3) were given 50 lg pure ZEN/kg bw per day in the diet for 22 days (Jiang et al.,
2012). ZEN led to decreased relative weights of testes compared with controls, but the size of the
testes was unchanged. Serum levels of progesterone and testosterone were lower in piglets given ZEN
compared to controls and the authors concluded that this exposure induced reproductive toxicity in
male piglets.
Gajezcka et al. (2016)conducted a controlled experiment where a group of pre-pubertal female gilts
(from 25 kg) were given either a daily oral dose corresponding to 40 lg/kg bw) or a control diet
(n = 21) for 42 days in form of water-soluble capsules every morning. Blood samples were taken
weekly during the exposure period. Small, but statistically signiﬁcant changes were observed in
biochemical and haematological parameters, but none of the differences between the exposed and
controls animals were consistent over the feeding period. The weight gain was signiﬁcantly higher in
the control group than in the ZEN group after 1 and 4 weeks of exposure, while after 6 weeks, the
weight gain was signiﬁcantly higher in the ZEN group compared to controls. There were no signiﬁcant
differences in weight gain after 2, 3 and 5 weeks of exposure. The authors claim that a stimulating
effect of ZEN on the metabolism in the beginning of the exposure period is eliminated due to
compensatory and adaptive mechanisms later on.
The same protocol was used for prepubertal gilts (n = 18/group) (Lewczuk et al., 2016). The pigs
were euthanised after exposure for 1, 2, 3, 4, 5 or 6 weeks. ZEN did not alter the architecture of the
mucosa layer or the ratio between goblet cells and adsorptive cells in the epithelium of the duodenum,
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but it did increase the quantity of lymphocytes, plasma cells and macrophages with black brown
granules in the lamina propria.
Using again this study protocol, the same research group investigated the effects of ZEN on the
jejunum (Przybylska-Gornowicz et al., 2015) in pigs. The microscopic examinations revealed an
increased number of goblet cells and lymphocyte number in the villi after one week, but not at other
time points. The number of plasma cells in the lamina propria was increased after 1, 3 and 6 weeks of
exposure, but not after 2 and 4. No effects were observed in pigs given ZEN in mucosal thickness,
crypt depth, ultrastructure of the mucosal epithelium, lamina propria or intestinal barrier permeability.
Piglets weaned at an age of 28 days with an average body weight of 8.74 kg were fed a ZEN
supplemented diet (1.04 mg ZEN/kg diet, approximately 70 lg ZEN/kg bw per day) for 35 days
(corresponding to approximately 70 lg/kg bw per day) and investigated for protein and mRNA
expression of ghrelin and proliferating cell nuclear antigen (PCNA) in the ovaries (Dai et al., 2016).
Results revealed that ZEN exposure could promote the autocrine action or expression of the ghrelin
gene and additionally accelerate the development of follicles.
Twelve ﬁstulated barrows with an initial mean body weight of 20.6 kg/bw were given 10 mg ZEN or
DON /kg feed in a latin square design with three diets and 2 periods of 5-day adaptation and a 3-day
sampling period. ZEN reduced the apparent ileal digestibility of tryptophan from 0.840 to 0.771
(p = 0.04), while the digestibility of proteins or other amino acids were not affected (Jo et al., 2016).
An oral dose of 40 lg ZEN/kg bw per day pure ZEN (purity not speciﬁed) administered for 6 weeks
had no signiﬁcant effect on the composition of peripheral blood lymphocytes in gilts (mean body
weight of 25 kg bw at the start of the experiment. See Dazbrowski et al., 2016).
b) Controlled feeding experiments with naturally contaminated feedstuffs and feed contaminated
with fungal material
In the human risk assessment of ZEN in food in 2011, EFSA CONTAM Panel reviewed feeding
studies of the effects of ZEN in pigs. The review included feeding studies where naturally infected
maize containing ZEN was mixed into the feed and given to female pigs (e.g. Alm et al., 2006). The
key study in the assessment was the study of D€oll et al. (2003) where female piglets were given feed
containing 0.01, 0.06, 0.15, 0.22 or 0.42 mg ZEN/kg feed prepared by mixing naturally contaminated
maize into the feed, corresponding to 0.5, 3.0, 7.4, 10.4 or 17.6 lg/kg bw per day, for 5 weeks
(n = 20/dose). The feed also contained 0.2–3.9 mg DON/kg feed, corresponding to 9.8–163.5 lg/kg
bw per day. The ZEN treatment resulted in increased weights of uteri and a dose-related increase in
the number of piglets with a red and swollen vulva and cervix. The increase was statistical signiﬁcant
from controls only at the highest dose. Both the authors and EFSA examined the reported effects and
attributed the typical oestrogenic effects to ZEN, based on existing knowledge on clinical effects and
mechanisms of action. EFSA also concluded that since feed intake and body weight gain were not
affected at these levels, the oestrogenic effects were probably not inﬂuenced by the presence of DON
in the feed (EFSA CONTAM Panel, 2011). From this study, EFSA established a NOEL of 10.4 lg ZEN/kg
bw per day which was used to derive a TDI for human chronic exposure. EFSA also stated that even if
this was a NOEL rather than a NOAEL since it is not known whether these alterations would affect the
fertility and reproductive performance later in life, the effects are undesirable and are relevant for a
risk assessment.
In Kong et al. (2015), gilts were fed with a feed containing graded levels of Fusarium-infected
barley for 2 weeks. The feed contained DON at 0.6 (control) – 14.6 mg DON/kg and below the
LOD–33.7 lg ZEN/kg. All effects were typical of DON, like reduced feed intake and weight gain and no
typical hormonal effects were observed.
Adverse effects in the male reproductive tract and its functioning have been recorded at
concentrations exceeding 20 mg ZEN/kg bw (Review in Diekman and Green, 1992; EFSA CONTAM
Panel, 2011, 2016). No effect on the male reproductive system was found when six sexually mature
boars were fed a naturally contaminated feed containing 1 mg ZEN/kg of feed (Sutkeviciene et al.,
2009). Based on these ﬁndings, the CONTAM Panel concluded that ZEN has been found to have
adverse effects on male reproduction but at levels far above the levels affecting females (EFSA
CONTAM Panel, 2011).
Time-dependent oestrogenic effects were reported for female rearing piglets fed diets prepared by
mixing naturally Fusarium-contaminated maize into the feed (Rempe et al., 2013b). The ﬁnal feed
contained 0.01, 0.05, 0.08, 0.17 and 0.29 mg ZEN/kg feed, and 0.03, 0.59, 1.27, 2.01 and 4.52 mg
DON/kg feed, respectively. Histological examination of the ovaries did not indicate differences in the
distribution of follicle stages between the control and highest exposed group.
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In a second feeding experiment, two groups of female rearing piglets were given a feed containing
0.03 mg of ZEN and 0.43 mg DON per kg feed or a feed containing 0.32 mg ZEN and 3.67 mg DON
per/kg feed for 4 weeks (Rempe et al., 2013a). The uterus weight and vulva width in female rearing
piglets increased slightly (p > 0.050 and p = 0.058, respectively). Signiﬁcant effects on typical DON-
related parameters like feed intake and growth were reported from the study, but there were no
statistical signiﬁcant alterations on oestrogenic effects or other effects that can be attributed to
zearalenone.
• Modiﬁed forms
Zeranol implants (36 mg) applied to peripubertal gilts (171 days of age, 109 kg) did not increase
the proportion of gilts available for breeding (treated, 21/39; control, 18/40) as checked daily with a
mature boar on days 3–58 of the experiment (Trout et al., 2007). The gilts detected in oestrus were
inseminated twice 24 h apart with pooled semen. Gilts were slaughtered on days 58–62 of gestation.
Of the gilts inseminated on days 44–58, 16/21 treated gilts and 16/18 control gilts were pregnant.
Number of fetuses (7.5 vs 12), fetal weight (83 vs 121 g), fetal length (117 vs 132 mm) and fetal
survival (45% vs 78%) were reduced (p < 0.001) by Zeranol implants. The authors concluded that the
implant did not increase the proportion of gilts available for breeding but was toxic to the fetuses.
Conclusion on pigs
The pivotal study when EFSA derived a human TDI in 2011 was a feeding study by D€oll et al.
(2003) where female prepubertal piglets were exposed to 0.01–0.42 mg ZEN/kg feed f (0.5, 3.0, 7.4,
10.4 and 17.6 lg ZEN/kg bw per day) rom naturally contaminated maize. No effects were observed in
pigs given 10.4 lg ZEN/kg bw per day (NOEL), while oestrogenic effects like increased uterus weight
and reddened and swollen vulva were observed in pigs given 17.6 lg ZEN/kg bw (LOEL). Several other
papers, including papers not reviewed in previous EFSA opinions, have reported oestrogenic effects at
similar exposure levels of 20 lg/kg bw per day (Gajezcka et al., 2012, 2016; Rempe et al., 2013a,b;
Jakimiuk et al., 2015; Przybylska-Gornowicz et al., 2015; Lewczuk et al., 2016). A review of the
reported effect levels and no-effect levels indicate that young and developing gilts (until ﬁrst cycling)
are most vulnerable to ZEN, as indicated by studies ﬁnding effects from 17.6 lg/kg bw per day for
female piglets. These effects were not regarded as adverse by EFSA since it was not known whether
the observed alterations would have any impact on the reproduction later. However, the alterations
were still regarded as undesirable and were the critical effects in the derivation of a human TDI (EFSA
CONTAM Panel, 2011). The CONTAM Panel considers these alterations as relevant for the derivation of
a reference point for pigs.
For sexually mature female pigs, the prolonged cycling was reported for cycling sows from 200 lg/
kg bw per day, with no effect at 40 lg/kg bw per day (Edwards et al., 1987a), which is the lowest
reported NOAEL for mature female pigs.
The database for boars is limited. Precocious spermatogenesis, damage to the germinal epithelium
and interstitial cell hyperplasia were reported from young boars given feed containing 30 mg ZEN/kg,
corresponding to 1.2 mg/kg bw per day in the study, for varying time periods (Vanyi and Szeky, 1980)
and reduced serum concentrations of progesterone and testosterone was observed in male piglets
given 50 lg ZEN/kg bw per day for 22 days (Jiang et al., 2012).
Poultry
• Zearalenone
EFSA (2004) evaluated feeding experiments with poultry and concluded that poultry species can be
regarded as quite tolerant because ZEN effects are observed only at exposure levels hardly to occur
under practical feeding conditions.
a) Controlled experiments using pure ZEN
Dietary concentrations of 800 mg ZEN/kg diet fed to broilers for 6–9 weeks of life failed to evoke
negative effects (Allen et al., 1981). JECFA concluded from this experiment the NOEL to be higher than
59 mg/kg bw per day. Weight gain, feed consumption, feed to gain ratio, weights of liver, heart,
spleen, testicles, oviduct, comb, and bursa of Fabricius, haematocrit, haemoglobin, erythrocytes, and
serum concentrations of calcium, phosphorus, total protein, alkaline phosphatase, and cholesterol
remained unaltered in growing broiler chickens fed diets with 10, 25, 50, 100, 200, 400 and 800 mg
ZEN/kg diet corresponding to calculated exposures of 1,500, 3,750, 7,500, 15,000, 3,0000, 60,000 and
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120,000 lg ZEN/kg bw per day (Chi et al., 1980a), respectively. Lymphocyte count was the only
endpoint signiﬁcantly inﬂuenced by increasing dietary ZEN concentrations irrespective of sex. For this
endpoint a calculated LOAEL of 30,000 lg/kg bw per day and a NOAEL of 7,500 lg/kg bw per day,
corresponding to estimated exposure levels of 200 and 50 mg/kg diet, respectively, have been
identiﬁed.
Hyperoestrogenism was detected in male and female Leghorn chicks exposed to 10 mg ZEN/kg bw
per day via crop intubation over a period of 20 days (Maryamma et al., 1992) and in turkeys fed a diet
with a ZEN concentration of 800 mg/kg feed (Olsen et al., 1986). Egg production was decreased in
female turkeys fed a diet with 100 mg ZEN/kg (Allen et al., 1983).
Male and female turkeys were fed ZEN contaminated diets from 3.5 to 6.5 weeks of age at 10, 25,
50, 100, 200, 400 and 800 mg/kg feed which corresponded to estimated exposure levels of 940,
2,230, 4,500, 9,100, 19,000, 37,580 and 76,630 lg ZEN/kg bw per day, respectively (Allen et al.,
1981). Male turkeys exhibited strutting behaviour when fed diets containing 400 or 800 mg ZEN/kg
diet. Moreover, these males showed a more pronounced development of the caruncles and dewlaps
compared to their control counterparts. Both males and females demonstrated an increased incidence
of swollen vents fed diets containing 200 mg ZEN/kg or more, a condition which was not observed in
the control group. Based on vent swelling a LOAEL of 19,000 lg ZEN/kg bw per day and a NOAEL of
9,100 lg ZEN/kg bw per day were calculated, corresponding to a dietary ZEN concentration of
200 mg/kg diet and 100 mg/kg diet, respectively.
b) Controlled feeding experiments with naturally contaminated feedstuffs and feed contaminated with
fungal material
Studies before 2004 were already evaluated by EFSA (2004). This literature compilation revealed
that the broiler performance remained uninﬂuenced after 7 weeks feeding of a ZEN contaminated diet
(30 mg/kg feed) (Bacon and Marks, 1976).
Laying hens fed a diet containing naturally contaminated maize with a ZEN concentration of 1.1 mg
ZEN/kg diet did not show signs of hyperoestrogenism (D€anicke et al., 2002). A number of adverse
effects were found in this study which could rather be ascribed to the presence of DON in the diet;
such as a decreased feed intake, a depressed nutrient digestibility, decreased serum titres to
Newcastle disease virus (NDV) and increased yolk titres to the bacterial antigen K88. Since the EFSA
evaluation one additional experiment with laying hens was identiﬁed. Feeding of laying hens during the
period of onset of laying with a diet containing 260.2 lg/kg feed from week 18 to 23 of age did not
result in adverse effects on laying performance and egg quality traits (Jia et al., 2016).
• Modiﬁed forms
No data on the adverse effects of ZEN modiﬁed forms in poultry were identiﬁed.
Conclusion on poultry
Poultry are very resistant to ZEN as indicated by studies performed in chicken and turkey. In male
and female broiler chickens, lymphocyte count was the only endpoint signiﬁcantly inﬂuenced by diets
fortiﬁed with pure ZEN. A LOAEL of 30,000 lg ZEN/kg bw per day and a NOAEL of 7,500 lg ZEN/kg bw
per day were calculated corresponding to exposure levels of 200 mg/kg diet 50 mg/kg diet, respectively.
Based on vent swelling of female and male turkeys the LOAEL of 19,000 lg ZEN/kg bw per day
and the NOAEL of 9,100 lg ZEN/kg bw per day were identiﬁed, based on dietary ZEN concentrations
of 200 mg/kg and 100 mg/kg diet, respectively.
No data on the adverse effects of ZEN modiﬁed forms in poultry were identiﬁed.
Horses
Zearalenone
a) Controlled experiments using pure ZEN
Six cycling trotter mares (age 6–14 years, weight range 530–650 kg) were offered a diet containing
7 mg puriﬁed ZEN/day, starting 10 days after ovulation until the subsequent ovulation (approximately 8–
10 days). According to the authors, the dose was intended to mimic a ‘natural’ contamination of about
1 mg ZEN/kg feed based on an average consumption of 7 kg feed/day. A control group was not included,
but the selected parameters were compared to those recorded in the same animals before treatment.
The mycotoxin did not affect the length of the interovulatory intervals and the plasma progesterone
proﬁles as well as the duration of the ovarian follicular and luteal phases or uterine oedema. The authors
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concluded that the short exposure to toxin concentrations corresponding to 11–13 lg ZEN/kg bw per
day did not apparently affect the reproductive parameters of cycling mares (Juhasz et al.,
2001). However, the limitations in experimental design did not allow deriving a NOAEL or LOAEL.
b) Controlled feeding experiments with naturally contaminated feedstuffs and feed contaminated with
fungal material
Three mature mares fed with diets containing naturally contaminated grains averaging 15.0 mg/kg
of DON, 0.8 mg/kg of 15-acetyldeoxynivalenol, 9.7 mg/kg of fusaric acid, and 2.0 mg/kg of ZEN for
21 days. When compared with controls, treated mares exhibited a reduction in feed intake and an
increase in serum ɣ-glutamyltransferase activity at 7 and 14 days but not at 21 days of treatment
(Raymond et al., 2003).
Raymond et al. (2005) reported about six mature mares fed with concentrates containing naturally
contaminated grains averaging 11.0 mg/kg DON, 0.7 mg/kg 15-acetyldeoxynivalenol, and 0.8 mg/kg
zearalenone for 21 days. Reduced feed intake and weight loss were observed in treated mares in the
absence of a reduction in athletic performances. As DON is known to reduce feed intake, it is difﬁcult
to decipher the effect of ZEN in this experiment. In a further trial (Aurich et al., 2006), six mature
Haﬂinger mares were fed naturally contaminated oats containing 12 mg DON and 1 mg ZEN per kg.
Feeding of the contaminated diet started on the day of ovulation and continued for the whole duration
of the oestrous cycle. Previous oestrous cycles in which the experimental mares were offered a
non-contaminated diet served as controls. The treatment did not affect the circulating levels of LH,
oestradiol and progesterone, the length of cycle, or the histological picture of uterine biopsies.
However, an increased number of growing follicles was noticed during the second part of the cycle. It
should be noted that the experimental design suffers from some limitations since it included a recovery
period followed by the re-feeding of the contaminated diet.
• Modiﬁed forms
No data on the adverse effects of ZEN modiﬁed forms in horses were identiﬁed.
Conclusion on horses
The only available study performed with the puriﬁed mycotoxin (11–13 lg ZEN/kg bw per day for
8–10 days) did not allow to derive a NOAEL or a LOAEL due to limitations of the experimental design.
Rabbits
• Zearalenone
In its 2004 opinion, EFSA did not review rabbit studies (EFSA, 2004). A subacute experiment on
two groups of 1-year-old female rabbits orally exposed for 14 days to 10 or 100 lg puriﬁed ZEN/kg bw
was reported (Conkova et al., 2001). When compared to control animals (receiving the diluent 1 mL of
8% ethanol per kg bw), the 100 lg/kg bw dose resulted in a signiﬁcant increase of AST, ALP, GGT and
LDH activity. However, no oestrogenic effect was observed in the experimental animals.
In a subsequent study by the same group using the same design, the lowest dose (10 lg/kg bw)
was tested for plasma levels of catecholamines at 1, 3, 7 and 14 days (Pastorova et al., 2004). When
compared to control animals, ZEN induced an increase in dopamine, noradrenaline and adrenaline
which lasted for 3, 3 and 7 days, respectively, until the values returned to the control values. No effect
level to characterise the hazard could be derived due to the use of one dose and the transient effect.
• Modiﬁed forms
Ovariectomised rabbits were fed a high-cholesterol diet supplemented with 0.01 or 0.05 mg a-ZAL /kg
bw per day for 12 weeks. The aortic intimal atherosclerotic plaque was signiﬁcantly larger in the
cholesterol- fed group. a-ZAL treatments signiﬁcantly reduced plaque formation and improved serum
proﬁle of lipid (TC, TG, HDL-C and LDL-C) and lipoprotein (ApoAl and ApoB). a-ZAL reconciled
ovariectomy-induced uterine atrophy. These ﬁndings indicate that a-ZAL has an important anti-
atherogenic property, analogous to that of oestrogen (Dai et al., 2004).
The CONTAM Panel has been unable to derive any LOAEL or NOAEL for modiﬁed forms in rabbits.
Conclusion on rabbits
Very few studies are available for rabbits. One study revealed that the only dose tested of 10 lg/kg
bw induced a transient increase of cathecholamines. Another study indicated that 100 lg/kg bw
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induced no oestrogenic effects. From the data available, the CONTAM Panel has been unable to
identify a LOAEL or NOAEL for ZEN or its modiﬁed forms in rabbits.
Fish
• Zearalenone
a) Controlled experiments using pure ZEN:
Carp
Juvenile carp (4 tanks, 6 ﬁsh/tank for each treatment) were given 0.3, 0.6 or 0.8 mg pure ZEN/kg
feed for 4 weeks. Other groups were given the same feed for 4 weeks, followed by a 2-weeks
recovery period where the ﬁsh was given uncontaminated feed (Pietsch et al., 2015a). ZEN had no
effect on growth. Low concentrations of ZEN and a-ZEL (reaching 0.22 and 0.16 ng/g dry weight in
the medium-dose group and 0.15 and 0.05 in the high-dose group) were detected in the ﬁsh muscle
at the end of the exposure period (see Section 3.1.1.5). The levels decreased to 0.03 and below the
LOD after the 2-weeks recovery period. The relative spleen weight was signiﬁcantly reduced compared
to control only in the low dose. Furthermore, a decrease in monocytes and increase in granulocytes
were observed in blood samples from the medium- and high-dose groups compared to control, while
no effect was found in blood samples from the low-dose group. Haemoglobin concentration was
signiﬁcantly reduced at the medium ZEN concentration of 0.6 mg/kg diet. A signiﬁcant increase in
micronuclei occurrence in erythrocytes was found from all groups given ZEN in the feed, indicating a
genotoxic potential of ZEN. ZEN did not affect the vitellogenin plasma concentrations in this study.
Indications of reactive oxygen species (ROS) formation and DNA breaks were also reported from an
in vitro study using cultures of several ﬁsh cells lines (Pietsch et al., 2014).
The effects of ZEN on the immune function of carp were studied in carp given the same feed and
experimental design as that described above (Pietsch et al., 2015b). Leukocytes from the head kidney
and trunk kidney were isolated from the ﬁsh at the termination of the experiment and the immune
function of the cells was assessed by measuring NO production, the respiratory burst assay,
chemiluminescence assay and measurement of arginase activity. Although the results varied between
different assays and also between leukocytes from head kidney vs trunk kidney, the authors concluded
that the immune response was increased after exposure to low ZEN concentrations in the feed and
decreased after exposure to high mycotoxin concentrations. Furthermore, in carp exposed to ZEN
through the same experimental design, ZEN affected the lipid peroxidation in liver and gill of exposed
ﬁsh compared to controls (Pietsch and Junge, 2016). The authors of this study also reported
alterations in the carbohydrate metabolism and increased metabolic oxygen demand in carp fed 0.6 or
0.8 mg ZEN/kg feed.
It is known that oestrogens inﬂuence the immune system in ﬁsh (Iwanowicz and Ottinger, 2009;
Burgos-Aceves et al., 2016), and it cannot be excluded that the effects on the immune system is
related to the potential oestrogenic effects of zearalenone.
The Panel does not consider the formation of micronuclei in erythrocytes as a relevant endpoint for
derivation of a reference point of hazard characterisation for ﬁsh feed. The altered relative weight of
the spleen was not dose-dependent as the effect was only observed at the lowest dose.
The Panel therefore considers 0.3 mg/kg feed as a NOAEL, based on alterations in number of
monocytes and granulocytes of immune cells and lipid peroxidation in liver and gill and alteration in
metabolism observed at 0.6 and 0.8 mg/kg feed.
Red tilapia
Red tilapia (Oreochromis niloticus 9 Oreochromis mossambicus) given a feed based on wheat
naturally infected by Fusarium containing 0.01–0.98 mg ZEN/kg feed and 0.07–1.15 mg DON/kg feed
had a lower feed intake, growth rate and feed efﬁcacy compared to control ﬁsh (Tola et al., 2015),
while no other effects were observed. The feed was co-contaminated with DON, and probably other
Fusarium toxins, and the observed effects are more likely (at least partly) attributed to DON than ZEN.
The study is consequently not suitable for the establishment of a effect level to characterise the hazard
of ZEN in ﬁsh feed.
Rainbow trout
ZEN (1.81 mg/kg feed) given to premarked size rainbow trout (250 g) for 37 or 71 days did not
affect ﬁsh growth (Wozny et al., 2015). Histological examinations of liver cross-sections revealed
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necrotic areas, disorders of the polygonal hepatocytes, cytoplasmic vacuolisation and macrophage
aggregation. ZEN did not alter the plasma biochemical markers. The ovarian development was more
advanced in the exposed group compared to controls, but there vitellogenin mRNA was not
affected.
The CONTAM Panel concluded that 1.8 mg/kg feed could be considered as a LOAEL in rainbow
trout in the latter study as this feed concentrations affected liver histology and ovarian development.
Salmon
No studies with oral administration could be found.
• Modiﬁed forms
Rainbow trout
Graded levels of Zeranol (0, 2.5, 5, 10 and 20 mg/kg feed) were mixed into the diet given to rainbow
trout for 21 days (Keles et al., 2002). Increased length was observed in ﬁsh from 5 mg/kg feed, and
increased weight from 10 mg/kg feed. Zeranol also increased the phagocytic and bactericidal activities of
the leucocytes. The study indicates that zeranol has an anabolic effect in ﬁsh and in addition it may
stimulate the non-speciﬁc immune system. No adverse effect was observed in the study.
Salmon
Single i.p. injections of 1 and 10 mg/kg of ZEN and a-ZEL in juvenile salmon induced vitellogenin
and zona radiate proteins while b-ZEL did not cause any signiﬁcant change in these parameters. The
authors concluded that ZEN and a-ZEL possess oestrogenic potencies that are approximately 50%
compared to that of E2, and the order of oestrogenic molar potency is a-ZEL > ZEN > b-ZEL (Arukwe
et al., 1999).
Only one study with oral exposure to a-ZAL in ﬁsh was available in which no adverse effect was
observed. No data on the adverse effects of oral exposure to other ZEN modiﬁed forms in ﬁsh were
identiﬁed.
Conclusion on ﬁsh
Feeding studies with graded levels applied to ﬁsh are only available for carp. In this species, ZEN
did not induce vitellogenin synthesis, which is the classical sign of hyperoestrogenism in ﬁsh. A NOAEL
of 0.3 mg/kg feed to correspond to 9 lg/kg bw per day could be identiﬁed based on a decreased the
number of monocytes, an increased the number of granulocytes and a increased lipid peroxidation. No
NOAEL/LOAEL could be derived for the modiﬁed forms of ZEN.
3.1.3.2. Adverse effects in companion animals – Evaluation of different types of studies
Cats
• Zearalenone
No information on the adverse effects of ZEN in cats could be identiﬁed in the available literature.
• Modiﬁed forms
No data on the adverse effects of ZEN modiﬁed forms in cats were identiﬁed.
Dogs
• Zearalenone
The effects of the repeated dietary administration of ZEN on reproductive parameters in
prepubertal female dogs have been the subject of a recent review (Gajezcka et al., 2015). Most of the
available information is derived from a set of studies performed by Gajecka and collaborators in female
dogs while no speciﬁc reports concerning male dogs could be identiﬁed.
ZEN was administered daily at doses equivalent to 0 (control), 25 or 50 lg/kg bw for 100 days
corresponding to about 1.7 or 3.5 mg ZEN/kg diet assuming a standard body weight of 25 kg and
0.36 kg daily feed consumption (see Appendix D). Each group consisted of three 1- to 3-year-old-
bitches of mixed breed (body weight not reported) in the anoestrous phase which underwent
ovariohysterectomy at the end of the treatment. Uterine specimens from both treated groups revealed
degenerative lesions of myometrium and endometrium, including enlargement and atrophy of the
uterine glands with oedema and extravasation. As detected by the number of PCNA-positive cells, the
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proliferative activity of the uterine mucosal cells was much lower in treated bitches compared with the
control animals (Gajezcka et al., 2007, 2008a). The ultrastructural changes (Gajezcka et al., 2008a) were
mostly conﬁned to the 50 lg/kg bw group with an increase in the endoplasmic reticulum in the
granulosa cells along with mitochondrial alterations. After 100 days of administration, treated dogs also
exhibited a statistically signiﬁcant decrease in mean cell volume (MCV) (both groups) as well as in
mean cell haemoglobin (MCH) and Hb (25 lg/kg bw) along with an unchanged erythrocyte number;
WBC number was increased in both treatment groups, but reached the statistical signiﬁcance only in
animals exposed to the lower ZEN dose. Treated animals had also a dose-related statistically signiﬁcant
rise in bilirubin (up to 66% at 50 lg/kg bw) and a statistically signiﬁcant decrease in both ALT and AST
activities (Gajezcka et al., 2007, 2008a). An increase in progesterone (P4) serum levels was noticed in
both treatment groups (25- or 50 lg ZEN/kg bw)12 with non consistent effects on 17b-estradiol (E2)
serum levels (Gajezcka et al., 2008b).
A second set of studies of the same group of investigators involved 30 immature female Beagle
dogs aged approximately 70 days (average weight 8  0.95 kg). The animals were daily dosed by the
oral route with 0 (control), 50 or 75 lg ZEN/kg bw for 42 days corresponding to about 2.7 or 4 mg
ZEN/kg diet. One study was aimed at investigating the ZEN metabolite blood proﬁle by LC–MS and the
effects on circulating E2 and P4 levels by RIA. Throughout the experiment, plasma ZEN levels were
higher13 in the 50 lg/kg bw group than in the 75 lg/kg bw and lower than those of a-ZEL and b-ZEL,
a-ZEL concentrations were consistently higher than those of b-ZEL in both treated groups. A rise (two-
to threefold over the other groups) in the plasma P4 levels occurred in the 75 lg/kg bw dosed dogs
only; statistically signiﬁcant values (p < 0.01) were reached at week 2, 3 and 4 along with the plasma
peaks of a-ZEL. Both treated groups displayed 3 to 4- fold higher E2 plasma levels, particularly at
weeks 5 and 6 (Gajezcka, 2013). Histological and ultrastructural lesions related to hyperoestrogenism
consisting in degeneration and atrophy of ovarian tissues and granulosa cells and pictures of apoptotic
cells along with an increase in mitochondrial calcium storage cells were more pronounced in animals
exposed to 75 lg ZEN/kg bw (Gajezcka and Przybylska-Gornowicz, 2012). A further report was
concerned with the effects on uterine enzymes involved in either steroidogenesis (CYPscc) or in the
reductive biotransformation of the mycotoxin (3b-HSD) (Gajezcka et al., 2011b). The treatment did not
cause statistically signiﬁcant changes in CYPscc gene expression but elicited an over four-fold increase
in 3b-HSD mRNA, although limited to animals receiving the higher ZEN dosage. This ﬁnding was
consistent with the increase in plasma b-ZEL reported in another paper (Gajezcka et al., 2013).
Immunohistochemical investigations performed on ovarian specimens collected at the end of ZEN
administration revealed no positive staining for ERa in all experimental animals; a dose-related decline
in ERb-related immunostaining was instead observed in oocyte nuclei, granulosa cells and interstitial
cells from both treated groups when compared to control animals (Gajezcka, 2013). Finally, a further
report (Stopa et al., 2014) addressed the morphometric and histologic changes in bitches exposed as
described above (0, 50 or 75 lg ZEN/kg bw for 42 days). Compared with the untreated bitches, there
was a dose-related increase in both the weight of the uterine horns and the length of the body uterus.
Signiﬁcant dilation and congestion of capillary vessels were present in both the uterine horns and
body, irrespective of the ZEN dose. Cellular hyperplasia was found in the uterus body only and tended
to be of lower degree in animals exposed to the lower ZEN dosage. The authors interpreted the latter
results as a hormetic response. No data on the effects on male fertility were identiﬁed.
Based on the histological, histochemical, haematological, and blood biochemical changes, a LOAEL
of 25 lg ZEN/kg bw per day could be established, corresponding to about 1.7 mg ZEN/kg diet.
• Modiﬁed forms
No data on the adverse effects of ZEN modiﬁed forms in dogs were identiﬁed.
Appendix H presents an overview about the available relevant toxicity studies with ZEN in female
dogs.
Conclusion on companion animals
No information could be found among the adverse effects of ZEN or its modiﬁed forms on cats. In
keeping with the higher formation of a-ZEL compared to b-ZEL, the dog appears to be one of the most
sensitive species to ZEN. Despite some limitations in the experimental design, the available published
studies revealed that already at a dose of 25 lg ZEN/kg bitches displayed uterine and ovarian gross
12 Statistical signiﬁcance not reported.
13 Mean values not reported and derived from a bar graph.
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and microscopic changes as well as changes in the haematological and blood biochemical proﬁle.
Based on these results, the CONTAM Panel estimated a LOAEL of 25 lg ZEN/kg bw per day for dogs.
3.1.3.3. Adverse effects in other animals - Evaluation of different types of studies
Farmed mink
Zearalenone
In a study performed by Bursian et al. (1992), two experiments were carried out. In the ﬁrst one,
ovariectomised female mink were offered a diet containing 0 (n = 4), 10 (n = 5) or 20 mg ZEN/kg
feed (n = 5) for 24 days (corresponding to about 1,000 or 2,000 lg ZEN/kg bw) and then euthanised.
Vulvar swelling did not differ between controls and ZEN-treated animals, whereas ZEN exposure
caused a two- (10 mg/kg) to threefold (20 mg/kg) increase in uterine weight. In the second one,
intact female mink were dietary exposed to 0 (n = 6) or 20 mg ZEN/kg diet (n = 6) for 115–135 days
(until whelping). ZEN treatment did not affect the number of individuals that whelped, but caused an
increase in the gestation length along with a marked reduction in the number of living pups (3 vs 36 in
the control group). Other studies (Yang et al., 1995; Yamini et al., 1997) administering diets containing
ZEN at 20 mg/kg point to similar adverse effects on reproduction.
• Modiﬁed forms
No data on the adverse effects of ZEN modiﬁed forms in fur animals were identiﬁed.
Conclusion on farmed mink
The available studies concerning the effects of dietary ZEN on reproduction in female mink
exhibited overt oestrogenic effects at the lowest tested dose but were performed at very high dosages
only 10 or 20 mg/kg feed (corresponding to about 1,000 or 2,000 lg ZEN/kg bw per day) and
therefore were not used to derive a reference point for adverse effects for famed mink.
3.1.3.4. Conclusions on toxic effects in farm and companion animals
There are only rather limited data available on oral toxicity in livestock species, horses, ﬁsh and
dogs, especially studies using puriﬁed toxins. Only a few of these are suitable for the derivation of
NOAELs and LOAELs. Table 4 summarises the adverse effects observed in ruminants, pigs, poultry, ﬁsh
and dogs. No suitable data to derive NOAEL or LOAEL were available for cattle, goats, horse, rabbits,
cats and fur animals.
The main adverse effects seen in pigs, poultry, ﬁsh, dogs, and mink are related to reproductive
parameters. They include depressed ovulation rates and lower lambing percentages (sheep),
prolonged cycle (pig), increased uterus weight (mink and pig) and red and swollen vulva (pig), vent
swelling (turkeys), uterine and ovarian gross and microscopic changes as well as changes in P4 and E2
blood levels (dogs). Of note, in chicken and carp the adverse effect was not hyperoestrogenism. For
chicken, it was decreased lymphocyte number and for carp it was decreased number of monocytes,
increased number of granulocytes and increased lipid peroxidation in liver and gill and altered the
carbohydrate metabolism.
Pigs and dogs were sensitive to ZEN as evidenced by a low LOEL/LOAEL (17.6 and 25 lg/kg bw per
day, respectively) and the low NOEL of 10.4 lg/kg bw per day for pigs. Regarding ﬁsh, feeding studies
with graded level of ZEN were only available for carp for which a NOAEL of 9 lg/kg bw per day was
derived.
A NOAEL of 28 lg ZEN/kg bw per day was calculated for sheep. Although neither a LOAEL nor a
NOAEL could be derived, cattle appear quite resistant to the adverse effects of ZEN, in line with the
prevalent biotransformation to the less oestrogenic metabolite b-ZEL. Among the examined species,
poultry are the least sensitive, with NOAELs for chickens and turkey of 7,500 and 9,100 lg/kg bw per
day, respectively.
It was not possible to derive a reference points for horses. However, in view of the only available
study performed with the puriﬁed mycotoxin and the toxicokinetic data, this animal species can be
considered as relatively resistant.
Very limited studies are available for rabbit. No NOEAL/LOAEL could be identiﬁed due to the use of
one dose and the transient effect.
In the case of mink, only very high concentrations were tested; no LOAEL/NOAEL could be identiﬁed.
Very few experiments investigated the adverse effect of the modiﬁed form of ZEN on livestock
species, horses, ﬁsh and dogs and none of them was suitable to derive a NOAEL or LOAEL.
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3.2. Feed occurrence data
3.2.1. Feed Occurrence data submitted to EFSA
All the data related to the presence of zearalenone and its modiﬁed forms (total ZEN, a-ZAL, b-ZAL,
a-ZEL and b-ZEL and ZAN) in feed were considered.
A total of 17,706 analytical results for ZEN (n = 14,970; 84%), a-ZAL (n = 882; 5%), and ZAN
(n = 664; 4%), b-ZAL (n = 882; 5%), a-ZEL (n = 154; 1%) and b-ZEL (n = 154; 1%) from 25
European countries were available for the assessment.
Table 4: Relevant zearalenone toxicity studies with ruminants, pigs, poultry, ﬁsh and dogs to
possibly set NOAELs/LOAELs for zearalenone
Species
No
observed
adverse
effect levels
(NOAEL)
Lowest
observed
adverse
effect level
(LOAEL)
Adverse effects
observed
(Type of study)
References Comments
Sheep 28 lg/kg bw
per day
1.5 mg kg
feed
56 lg/kg bw
per day
3 mg/kg feed
Depressed ovulation rates
and lower lambing
percentages (Puriﬁed
ZEN)
Smith et al.
(1990)
Piglets 10.4 lg/kg
bw per day
(NOEL)
0.22 mg/kg
feed
17.6 lg/kg
bw per day
(LOEL)
0.42 mg/kg
feed
Swollen and reddened
vulva, increased uterus
weight (Naturally
contaminated feed)
D€oll et al.
(2003)
Co-contamination with
DON and other
mycotoxins.
In the same range of
other studies.
Gilts 40 lg/kg bw
per day
1 mg/kg feed
200 lg/kg bw
per day
5 mg/kg feed
Prolonged cycling Edwards et al.
(1987a)
Chickens
for
fattening
7,500 lg/kg
bw per day
50 mg/kg
diet feed
30,000 lg/kg
bw per day
200 mg/kg
feed
Lymphocyte count
decreased (Puriﬁed ZEN)
Chi et al.
(1980a)
Exposure estimated based
on published data and
assumptions
Turkeys 100 mg/kg
feed
9,100 lg/kg
bw per day
200 mg/kg
feed
19,000 lg/kg
bw per day
Vent swelling Allen et al.
(1981)
Carp 0.3 mg
kg/feed
9 lg/kg bw
per day
0.6 mg/kg
feed
18 lg/kg bw
per day
Decreased number of
monocytes, increased
number of granulocytes.
Lipid peroxidation in liver
and gill.
Metabolic alterations
activation (Puriﬁed ZEN)
Pietsch et al.
(2015a)
Dogs No data 25 lg/kg bw
per day
Degenerative lesions of
myometrium and
endometrium,
enlargement and atrophy
of the uterine glands;
decrease in MCV, MCH
and Hb, increase in WBC,
bilirubin and P4 levels,
decrease in AST and ALT
Gajezcka et al.
(2007, 2008a,b)
Several reports based on
two set of studies.
Reduced number of dogs
(1 study).
Experimental design (e.g.
unknown animal
weights); dietary
concentration for LOAEL
based on assumptions.
ALT: alanine aminotransferase; AST: aspartate aminotransferase; Hb: haemoglobin; LO(A)EL: lowest observed (adverse) effect
level; NO(A)EL: no observed (adverse) effect level; MCH: mean cell haemoglobin; MCV: mean cell volume; WBC: white blood
cells; ZEN: zearalenone.
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The major contributing countries were France (24%), the UK (22%) and Bulgaria (12%) (Table 5).
Occurrence data on ZEN were provided by all countries, whereas data on modiﬁed forms were
provided by only three countries, namely Belgium (ZAN), Bulgaria (a-ZAL, b-ZAL) and the Netherlands
(a-ZAL, b-ZAL, ZAN, a-ZEL, and b-ZEL). It should be noted that the origin of the samples was not
always the European country reporting the data, i.e. the data set also contained samples originating
from North and South America, Africa, Asia and Australia.
The distribution of the occurrence data over the sampling years is presented in Figure 7. Data on
ZEN were sampled throughout 2001–2015, whereas occurrence data on the modiﬁed forms were only
available from sampling year 2011 onward.
Table 5: Distribution of analytical results for ZEN and its modiﬁed forms in feed per sampling
country (2001–2015)
Country
ZEN and its modiﬁed forms (N)
Total % of total
a-ZAL b-ZAL ZAN a-ZEL b-ZEL ZEN
Austria . . . . . 132 132 < 1
Belgium . . 503 . . 368 871 5
Bulgaria 728 728 . . . 739 2,195 12
Croatia . . . . . 34 34 < 1
Cyprus . . . . . 32 32 < 1
Czech Republic . . . . . 962 962 5
Denmark . . . . . 5 5 < 1
Estonia . . 4 . . 29 33 < 1
Finland . . . . . 3 3 < 1
France . . . . . 4,327 4,327 24
Germany . . . . . 1,150 1,150 7
Hungary . . . . . 308 308 2
Italy . . . . . 540 540 3
Lithuania . . . . . 2 2 < 1
Luxembourg . . . . . 241 241 1
Netherlands 154 154 154 154 154 154 924 5
Norway . . . . . 14 14 < 1
Poland . . . . . 5 5 < 1
Portugal . . . . . 546 546 3
Romania . . . . . 11 11 < 1
Slovakia . . . . . 488 488 3
Slovenia . . . . . 225 225 1
Spain . . 3 . . 332 335 2
Sweden . . . . . 385 385 2
United Kingdom . . . . . 3,938 3,938 22
Total 882 882 664 154 154 14,970 17,706 100
N: number of samples; ZAL: zearalanol; ZAN: zearalanone; ZEL: zearalenol; ZEN: zearalenone.
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Results were reported on whole weight (82% samples) or on 88% DM (18% of samples). For
consistency in the assessment, the latter were converted to values expressed on a whole-weight basis.
Analytical methods
Only occurrence data with information on the analytical method and on LOD/LOQ levels that
fulﬁlled the inclusion criteria for the present analysis were included. The CONTAM Panel considered
only quantitative methods able to return a conﬁrmation of the analyte identiﬁcation and with an
adequate sensitivity (Table 6). For this reason, the measurements obtained by ELISA, EIA and TLC
methods, as well as missing information were not considered reliable. By this approach, about 37% of
feed data were excluded. Mass spectrometry-based methods (Group 1, 57%) were mostly used,
followed by chromatographic methods (Group 2, 23%). Data generated by HPTLC methods have been
considered for the occurrence, since this techniques is quantitative and well-established throughout
Europe, especially for the determination of contaminants in feed.
The data set includes 61% of left-censored data (results below the LOD/LOQ), of which 13% below
LOD and 47% between LOD and LOQ. The mean and range LOQs (expressed in lg/kg) varied with
the compound: ZEN (11, 0.03–200), a-ZAL (25, 20–50), b-ZAL (25, 20–50), ZAN (20, 10–100), a-ZEL
(50, 40–50) and b-ZEL (10, 10).
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Figure 7: Distribution of occurrence of zearalenone and its modiﬁed forms over sampling years
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Occurrence data on feed by feed group
Table 7 shows the feed samples classiﬁed according to the catalogue of feed materials described in
Commission Regulation 68/2013. Molar RPFs of the modiﬁed forms relative to ZEN were applied to
occurrence levels of the respective ZEN metabolites according to EFSA CONTAM Panel (2016) (see
section 2.5 1.1).
Occurrence levels corrected for molar RPFs are presented in Table 7. Occurrence levels without the
RPFs applied are presented in Appendix G. Overall, 61% of the results were below the LOD or LOQ,
accounting for 52% for ZAN, 56% for ZEN, 99.8 % for b-ZAL, 99.9% for a-ZAL, 100% for a-ZEL, and
100% for b-ZEL.
Apart from ‘Cereal grains, their products and by-products’ and ‘Compound feed’ only a limited
number of quantiﬁed data were available for other feed groups, i.e. forages, land animal products,
legume seeds, minerals, oil seeds and tubers.
ZEN was quantiﬁed mainly in wheat unspeciﬁed (n = 6,177, mean LB–UB values of 21–24 lg/kg),
maize and corn (n = 2,047, mean LB–UB values of 102–105 lg/kg), barley (n = 1,586, mean LB–UB
values of 11–15 lg/kg), and oats (n = 779, mean LB–UB values of 10–14 lg/kg).
ZAN was quantiﬁed mainly in barley (n = 38, mean LB–UB values of 9–55 lg/kg), cereal grains
(n = 49, mean LB–UB values of 20–31 lg/kg), maize and corn (n = 35, mean LB–UB values of 101–107
lg/kg), distillers’ dark grains (n = 24, mean LB–UB values of 96–97 lg/kg), wheat (n = 40, mean
LB–UB values of 66–74 lg/kg), complementary feed (incomplete diet) (n = 131, mean LB–UB values of
29–30 lg/kg), and complete feed (n = 172, mean LB–UB values of 39–41 lg/kg).
a-ZAL was quantiﬁed in one sample of wheat feed (n = 65, mean LB–UB values of 17–95 lg/kg),
b-ZAL in one sample of cereal grains (n = 12, mean LB–UB values of 4–39 lg/kg), and one sample of
wheat feed (n = 65, mean LB–UB values of 4–43 lg/kg).
The CONTAM Panel considered it important to estimate the occurrence and the animal exposure to
the total concentration of ZEN and the modiﬁed forms a-ZAL, b-ZAL, ZAN, a-ZEL, b-ZEL through feed.
However, it is very important to stress that estimating the occurrence and exposure with such a high
number of left censored data leads to a very high uncertainty, especially for the more potent
compounds. This should be taken into account in the interpretation of the results. This high level of
uncertainty is expressed by the very broad interval between the LB and the UB.
Thus, to estimate the total concentration of ZEN and its modiﬁed forms, the CONTAM
Panel calculated the sum of the concentrations of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL, b-ZEL by
summing up the available analytical concentrations for each analytical sample. However, only 154
samples of the data set (< 1 %) were analysed for all the different forms, 728 (4%) samples were
analysed for a-ZAL, b-ZAL and ZEN, and 372 (2%) for ZAN and ZEN. Therefore, in order to estimate
the concentrations of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL, b-ZEL in each feed sample, the following
approach was used. For samples in which the compound (i.e. ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL,
b-ZEL) was analysed, but not quantiﬁed, the substitution method was used to estimate the LB and
the UB (see Section 2.1). For samples in which none of the compounds was analysed, the levels
were estimated by using the mean concentration of the closest feed group available. For example
(see Table 7), for a-ZAL in ‘Barley, unspeciﬁed’ (100% left-censored) the LB and UB were estimated
with the substitution method (i.e. LB = 0 and UB = 167). For ‘barley bran’, since a-ZAL was not
analysed, a-ZAL level was estimated using the mean measured concentration available of the closest
Table 6: Distribution of analytical results by analytical method
Analytical method group(a)
Abbreviation
N %
a-ZAL b-ZAL ZAN a-ZEL b-ZEL ZEN
Group 1 882 882 158 154 154 7,867 10,097 57.0
Group 2 – – 506 – – 3,638 4,144 23.4
Group 3 – – – – – 21 21 0.1
Group 4 – – – – – 3,444 3,444 19.5
Total 882 882 664 154 154 14,970 17,706 100
ZAL: zearalanol; ZAN: zearalanone; ZEL: zearalenol; ZEN: zearalenone.
(a): GROUP 1: LC–MS/MS, LC-MS, LC-MS quadrupole⟶ mass spectrometry based methods. GROUP 2: HPLC-FLD, HPLC-UV,
HPLC with standard detection methods, HPLC-Electrical Conductivity Detector, HPLC-CF, AAS, ETAAS (GFAAS)⟶
chromatographic methods with spectroscopic detection. GROUP 3: GC with standard detection methods, GC-MS, GC-HRMS,
GC-MS-MS. GROUP 4: High -Performance TLC methods, HPTLC/TLC.
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feed group (i.e. in this case the mean of levels quantiﬁed in ‘barley, unspeciﬁed’ and in ‘malt
rootlets’, Table 7).
Appendix F gives the distribution of LODs and LOQs for the different feed categories and
compound.
Zearalenone and its modiﬁed forms in feed
www.efsa.europa.eu/efsajournal 49 EFSA Journal 2017;15(7):4851
Table 7: Statistical description of the concentrations (lg/kg whole-weight) of zearalenone and its modiﬁed forms in feed samples classiﬁed according to
the Catalogue of feed materials speciﬁed in Commission Regulation (EU) No 68/201314 corrected for molar RPFs
Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Cereal grains,
their products
and by-products
Barley Barley,
unspeciﬁed
a-ZAL 4 26 100 0 167 0 200 0 200 – –
b-ZAL 2 26 100 0 84 0 100 0 100 – –
ZAN 1.5 38 82 9 55 0 75 0 75 – –
a-ZEL 60 19 100 0 3,000 0 3,000 0 3,000 – –
b-ZEL 0.2 19 100 0 2 0 2 0 2 – –
ZEN 1 1,586 71 11 15 0 5 5 9 20 35
Barley bran ZEN 1 2 0 4,391 4,391 4,391 4,391 8,750 8,750 – –
Barley middlings a-ZAL 4 1 100 0 79 0 79 0 79 – –
b-ZAL 2 1 100 0 39 0 39 0 39 – –
ZAN 1.5 2 100 0 15 0 15 0 15 – –
ZEN 1 1 100 0 10 0 10 0 10 – –
Barley protein
feed
a-ZAL 4 1 100 0 79 0 79 0 79 – –
b-ZAL 2 1 100 0 39 0 39 0 39 – –
ZEN 1 1 100 0 10 0 10 0 10 – –
Malt ZEN 1 2 100 0 24 0 24 0 25 – –
Malt rootlets ZAN 1.5 2 50 31 38 31 38 61 61 – –
ZEN 1 4 0 13 13 13 13 20 20 – –
Buckwheat Buckwheat,
unspeciﬁed
a-ZAL 4 1 100 0 200 0 200 0 200 – –
b-ZAL 2 1 100 0 100 0 100 0 100 – –
ZAN 1.5 1 100 0 75 0 75 0 75 – –
a-ZEL 60 1 100 0 3,000 0 3,000 0 3,000 – –
b-ZEL 0.2 1 100 0 2 0 2 0 2 – –
ZEN 1 4 100 0 21 0 15 0 35 – –
Cereal grains, their
products and
by-products
Cereal grains,
their products
and by-products
a-ZAL 4 12 100 0 77 0 77 0 77 – –
b-ZAL 2 12 92 4 39 0 39 0 39 – –
ZAN 1.5 49 76 20 31 0 14 0 15 – –
ZEN 1 164 79 28 103 0 50 0 200 82 200
Grains as crops Other grains ZEN 1 1 100 0 3 0 3 0 3 – –
14 Commission Regulation (EU) No 68/2013 of 16 January 2013 on the Catalogue of feed materials Text with EEA relevance(OJ L 29, 16.1.2013, p. 1).
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Zearalenone and its modiﬁed forms in feed
Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Maize and Corn Maize screenings ZEN 1 1 0 18 18 18 18 18 18 – –
Maize and Corn a-ZAL 4 114 100 0 73 0 73 0 73 0 73
b-ZAL 2 114 100 0 37 0 37 0 37 0 37
ZAN 1.5 35 43 101 107 22 22 77 77 – –
ZEN 1 2,047 31 102 105 24 25 97 98 481 481
Millet Millet a-ZAL 4 1 100 0 200 0 200 0 200 – –
b-ZAL 2 1 100 0 100 0 100 0 100 – –
ZAN 1.5 6 83 8 30 0 14 0 48 – –
a-ZEL 60 1 100 0 3,000 0 3,000 0 3,000 – –
b-ZEL 0.2 1 100 0 2 0 2 0 2 – –
ZEN 1 1 100 0 50 0 50 0 50 – –
Mixed grains Brewers’ grains ZEN 1 3 100 0 15 0 10 0 25 – –
Distillers’ dark
grains; [Distillers’
dried grains
and solubles]
ZAN 1.5 24 8 96 97 74 74 129 129 – –
ZEN 1 1 0 2,400 2,400 2,400 2,400 2,400 2,400 – –
Distillers’
dried grains
ZEN 1 10 30 14 18 19 19 19 20 – –
Grain ﬂour ZEN 1 1 0 11 11 11 11 11 11 – –
Mixed grains,
unspeciﬁed
ZEN 1 32 81 4 13 0 10 0 11 – –
Oats Oat feed ZEN 1 72 96 1 6 0 5 0 5 0 7
Oat ﬂour ZEN 1 1 100 0 0 0 0 0 0 – –
Oat groats a-ZAL 4 1 100 0 80 0 80 0 80 – –
b-ZAL 2 1 100 0 40 0 40 0 40 – –
ZEN 1 1 100 0 10 0 10 0 10 – –
Oats,
unspeciﬁed
a-ZAL 4 14 100 0 174 0 200 0 200 – –
b-ZAL 2 14 100 0 87 0 100 0 100 – –
ZAN 1.5 13 92 3 67 0 75 0 75 – –
a-ZEL 60 11 100 0 3,000 0 3,000 0 3,000 – –
b-ZEL 0.2 11 100 0 2 0 2 0 2 – –
ZEN 1 779 78 10 14 0 3 0 8 48 53
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Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Rice, broken Rice bran ZEN 1 1 0 128 128 128 128 128 128 – –
Rice middlings ZAN 1.5 1 100 0 15 0 15 0 15 – –
Rice, broken,
unspeciﬁed
a-ZAL 4 108 100 0 200 0 200 0 200 0 200
b-ZAL 2 108 100 0 100 0 100 0 100 0 100
ZAN 1.5 108 100 0 75 0 75 0 75 0 75
a-ZEL 60 108 100 0 3,000 0 3,000 0 3,000 0 3,000
b-ZEL 0.2 108 100 0 2 0 2 0 2 0 2
ZEN 1 152 98 0 37 0 50 0 50 0 50
Rice, milled a-ZAL 4 1 100 0 82 0 82 0 82 – –
b-ZAL 2 1 100 0 41 0 41 0 41 – –
ZEN 1 1 100 0 10 0 10 0 10 – –
Rye Rye,
unspeciﬁed
a-ZAL 4 9 100 0 200 0 200 0 200 – –
b-ZAL 2 9 100 0 100 0 100 0 100 – –
ZAN 1.5 9 100 0 75 0 75 0 75 – –
a-ZEL 60 9 100 0 3,000 0 3,000 0 3,000 – –
b-ZEL 0.2 9 100 0 2 0 2 0 2 – –
ZEN 1 312 90 2 9 0 5 0 5 7 26
Rye bran ZEN 1 1 0 110 110 110 110 110 110 – –
Rye middlings ZAN 1.5 1 100 0 15 0 15 0 15 – –
Sorghum; [Milo] Sorghum; [Milo] ZAN 1.5 2 50 24 31 24 31 48 48 – –
ZEN 1 3 33 151 152 14 14 440 440 – –
Spelt Spelt ZAN 1.5 4 75 9 20 0 15 18 26 – –
ZEN 1 33 85 3 8 0 5 0 10 – –
Triticale Triticale a-ZAL 4 2 100 0 79 0 79 0 79 – –
b-ZAL 2 2 100 0 40 0 40 0 40 – –
ZEN 1 67 72 17 21 0 6 8 13 22 22
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Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Wheat Malting wheat
screenings
ZEN 1 2 100 0 25 0 25 0 25 – –
Vital wheat gluten ZEN 1 5 60 273 279 0 10 15 15 – –
Wheat,
unspeciﬁed
a-ZAL 4 12 100 0 79 0 79 0 79 – –
b-ZAL 2 12 100 0 40 0 40 0 40 – –
ZAN 1.5 40 53 66 74 0 16 37 37 – –
ZEN 1 6,177 55 21 24 0 5 8 12 81 82
Wheat bran a-ZAL 4 89 100 0 79 0 79 0 79 0 79
b-ZAL 2 89 100 0 40 0 40 0 40 0 40
ZAN 1.5 6 67 14 24 0 15 37 37 – –
ZEN 1 111 86 4 12 0 10 0 10 – –
Wheat feed a-ZAL 4 65 98 17 95 0 79 0 79 0 79
b-ZAL 2 65 98 4 43 0 40 0 40 0 40
ZAN 1.5 6 50 15 23 8 15 37 37 – –
ZEN 1 99 84 43 51 0 10 0 10 40 40
Wheat germ ZAN 1 100 0 15 0 15 0 15 – –
Wheat
gluten
feed
ZAN 1.5 2 50 8 15 8 15 16 16 – –
ZEN 1 3 100 0 10 0 10 0 10 – –
Wheat middlings ZAN 3 67 25 35 0 15 74 74 – –
ZEN 1 102 50 18 22 3 10 33 34 65 65
Compound feed Complementary/
complete feed
Breeding pigs a-ZAL 4 2 100 0 44 0 44 0 54 – –
b-ZAL 2 2 100 0 22 0 22 0 27 – –
ZEN 1 97 48 32 37 3 15 25 30 231 231
Calves a-ZAL 4 4 100 0 54 0 54 0 54 – –
b-ZAL 2 4 100 0 27 0 27 0 27 – –
ZEN 1 12 42 100 105 17 25 90 90 – –
Complementary
feed (incomplete
diet)
a-ZAL 4 1 100 0 34 0 34 0 34 – –
b-ZAL 2 1 100 0 17 0 17 0 17 – –
ZAN 1.5 131 22 29 30 14 14 33 33 113 113
ZEN 1 248 64 44 66 0 49 1 50 264 264
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Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Complete feed ZAN 1.5 172 27 39 41 21 21 43 43 126 126
ZEN 1 224 57 57 81 0 50 3 50 335 335
Dairy cows a-ZAL 4 53 100 0 53 0 54 0 54 – –
b-ZAL 2 53 100 0 26 0 27 0 27 – –
ZEN 1 379 48 14 18 0 7 16 20 56 56
Fattening calves ZEN 1 127 39 28 32 15 16 35 35 86 86
Fattening cattle a-ZAL 4 15 100 0 51 0 54 0 54 – –
b-ZAL 2 15 100 0 26 0 27 0 27 – –
ZEN 1 72 69 15 21 0 8 2 13 74 74
Fattening chickens ZEN 1 129 37 31 36 7 18 31 34 126 126
Fattening ducks/
Complete feed
ZEN 1 7 100 0 10 0 10 0 10 – –
Fattening geese/
Complementary
feed
ZEN 1 1 100 0 30 0 30 0 30 – –
Fattening geese/
Complete feed
ZEN 1 5 60 34 40 0 10 50 50 – –
Fattening rabbits ZEN 1 14 57 1,081 1,087 0 10 20 21 – –
Fattening sheep ZEN 1 7 57 5 11 0 10 12 12 – –
Fattening turkeys/
Complete feed
ZEN 1 27 48 24 37 4 20 20 50 – –
Fish/Complete feed ZEN 1 1 100 0 10 0 10 0 10 – –
Fur animals/
Complete feed
ZEN 1 1 0 140 140 140 140 140 140 – –
Goat (kids)
(weaning diets)/
Complementary feed
ZEN 1 2 0 59 59 59 59 108 108 – –
Growing/
fattening pigs
a-ZAL 4 4 100 0 44 0 44 0 54 – –
b-ZAL 2 4 100 0 22 0 22 0 27 – –
ZEN 1 443 41 35 40 7 13 26 27 95 95
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Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Horses ZEN 1 7 43 16 40 10 20 29 54 – –
Lactating/dairy
goats/Complete
feed
ZEN 1 28 64 8 12 0 5 11 11 – –
Lactating/dairy
sheep
a-ZAL 4 4 100 0 49 0 54 0 54 – –
b-ZAL 2 4 100 0 24 0 27 0 27 – –
ZEN 1 78 59 14 17 0 5 14 14 73 73
Lambs a-ZAL 4 1 100 0 34 0 34 0 34 – –
b-ZAL 2 1 100 0 17 0 17 0 17 – –
ZEN 1 12 67 20 26 0 10 36 36 – –
Laying hens ZEN 1 98 47 48 53 1 10 34 34 186 186
Pet food, birds a-ZAL 4 1 100 0 54 0 54 0 54 – –
b-ZAL 2 1 100 0 27 0 27 0 27 – –
ZEN 1 15 7 15 15 20 20 20 20 – –
Pet food, cats/
Complete feed
ZEN 1 4 50 19 24 12 17 38 38 – –
Pet food, dogs ZEN 1 7 86 4 10 0 10 0 10 – –
Poultry
(starter diets)
a-ZAL 4 52 100 0 53 0 54 0 54 – –
b-ZAL 2 52 100 0 26 0 27 0 27 – –
ZEN 1 132 46 31 35 10 10 38 38 125 125
Rabbits/Complete
feed
ZEN 1 1 0 2 2 2 2 2 2 – –
Complementary/
Complete feed,
unspeciﬁed
ZEN 1 102 34 51 54 15 15 36 36 145 145
Weaning pigs a-ZAL 4 42 100 0 53 0 54 0 54 – –
b-ZAL 2 42 100 0 26 0 27 0 27 – –
ZEN 1 345 63 14 19 0 7 12 15 44 44
Compound feed Compound feed a-ZAL 4 106 100 0 80 0 80 0 80 0 80
b-ZAL 2 106 100 0 40 0 40 0 40 0 40
ZAN 1.5 3 67 8 65 0 23 23 150 – –
ZEN 1 201 69 17 24 0 10 11 12 77 77
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Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Fish, other quatic
animals and
products
derived thereof
Fish Fish meal ZEN 1 1 100 0 50 0 50 0 50 – –
Forages and
roughage, and
products
derived thereof
Cereals straw Cereal straw,
treated
a-ZAL 4 1 100 0 77 0 77 0 77 – –
b-ZAL 2 1 100 0 39 0 39 0 39 – –
ZEN 1 1 100 0 10 0 10 0 10 – –
Cereals straw,
unspeciﬁed
a-ZAL 4 40 100 0 77 0 77 0 77 – –
b-ZAL 2 40 100 0 39 0 39 0 39 – –
ZEN 1 41 100 0 10 0 10 0 10 – –
Forage meal;
[Grass meal];
[Green meal]
Forage meal;
[Grass meal];
[Green meal]
ZEN 1 4 75 43 80 0 50 85 110 – –
Forages and
roughage, and
products
derived thereof
Forages and roughage,
and products derived
thereof
ZEN 1 11 73 68 108 0 15 1 200 – –
Grass, ﬁeld
dried, [Hay]
Grass, ﬁeld dried,
[Hay]
a-ZAL 4 5 100 0 62 0 62 0 62 – –
b-ZAL 2 5 100 0 31 0 31 0 31 – –
ZEN 1 31 19 57 58 20 20 20 20 – –
Grass, herbs, legume
plants, [green forage]
ZEN 1 16 6 18 19 20 20 20 20 – –
Lucerne;
[Alfalfa]
Lucerne ﬁeld dried;
[Alfalfa ﬁeld dried]
ZEN 1 1 0 16 16 16 16 16 16 – –
Lucerne meal;
[Alfalfa meal]
ZEN 1 2 50 450 451 450 451 900 900 – –
Lucerne, high
temperature dried;
[Alfalfa, high
temperature dried]
ZEN 1 2 50 10 15 10 15 20 20 – –
Maize silage Maize silage a-ZAL 4 1 100 0 41 0 41 0 41 – –
b-ZAL 2 1 100 0 21 0 21 0 21 – –
ZEN 1 59 29 121 124 20 20 75 75 – –
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Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Land animal
products and
products derived
thereof
Animal by-
products
Animal by-products ZEN 1 1 0 20 20 20 20 20 20 – –
Processed
animal protein
Processed
animal protein
ZEN 1 1 100 0 2 0 2 0 2 – –
Legume seeds
and products
derived thereof
Carob, dried Carob pods, dried ZEN 1 1 100 0 10 0 10 0 10 – –
Horse beans Horse beans ZEN 1 1 0 20 20 20 20 20 20 – –
Peas Peas a-ZAL 4 1 100 0 77 0 77 0 77 – –
b-ZAL 2 1 100 0 38 0 38 0 38 – –
ZEN 1 1 100 0 10 0 10 0 10 – –
Sweet lupins Sweet lupins ZEN 1 1 100 0 3 0 3 0 3 – –
Legumes, nuts
and oilseeds
Other seeds Other seeds a-ZAL 4 5 100 0 184 0 200 0 200 – –
b-ZAL 2 5 100 0 92 0 100 0 100 – –
ZAN 1.5 5 100 0 57 0 75 0 75 – –
a-ZEL 60 5 100 0 2,760 0 3,000 0 3,000 – –
b-ZEL 0.2 5 100 0 2 0 2 0 2 – –
ZEN 1 5 100 0 38 0 50 0 50 – –
Minerals and
products derived
thereof
Calcium
carbonate;
[Limestone]
Calcium carbonate;
[Limestone]
ZEN 1 1 0 100 100 100 100 100 100 – –
Minerals and
products
derived thereof
Minerals and products
derived thereof
ZEN 1 4 75 1 7 0 8 3 10 – –
Miscellaneous Miscellaneous Miscellaneous ZEN 1 1 100 0 3 0 3 0 3 – –
Products from
the bakery
and pasta
industry
Feed beer a-ZAL 4 1 100 0 64 0 64 0 64 – –
b-ZAL 2 1 100 0 32 0 32 0 32 – –
ZEN 1 1 100 0 8 0 8 0 8 – –
Plants by-
products from
spirits production
ZEN 1 12 8 222 222 105 105 303 303 – –
Products from the
bakery and pasta
industry, ;unspeciﬁed
ZEN 1 4 100 0 9 0 9 0 16 – –
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Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Oil seeds, oil
fruits, and
products derived
thereof
Cocoa husks Cocoa husks ZEN 1 2 0 85 85 85 85 150 150 – –
Cotton seed Cotton seed ZEN 1 5 40 9 89 5 20 20 200 – –
Niger seed Niger seed ZEN 1 1 0 5 5 5 5 5 5 – –
Oil seeds, oil
fruits, and
products
derived thereof
Oil seeds,
oil fruits, and
products
derived thereof
ZEN 1 1 100 0 10 0 10 0 10 – –
Palm kernel
expeller
Palm kernel
expeller
ZEN 1 1 100 0 10 0 10 0 10 – –
Rape seed Rape seed,
unspeciﬁed
a-ZAL 4 1 100 0 80 0 80 0 80 – –
b-ZAL 2 1 100 0 40 0 40 0 40 – –
ZEN 1 4 75 5 12 0 10 10 15 – –
Rape
seed meal
a-ZAL 4 1 100 0 80 0 80 0 80 – –
b-ZAL 2 1 100 0 40 0 40 0 40 – –
ZEN 1 8 25 11 15 13 20 20 20 – –
Rape
seed,
expeller
a-ZAL 4 1 100 0 80 0 80 0 80 – –
b-ZAL 2 1 100 0 40 0 40 0 40 – –
ZEN 1 5 60 5 35 0 20 5 25 – –
Safﬂower seed Safﬂower seed meal,
partially decorticated
ZEN 1 1 100 0 10 0 10 0 10 – –
Sunﬂower seed Sunﬂower seed,
unspeciﬁed
a-ZAL 4 42 100 0 83 0 83 0 83 – –
b-ZAL 2 42 100 0 41 0 41 0 41 – –
ZEN 1 47 91 74 83 0 10 0 10 – –
Sunﬂower
seed expeller
a-ZAL 4 29 100 0 83 0 83 0 83 – –
b-ZAL 2 29 100 0 41 0 41 0 41 – –
ZEN 1 30 97 1 11 0 10 0 10 – –
Sunﬂower
seed meal
a-ZAL 4 4 100 0 83 0 83 0 83 – –
b-ZAL 2 4 100 0 41 0 41 0 41 – –
ZEN 1 6 83 3 14 0 10 0 20 – –
Sunﬂower seed
meal, dehulled
ZEN 1 2 0 20 20 20 20 20 20 – –
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Feed category Abbreviation RPF* N
% Left-
Censored
Mean
(lg/kg)(a),(b)
Median
(lg/kg)(a),(b)
P75
(lg/kg)(a),(b)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Toasted
soya (beans)
Soya (bean)
expeller
a-ZAL 4 5 100 0 80 0 80 0 80 – –
b-ZAL 2 5 100 0 40 0 40 0 40 – –
ZEN 1 7 57 36 41 0 10 64 64 – –
Soya (bean)
meal, unspeciﬁed
ZEN 1 14 79 7 22 0 20 0 20 – –
Soya (bean)
meal, dehulled
ZEN 1 5 20 13 17 20 20 20 20 – –
Soya (bean) protein
concentrate
ZEN 1 1 0 20 20 20 20 20 20 – –
Soya beans, extruded ZEN 1 3 100 0 11 0 15 0 15 – –
Toasted soya (beans),
unspeciﬁed
a-ZAL 4 3 100 0 80 0 80 0 80 – –
b-ZAL 2 3 100 0 40 0 40 0 40 – –
Oil seeds, oil
fruits, and
products
derived thereof
Toasted
soya (beans)
Toasted soya
(beans)
ZEN 1 8 100 0 10 0 10 0 10 – –
Other seeds and
fruits, and
products derived
thereof
Buckwheat Buckwheat ZEN 1 1 0 65 65 65 65 65 65 – –
Fruit kernels Fruit pulp, dried ZEN 1 1 0 20 20 20 20 20 20 – –
Perilla seed Perilla seed ZEN 1 1 0 14 14 14 14 14 14 – –
Tubers, roots,
and products
derived thereof
Sugar beet (Sugar) beet
molasses
ZEN 1 1 100 0 10 0 10 0 10 – –
Dried (sugar)
beet pulp
ZEN 1 1 0 20 20 20 20 20 20 – –
Dried (sugar)
beet pulp,
molasses
ZEN 1 1 100 0 10 0 10 0 10 – –
Sugar beet,
unspeciﬁed
ZEN 1 1 0 153 153 153 153 153 153 – –
N: number of samples; LB: lower bound; UB: upper bound; P75/P95: 75th/95th percentile; RPF: relative potency factor; ZAL: zearalanol; ZAN: zearalanone; ZEN: zearalenone; ZEL: zearalenol.
(a): The 95th percentile with less than 60 observations may not be statistically robust (EFSA, 2011b). Those estimates were not included in this table.
(b): Values were rounded to the nearest whole number (0 decimal places).
*: Molar RPFs of the modiﬁed forms relative to ZEN were applied to occurrence levels of the respective ZEN metabolites according to EFSA CONTAM Panel (2016) (see Table 1).
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3.2.2. Previously reported feed occurrence data in the open literature
Occurrence of ZEN in feed
ZEN occurs almost exclusively in cereals, particularly maize. As it is produced by Fusarium spp., ZEN
frequently co-occurs with other mycotoxins, mainly trichothecenes. Its occurrence in raw cereals and
animal feed has been described in the Scientiﬁc Opinion on zearalenone as undesirable substance in
animal feed (EFSA, 2004; EFSA CONTAM Panel, 2011). Although analytical methods have been
improved over the last decade, recent surveys indicate that the occurrence scenario previously
reported is still reliable.
A very comprehensive report on the occurrence of ZEN in animal feed has been published in 2011
by D€oll and D€anicke. Among raw materials, wheat, maize and oats were found to be mainly affected
by DON and ZEN occurrence (D€oll and D€anicke, 2011). According to the 2008 German ofﬁcial
monitoring data reported by the authors, more than 60% of the analyzed maize samples were
contaminated by DON and ZEN, although at relatively low levels compared to guidance values. Among
cereals, ZEN was found in 71 out of 95 maize samples, 120 out of 499 cereal grains, 26 out of 69 feed
for piglets, 18 out of 51 feeds for sow, and in 41 out of 126 feeds for fattening pigs.
The occurrence of ZEN and other Fusarium mycotoxins has been described in raw cereals and feed
from western Romania (Alexa et al., 2013). The occurrence of ZEN was in the range 69–77%, with an
average value of about 188 lg/kg. Although levels of ZEN were commonly low, this mycotoxin was
often found in co-occurrence with DON, as expected in consideration of the agro-climatic conditions of
the harvesting area.
According to a recent survey on the occurrence of mycotoxins in feed from Portugal (Abrunhosa
et al., 2016), ZEN was detected in 25% of the considered samples (n = 573), although at generally
low concentrations (range: 5.0–356.0 lg/kg). In particular, the highest levels of ZEN were found in
feed for pigs and in corn. Concerning fattening pigs, Almeida et al. (2011) reported on the presence of
ZEN in 7 out of 21 samples from Portugal. Also in this study, levels of ZEN were generally low but the
mycotoxins were found as co-contaminant with DON. The same authors reported on consistent results
found in compound feeds for sows (Almeida et al., 2011) and dairy cows (Almeida et al., 2013). In the
latter case, a co-occurrence of ZEN and aﬂatoxin B1 was described in 5 feed samples for ewes.
The co-occurrence of ZEN and DON in feed for dairy cows was investigated by Driehuis et al.
(2008). The authors analysed silage (n = 47), compound feed (n = 72), ensile by-products (n = 29),
feed commodities (n = 8), and forage products (n = 13). The highest incidence of ZEN was found in
compound feed (28%) together with the highest concentration (363 lg/kg feed). The same authors
investigated the occurrence of ZEN in maize, grass, and wheat silage for cattle (Driehuis et al., 2008).
The study reported on the signiﬁcance of maize silage on the total ZEN intake in cattle. In particular,
ZEN was detected in 49% of maize and 6% of grass silages, with an average concentration of 174 and
93 lg/kg, respectively, and maximum concentrations of 943 and 308 lg/kg, respectively.
ZEN is most commonly associated with cereal crops, and few studies have examined its presence in
pasture grasses. Engels and Kr€amer (1996) reported that two-thirds of more than 832 grass samples
examined were positive for ZEN using an ELISA method, with concentrations ranging between 40 and
2780 lg/kg dry matter. Golinski et al. (2003) reported the occurrence of ZEN in winter pasture from
Poland in 50–65% of pastures sampled in three locations. The concentrations reported were between
2 and 12 lg/kg DM. In an examination of maize (n = 140), grass (n = 120) and cereal silages (n = 30)
produced in the Netherlands between 2002 and 2004, ZEN was detected in 49% of maize and 6% of
grass silages. Average ZEN concentrations were 174 and 93 lg/kg, respectively, and maximum
concentrations 943 and 308 lg/kg, respectively (Driehuis et al., 2008). More recently, Skladanka et al.
(2011) have reported levels of up to 122 lg/kg in a multiyear study in the Czech Republic, although
there were large within- and between-year differences. In New Zealand, where ZEN-induced infertility
in sheep is common, concentrations of up to 2,600 lg ZEN/kg have been reported in pasture leaves
(di Menna et al., 1985). As Driehuis (2013) has noted, ZEN is a ﬁeld-derived rather than an ensilage-
derived mycotoxin; since grazed grass and grass for ensiling tend to be consumed or cut when the
plant is in an immature growth stage and it may be reasonable to assume that levels of ZEN will be
low in these feeds.
ZEN has also been reported in maize and poultry feed (total samples, n = 119) from Brazil (de
Lourdes Mendes de Souza et al., 2013). In particular, ZEN was found in 12% of raw maize and 36% of
poultry feed.
For horse feed, a recent survey from the Canadian and Irish market showed that all the considered feed
categories (total samples, n = 259) contained ZEN with the only exception of oats (Buckley et al., 2007).
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An incidence of 6–8% of positive samples were found in haylage, Canadian hay, and coarse mix, while
higher incidence were recorded for ZEN in Irish hay (21%) and pelleted feed (16%).
Concerning companion animals, a recent survey on the occurrence of mycotoxins in dry dog feed,
showed that nearly half (47%) of all samples (n = 76) were contaminated with ZEN, at levels of
10–298 lg/kg (Bohm et al., 2010).
Commercial complete ﬁsh feed for cyprinids was characterised by a marked variation of ZEN
concentrations ranging from 3 to 511 lg/kg (n = 11, Pietsch et al., 2013). Interestingly, the two diets
demonstrating the highest ZEN concentrations (80 and 511 lg/kg) contained corn or corn gluten feed
while all other feed mixtures did not contain any corn, pointing at the special importance of corn as a
speciﬁc ZEN source.
In general, data reported in the literature for ZEN are consistent with those received by EFSA and
used for calculating the exposure in terms of the range of concentrations.
Occurrence of modiﬁed forms of ZEN in feed from plant origin
Fungi can form phase I metabolites a- and b-ZEL from ZEN, while these can be converted to phase
II conjugates by both plants and fungi (Nathanail et al., 2015). Although surveys on feed products are
not available, the co-occurrence of ZEN, a- and b-ZEL and their glucosides has been reported in raw
cereals (De Boevre et al., 2013; Nathanail et al., 2015).
Cis-isomerisation of ZEN has been described to occur in the ﬁeld as an effect of sunlight (Drzymala
et al., 2014). As the current analytical methods do not include cis-ZEN, occurrence data in feed or raw
material are still not available.
Phase II conjugated forms usually co-occur with the parent compound and other mycotoxins, as
reported by Streit et al. (2013). Conjugates such as ZEN14Glc or ZEN14Sulf are mainly localised in
outer layers of cereals, and thus can be enriched in bran and ﬁbre fractions exceeding in some cases
the parent compound (Schwake-Anduschus et al., 2015).
Nathanail et al. (2015) reported for the ﬁrst time the occurrence of ZEN16Glc in naturally infected
cereals from Finland, together with ZEN, ZEN14Glc, ZEN14Sulf, a- and b-ZEL, and a- and b-ZEL14Glc.
The sum of modiﬁed forms (phase I and phase II) exceeded ZEN up to 150% in barley (n = 34), while
in oats and wheat they account for up to 50% in respect to the parent form. ZEN14Sulf was the most
abundant modiﬁed form in Finnish cereals, reaching the highest amount in oats.
Although extensive data on the occurrence of modiﬁed forms of ZEN in feed from plant origin are
not available, data reported in the literature so far cover a wider range of modiﬁed forms compared to
those received by EFSA and used for calculating the exposure. In particular, the EFSA database did not
receive any data on phase II conjugates (i.e. ZEN14Glc, ZEN16Glc) that are, on the other hand,
frequently reported in the literature. The inclusion of these compounds in extensive monitoring plans is
probably hampered by the lack of calibrants and reference materials on the market.
Occurrence of modiﬁed forms of ZEN in feed from animal origin
The occurrence of ZEN and its modiﬁed forms in feed of animal origin results from toxicokinetics.
Hereby, metabolism and tissue distribution give rise to occurrence patterns of modiﬁed forms of ZEN
different from plant derived feedstuffs. The consequences of toxicokinetics for the occurrence of
modiﬁed forms of ZEN in animal originated feedstuffs are addressed in the paragraph ‘Transfer (carry
over)’ within the Section ‘Toxicokinetics’ (see Section 3.1.1.6).
3.2.3. Feed processing
Cereal grains intended for use as animal feed are usually subject to processes such as cleaning,
sorting, drying, rolling/grinding and/or extrusion. In addition, by-products of processing grains for
human consumption are widely used as feeds for livestock.
As sorting and cleaning are mechanical processes, no signiﬁcant thermal degradation of mycotoxins
is expected at this stage. However, mechanical steps often result in an overall decrease of feed
contamination. Most mycotoxins and their modiﬁed forms tend to be mainly concentrated in the bran
fractions or outer layers of the grains (Edwards et al., 2011). Consistently, it has been described that
ZEN and its modiﬁed forms are mainly found in bran or ﬁbre-enriched products (De Boevre et al.,
2012b). Therefore, processes such as dehulling and milling may decrease the contamination in the
ﬂour, while enriching by-products such as bran and shorts.
ZEN is relatively heat stable, and thus thermal degradation is unlikely to occur as a result of heat
applied during the manufacturing and pelleting of compound feeds (ﬁnal temperature: 60–95°C).
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However, a signiﬁcant reduction of the parent compound was reported upon extrusion cooking of corn
grits (Ryu et al., 1999), while no speciﬁc information has been identiﬁed on the effect of the thermal
treatments on modiﬁed forms of ZEN.
Concerning silage, Gonzalez Pereyra et al. (2014) recently demonstrated that ensilage does not
signiﬁcantly affect the occurrence of ZEN and its modiﬁed forms in maize.
As already reported for DON and other mycotoxins, it can be concluded that feed production
processes have an impact on the distribution of ZEN and its modiﬁed forms between milling fractions,
with a possible enrichment of by-products for feed production (i.e. middlings). On the other side, there
is no evidence of degradation of modiﬁed forms of ZEN along the feed production chain.
3.3. Exposure assessment
3.3.1. Previously reported exposure assessments in animals
In 2004, the CONTAM Panel (EFSA, 2004) reviewed the presence of ZEN in feed, but concluded
that due to the variability in diet composition for the major farm animal species it was not possible to
estimate exposure levels based on the occurrence of ZEN in individual feed materials. More recently,
EFSA CONTAM Panel (2014) published a Scientiﬁc Opinion on the risks for human and animal health
related to the presence of modiﬁed forms of certain mycotoxins in food and feed. For ZEN and its
modiﬁed forms, the CONTAM Panel concluded that the mean exposure in pigs in general and the 95th
percentile exposure in piglets is not of concern. Occurrence data were inadequate to conclude on risks
for fattening pigs and sows receiving feed with a higher than average contamination level. Owing to
the lack of either occurrence data or NOAELs/LOAELs, the risk for cattle, goats, rabbits and ﬁsh could
not be fully characterised, while the estimated exposure in sheep, horses, poultry, cats and dogs was
not of concern.
3.3.2. Dietary exposure assessment for farm and companion animals
For all species, P95 and mean exposures have been estimated based on the 95th percentile and
the mean LB and UB concentrations, respectively. According EFSA (2010b), caution is needed when
calculating acute exposure (95th percentile) where data on less than 60 samples are available, since
the results may not be statistically robust. Therefore, in this Opinion, estimates of acute exposure
(95th percentile) have not been made where data on < 60 samples are available. Furthermore, mean
LB and UB data for feeds derived from less than 10 samples have not been used in the estimates of
exposure. Exposures by farmed livestock and companion animals are presented below for ZEN
(Section 3.3.3) and for the sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL, b-ZEL, applying the RPFs
(Section 3.3.4).
For many livestock in Europe, feeds are supplied in the form of commercially produced species-
speciﬁc blends or compound feeds, and for some species data on the ZEN + a-ZAL + b-ZAL + ZAN +
a-ZEL + b-ZEL contents were provided by the European countries (see Section 3.2.1, Table 7). Where
these data were available, P95 and mean exposures have been calculated using the concentrations
reported and assumed intakes (see Appendix D). For those livestock categories for which insufﬁcient
data on species-speciﬁc compound feeds were provided (i.e. for less than 10 samples), the CONTAM
Panel identiﬁed example diets and feed inclusion rates (see Appendix D for details), and used
concentrations of ZEN + a-ZAL + b-ZAL+ ZAN + a-ZEL+ b-ZEL in individual feed materials to estimate P95
and mean exposure.
As reported in Appendix D, a wide range of feeds and feeding systems are used for livestock in
Europe. It must be stressed that the feed intakes or diet compositions used in estimating exposures in
this scientiﬁc opinion are not ‘average’ diets, nor are they an attempt to describe ‘worst case’
scenarios. Rather, they are intended to provide an indication of likely exposure to ZEN and modiﬁed
forms across a range of feeding systems in Europe.
For ruminants and horses, forages – fed either fresh or conserved – are important ingredients of
the diet. The data submitted to EFSA conﬁrm the presence of ZEN and modiﬁed forms in certain
forages (Table 7). Although ZEN has been reported in fresh grass or grass silage (see Section 3.2.2),
no data for these feeds were available, and therefore it has been assumed that they make no
contribution to the exposure. In contrast, data have been provided to EFSA on levels of ZEN and the
modiﬁed forms in the grass hay, maize silage and cereal straws and these data have been used to
estimate exposure in those ruminant feeding systems where these are the main forages.
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3.3.3. Estimated exposure by farmed animals and companion animals (cats and
dogs) to zearalenone
3.3.3.1. Ruminants and horses
Two scenarios have been considered in estimating exposure by ruminant livestock to ZEN. In the
ﬁrst it has been assumed that species-speciﬁc compound feeds are fed together with fresh grass
and/or grass silage, and in the absence of data on the presence of ZEN in these feeds it is assumed
that the forages make no contribution to exposure. In the second scenario, grass hay has been
assumed to be the sole forage, and levels of ZEN in grass hay have been applied to calculate
exposure. Estimated P95 and mean exposures for high yielding dairy cows and fattening beef cattle to
ZEN are presented in Table 8.
For other ruminant production systems, insufﬁcient data on species-speciﬁc compound feeds were
available, and therefore exposures were estimated using example rations and concentrations in
individual feed materials (see Appendix D, Table D.1 for details of rations used). Estimates of
exposures for these are given in Table 9.
Table 8: Estimated P95 and mean exposure to ZEN for ruminants derived from UB concentrations
in species-speciﬁc compound feeds
Species
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure
lg/kg bw
P95 Mean P95 Mean P95 Mean
Cows: high yielding(a) LB 25.3 6.49 525 134 0.81 0.21
UB 25.3 8.11 525 168 0.81 0.26
Cows: high yielding(b) LB 224 45.0 4,632 932 7.13 1.43
UB 224 47.8 4,632 990 7.13 1.52
Fattening beef cattle(a) LB 12.6 2.52 121 24.2 0.30 0.06
UB 12.6 3.59 121 34.5 0.30 0.09
Fattening beef cattle (b) LB 294 57.1 2,820 549 7.05 1.37
UB 294 59.9 2,820 575 7.05 1.44
Sheep: lactating(a) LB 41.3 7.78 78.5 14.8 0.98 0.18
UB 41.3 9.48 78.5 18.0 0.98 0.23
Sheep: lactating(b) LB 207 39.9 393 75.8 4.91 0.95
UB 207 42.6 393 80.9 4.91 1.01
Goats: lactating(a) LB – (c) 1.44 – (c) 3.03 – (c) 0.05
UB – (c) 1.99 – (c) 4.18 – (c) 0.07
Goats: lactating(b),(c) LB – (c) 56.1 – (c) 118 – (c) 1.96
UB – (c) 58.3 – (c) 122 – (c) 2.04
bw: body weight; LD: lower bound; UB: upper bound; P95: 95th percentile.
(a): Fresh grass-based diet (i.e. assumes no exposure to ZEN from forages).
(b): Grass hay-based diets.
(c): Insufﬁcient samples available to estimate P95 exposure.
Table 9: Estimated P95 and mean exposure to ZEN by ruminants and horses, derived from UB
concentrations in individual feed materials and their relative proportions in diets
Species
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure
lg/kg bw
P95 Mean P95 Mean P95 Mean
Dairy cows: maize silage-based diet LB 777 117 21,223 3,191 32.6 4.91
UB 785 121 21,444 3,314 32.9 5.10
Beef cattle: cereal-based diet LB 12.75 7.81 128 78 0.32 0.20
UB 21.10 10.79 211 108 0.53 0.27
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3.3.3.2. Pigs and poultry
Estimates of P95 and mean exposure by pigs and poultry to ZEN were derived from data for
species-speciﬁc compound feeds, and are given in Table 10.
Species
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure
lg/kg bw
P95 Mean P95 Mean P95 Mean
Beef cattle: maize silage-based diet LB 795 105 5,250 695 17.5 2.32
UB 795 108 5,250 714 17.5 2.38
Beef cattle: straw-based diet LB 15.6 8.51 125 68.1 0.42 0.23
UB 27.9 15.0 223 120 0.74 0.40
Fattening goats(a) LB 89.4 5.60 134 8.40 3.35 0.21
UB 89.4 7.83 134 11.7 3.35 0.29
Fattening goats (b) LB 288 44.2 432 66.2 10.8 1.66
UB 288 47.6 432 71.3 10.8 1.78
Horses (a) LB 17.4 9.14 156 82.3 0.35 0.18
UB 18.9 11.6 170 105 0.38 0.23
Horses (b) LB 182 41.3 1,644 371 3.65 0.83
UB 184 44.7 1,659 403 3.69 0.89
bw: body weight; LB: lower bound; UB: upper bound; P95: 95th percentile.
(a): Fresh grass-based diet (i.e. assumes no exposure to ZEN from forages).
(b): Grass hay-based diets.
Note that the exposures indicated with (b) assume that grass hay is the sole forage. Where fresh grass or grass silage are the
main or sole forages, exposures are likely to be lower.
Table 10: Estimates of P95 and mean exposure to ZEN for pigs and poultry derived from UB
concentrations in species-speciﬁc compound feeds
Species
Diet concentration
lg/kg dry feed
matter
Exposure
lg/day
Exposure
lg/kg bw per day
P95 Mean P95 Mean P95 Mean
Pig starter LB 50.0 16.2 50.0 16.2 2.50 0.81
UB 50.0 21.3 50.0 21.3 2.50 1.07
Pig ﬁnisher LB 108 39.9 324 120 3.24 1.20
UB 108 45.1 324 135 3.24 1.35
Gilts LB 108 39.9 216 79.9 3.60 1.33
UB 108 45.1 216 90.2 3.60 1.50
Lactating sow LB 263 36.0 1,575 216 7.88 1.08
UB 263 41.8 1,575 251 7.88 1.25
Fattening chickens LB 143 35.2 17.2 4.22 8.59 2.11
UB 143 41.3 17.2 4.96 8.59 2.48
Laying hens LB 211 54.9 25.4 6.59 12.7 3.30
UB 211 60.7 25.4 7.28 12.7 3.64
Fattening turkeys(a) LB 153 26.9 61.4 10.8 5.11 0.90
UB 153 42.3 61.4 16.9 5.11 1.41
Fattening ducks(b) LB 74.2 15.8 10.4 2.21 3.46 0.74
UB 77.4 22.9 10.8 3.20 3.61 1.07
bw: body weight; LB: lower bound; UB: upper bound; P95: 95th percentile.
(a): Insufﬁcient samples were provided to allow reliable 95th percentile estimates of exposure to be made.
(b): Insufﬁcient species-speciﬁc samples were provided to allow reliable estimates of exposure to be made, and therefore
example diets have been used (see Appendix D).
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3.3.3.3. Farmed ﬁsh (salmonids, carp), rabbits and mink
In the absence of reliable data on concentrations of ZEN in species-speciﬁc compound feeds,
estimates of exposure were made by using example rations and concentrations in individual feed
materials (see Appendix D, Table D.2 for details of rations used) and are reported in Table 11.
The higher estimated exposures for rabbits reﬂect the higher proportions of cereals in the diet of
rabbits than for salmonids or mink.
3.3.3.4. Companion animals (dogs and cats)
Few data on levels of ZEN in proprietary feeds for dogs and cats were available, and therefore
exposure was estimated using example rations (see Appendix D, Table D.5 for details) and
concentrations of these toxins in individual feed materials. The exposures are reported in Table 12.
3.3.4. Estimated exposure by farmed animals and companion animals (cats and
dogs) to the sum of ZEN and modiﬁed forms
Different oestrogenic potencies are observed in vivo for zearalenone and modiﬁed forms. To
account for these differences, relative potency factors relative to ZEN (RPFs) were established (EFSA
CONTAM Panel, 2016). These RPFs were applied to the occurrence data to calculate exposure
estimates of ZEN and its modiﬁed forms.
3.3.4.1. Ruminants and horses
Estimates of P95 and exposures for high yielding dairy cows and fattening beef cattle to the sum of
ZEN and the modiﬁed forms for which data are available a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL
(corrected for RPFs as described in Section 1.3.1, Table 1), derived from data on species-speciﬁc
compound feed, are presented in Table 13.
Table 11: Estimated P95 and mean exposure to ZEN for rabbits, farmed ﬁsh and mink derived from
UB concentrations in individual feed materials and their relative proportions in diets
Species
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure
lg/kg bw
P95 Mean P95 Mean P95 Mean
Salmonids LB 24.6 4.13 0.99 0.17 0.49 0.08
UB 24.8 6.64 0.99 0.27 0.50 0.13
Carp LB 112 21.5 2.48 0.47 2.48 0.47
UB 113 28.7 2.48 0.63 2.48 0.63
Rabbits LB 11.4 10.1 1.70 1.51 0.85 0.76
UB 17.9 14.8 2.69 2.21 1.35 1.11
Mink LB 38.5 8.50 2.89 0.64 1.40 0.31
UB 38.8 8.98 2.91 0.67 1.41 0.33
bw: body weight; LB: lower bound; UB: upper bound; P95: 95th percentile.
Table 12: Estimated P95 and mean exposure to ZEN by companion animals (dogs and cats)
derived from concentrations in individual feed materials and their relative proportions in
diets
Species
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure
lg/kg bw
P95 Mean P95 Mean P95 Mean
Cats LB 50.1 14.6 3.01 0.88 0.75 0.22
UB 50.3 17.6 3.02 1.06 0.75 0.26
Dogs LB 55.4 19.4 20.0 6.99 0.80 0.28
UB 55.6 22.6 20.0 8.11 0.80 0.33
bw: body weight; LB: lower bound; UB: upper bound; P95: 95th percentile.
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As in the previous section (Section 3.3.4.1) two scenarios have been considered. In the ﬁrst, it is
assumed that the forage is either fresh grass or grass silage, and that these make no contribution to
exposure, while in the second grass hay has been assumed to be the forage, and data on levels of
ZEN plus the modiﬁed forms have been used.
For other ruminant production systems, insufﬁcient data on species-speciﬁc compound feeds were
available, and therefore exposures were estimated using example rations and concentrations in
individual feed materials (see Appendix D for details of rations used). Estimates of exposures for these
(corrected for RPFs as described in Section 1.3.1, Table 1) are given in Table 14.
Table 13: Estimated P95 and mean exposure to the sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL and
b-ZEL(a)
Species
Diet
concentration
lg/kg dry
matter
Exposurelg/day
Exposurelg/kg
bw
% of exposure
(lg/kg bw)
from modiﬁed
forms
P95 Mean P95 Mean P95 Mean P95 Mean
Dairy: high yielding(a) LB 25.3 6.49 525 134 0.81 0.21 0 0
UB 61.5 44.2 1,272 916 1.96 1.41 58.7 81.6
Dairy: high yielding(b) LB 223 45.0 4,632 932 7.13 1.43 0 0
UB 259 94.2 5,379 1,950 8.28 3.00 13.9 49.3
Fattening beef cattle(a) LB 25.4 2.52 121 24.2 0.30 0.06 0 0
UB 25.7 16.7 247 159 0.62 0.40 51.6 77.5
Fattening beef cattle(b) LB 223 57.1 2,820 548 7.05 1.37 0 0
UB 306 87.5 2,945 839 7.36 2.10 4.2 31.4
Sheep: lactating(b) LB 41.3 7.78 78.5 14.8 1.31 0.25 25.2 28.0
UB 82.9 51.0 157 97.0 2.62 1.62 62.6 85.8
Sheep: lactating(c) LB 206 39.9 392 75.8 6.54 1.26 24.9 24.6
UB 248 92.7 471 176 7.86 2.94 37.5 65.6
Goats: lactating(b),(d) LB 1.44 3.03 0.05 0
UB 1.99 4.18 0.07 0
Goats: lactating(c),(d) LB 56.1 117 1.96 0
UB 72.8 152 2.55 20.0
bw: body weight; LB: lower bound; UB: upper bound; P95: 95th percentile.
(a): The contributions from a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL have been corrected for their potencies relative to ZEN (see
Section 1.3.1).
(b): Exposure to fresh grass and species-speciﬁc compound feed only (i.e. assumes no exposure to ZEN from forages).
(c): Exposure to grass hay and species-speciﬁc compound feed.
(d): Insufﬁcient samples available to estimate P95 exposure.
Table 14: Estimated P95 and mean exposure to the sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL and
b-ZEL by ruminants and horses, derived from concentrations in individual feed materials
and their relative proportions in diets(a)
Species
Diet
concentration
lg/kg dry
matter
Exposure
lg/day
Exposure
lg/kg bw
% of exposure
(lg/kg bw)
from modiﬁed
forms
P95 Mean P95 Mean P95 Mean P95 Mean
Dairy cows: maize
silage-based diet
LB 777 117 21,223 3,191 32.6 4.91 0 0
UB 788 124 21,505 3,397 33.1 5.23 0.6 2.5
Beef cattle: cereal-based
diet
LB 16.2 10.6 162 106 0.41 0.26 22.0 23.1
UB 46.3 55.5 463 555 1.16 1.39 54.3 80.6
Beef cattle: maize
silage-based diet
LB 795 105 5,250 695 17.5 2.32 0 0
UB 826 140 5,454 924 18.2 3.08 3.7 22.7
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3.3.4.2. Pigs and poultry
Estimates of P95 and mean exposure by pigs and poultry to the sum of ZEN, a-ZAL, b-ZAL, ZAN,
a-ZEL and b-ZEL were derived from data for species-speciﬁc compound feeds, and are given in
Table 15 (values corrected for RPFs as described in Section 1.3.1). No data on levels of a-ZAL, b-ZAL,
ZAN, a-ZEL or b-ZEL were provided in species-speciﬁc compound feeds for laying hens, fattening
chickens and fattening turkeys, and therefore no exposure estimates were made for these species.
Species
Diet
concentration
lg/kg dry
matter
Exposure
lg/day
Exposure
lg/kg bw
% of exposure
(lg/kg bw)
from modiﬁed
forms
P95 Mean P95 Mean P95 Mean P95 Mean
Beef cattle:
straw-based diet
LB 15.6 8.54 125 68.2 0.42 0.23 0 0
UB 95.2 102 761 820 2.54 2.73 70.9 85.3
Fattening goats(b) LB 90.3 7.23 134 10.8 3.36 0.27 0.3 22.2
UB 91.2 33.0 137 49.5 3.41 1.24 1.8 76.6
Fattening goats(c) LB 288 45.8 432 68.7 10.8 1.72 0 3.5
UB 289 83.0 434 124 10.9 3.11 0.6 42.8
Horses(b) LB 23.0 14.8 207 133 0.46 0.30 23.9 40.0
UB 54.3 48.0 489 432 1.09 0.96 65.1 76.0
Horses(c) LB 188 46.9 1,695 422 3.77 0.94 3.2 11.7
UB 219 89.7 1,977 807 4.39 1.79 15.9 50.3
bw: body weight; LB: lower bound; UB: upper bound; P95: 95th percentile.
(a): The contributions from a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL have been corrected for their potencies relative to ZEN (see
Section 1.3.1)
(b): Exposure to species-speciﬁc compound feed only (i.e. assumes no exposure to ZEN from forages)
(c): Assumes that the diet contains 50% grass hay
Table 15: Estimated P95 and mean exposure to the sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL
for pigs and poultry derived from concentrations in species-speciﬁc compound feeds(a)
Species
Diet
concentration
lg/kg dry feed
matter
Exposure
lg/day
Exposure
lg/kg bw
% of exposure
(lg/kg bw)
from modiﬁed
forms
P95 Mean P95 Mean P95 Mean P95 Mean
Pig starter LB 50.0 16.2 50.0 16.2 2.50 0.81 0 0
UB 140 111 140 111 7.00 5.57 64.3 80.8
Pig ﬁnisher LB 108 39.9 324 120 3.24 1.20 0 0
UB 182 119 548 359 5.48 3.59 40.9 62.4
Gilts LB 108 39.9 216 79.9 3.60 1.33 0 0
UB 183 120 365 240 6.09 3.99 40.9 66.6
Lactating sow LB 263 36.0 1575 216 7.88 1.08 0 0
UB 337 116 2023 699 10.1 3.49 22.1 64.2
Chickens for fattening LB 143 35.2 17.2 4.22 8.59 2.11 0 0
UB 143 41.3 17.2 4.96 8.59 2.48 0 0
Laying hens LB 211 54.9 25.4 6.59 12.7 3.30 0 0
UB 211 60.7 25.4 7.28 12.7 3.64 0
Turkeys for fattening LB 153 26.9 61.4 10.8 5.11 0.90 0 0
UB 153 42.3 61.4 16.9 5.11 1.41 0 0
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3.3.4.3. Farmed ﬁsh (salmonids, carp), rabbits and mink
In the absence of reliable data on concentrations of the sum of sum of ZEN, a-ZAL, b-ZAL, ZAN,
a-ZEL and b-ZEL in species-speciﬁc compound feeds, estimates of exposure were made by using
example rations and concentrations in individual feed materials (see Appendix D Table D.2 for details
of rations used) and are reported in Table 16 (values corrected for RPFs as described in Section 1.3.1).
It should be noted that there is considerable uncertainty in the estimate of exposure for rabbits.
Two feeds, wheat feed and sunﬂower meal, accounted for over 85% of the exposure to ZEN and
ZEN + a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL, yet for these feeds there were limited numbers of samples
(n = 99 and 30, respectively), while 84% and 97% of the data, respectively, were left censored.
3.3.4.4. Companion animals (Dogs and cats)
Few data on levels of ZEN, a-ZAL and b-ZAL in proprietary feeds for dogs and cats were available,
and therefore exposure was estimated using example rations (see Appendix D, Table D.5 for details)
and concentrations of these toxins in individual feed materials. The exposures are reported in Table 17
(values corrected for RPFs as described in Section 1.3.1, Table 1).
Species
Diet
concentration
lg/kg dry feed
matter
Exposure
lg/day
Exposure
lg/kg bw
% of exposure
(lg/kg bw)
from modiﬁed
forms
P95 Mean P95 Mean P95 Mean P95 Mean
Fattening ducks (b) LB 75.0 16.6 10.5 2.32 3.50 0.77 1.1 3.9
UB 83.9 33.6 11.7 4.71 3.92 1.57 7.9 31.8
bw: body weight; LB: lower bound; UB: upper bound; P95: 95th percentile.
(a): The contributions from a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL have been corrected for their RPFs (see Section 1.3.1).
(b): Insufﬁcient species-speciﬁc samples were provided to allow reliable estimates of exposure to be made, and therefore
example diets have been used (see Appendix D, Table D.5).
Table 16: Estimated P95 and mean exposure to the sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL and
b-ZEL for rabbits, farmed ﬁsh and mink derived from concentrations in individual feed
materials and their relative proportions in diets(a)
Species
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure
lg/kg bw
% of exposure
(lg/kg bw) from
modiﬁed forms
P95 Mean P95 Mean P95 Mean P95 Mean
Salmonids LB 24.6 4.13 0.99 0.17 0.49 0.08 0 0
UB 25.4 6.68 1.02 0.27 0.51 0.13 2.0 0
Carp LB 112 21.5 2.48 0.47 2.48 0.47 0 0
UB 132 46.4 2.89 1.02 2.89 1.02 14.2 38.2
Rabbits LB 17.8 16.5 2.67 2.48 1.34 1.24 36.6 38.7
UB(b) 76.2 80.4 11.4 12.1 5.71 6.03 76.4 81.6
Mink LB 38.5 8.50 2.89 0.64 1.40 0.31 0 0
UB 39.5 9.88 2.96 0.74 1.43 0.36 1.4 8.3
bw: body weight; LB: lower bound; UB: upper bound; P95: 95th percentile.
(a): The contributions from a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL have been corrected for their RPFs (see Section 1.3.1).
(b): The Estimated mean exposure is higher than the P95 due to the very skewed distribution of the data.
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3.3.4.5. Concluding remarks
There was considerable variation in the estimated exposure by farmed livestock and companion
animals to ZEN. While the average LB and UB exposures at the mean and 95th percentile for all
species were 1.00/1.14 and 5.18/5.24 lg/kg bw per day, respectively, the highest exposure to ZEN,
both at the mean and 95th percentile was estimated for dairy cows fed a maize silage-based diet
(Mean LB/UB = 4.91/5.10 lg/kg bw per day; 95th percentile LB/UB = 32.6/32.9 lg/kg bw per day).
Similarly, there was variation between the farmed livestock and companion animals for exposure to
the sum of ZEN + a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL (corrected for RPFs). The average LB and UB
exposures across all species, at the mean and 95th percentile, were 1.04/2.20 and 5.28/6.23 lg/kg
bw per day, respectively. Again, the highest estimated exposures were for dairy cows fed a maize
silage-based ration (P95 LB/UB = 32.36/33.1). These results clearly reﬂect the markedly higher levels
of ZEN and its modiﬁed forms in maize silage than in any other forage or feed material reported in this
Opinion (see Appendix E).
As indicated in Tables 13–17, there was considerable variation between livestock groups in the
percentage of the total exposure (ZEN + a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL) that was accounted
for by the sum of the modiﬁed forms (a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL). For many species,
notably poultry, ZEN accounted for the total exposure (93–100%) because of lack of data for the
modiﬁed forms of ZEN. For dairy cows, beef cattle, lactating sheep, horses, weaned pigs and rabbits
the modiﬁed forms accounted for 50% or more of the total UB exposure, both at the mean and 95th
percentile. More than half of the UB mean exposure for fattening pigs, lactating sows, cats and dogs
was from the modiﬁed forms, but was < 50% at the 95th percentile.
The difference between LB and UB exposure to ZEN alone was low with the average UB value for
all species approximately 1.1 times the LB value. When modiﬁed forms were included in the sum, the
difference between LB and UB exposure increased notably, so that the average (across all species) of
the UB was 64 and 33 times greater than the LB for the mean and P95 exposures (lg/kg bw).
3.4. Risk characterisation
There is limited knowledge on the effects of ZEN and its modiﬁed forms on farm and companion
animals. Furthermore, there is no comprehensive database on feed consumption by livestock in the
EU. It has therefore not been possible to fully assess the risks of ZEN and its modiﬁed forms for farm
and companion animal health.
However, for a number of farm livestock and companion animal categories the chronic exposure of
ZEN in feed could be estimated at the mean and 95th percentile concentrations in animal diets based
on expected feed intakes and example diets. Furthermore, exposure to the sum of ZEN and modiﬁed
forms was calculated by use of molar RPFs of the modiﬁed forms relative to the oestrogenic activity of
ZEN derived from information in rodents (EFSA CONTAM Panel, 2016).
These exposures to ZEN and to the sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL have been
compared with identiﬁed reference points (NOAELs and LOAELs) in farm and companion animals
(Table 18 and 19). The identiﬁed NOAELs or LOAELs for sheep, pigs, poultry, ﬁsh and dogs were used
for risk characterisation. For cattle, horses, rabbits, goats, ducks, cats and mink the health risk from
the exposure to ZEN could not be assessed as no NOAELs or LOAELs have been identiﬁed.
Table 17: Estimated P95 and mean exposure to the sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL and
b-ZEL by companion animals (dogs and cats) derived from concentrations in individual
feed materials and their relative proportions in diets(a)
Species
Diet concentration
lg/kg dry matter
Exposure
lg/day
Exposure
lg/kg bw
% of exposure
(lg/kg bw) from
modiﬁed forms
P95 Mean P95 Mean P95 Mean P95 Mean
Cats LB 55.0 19.47 3.30 1.17 0.82 0.29 8.5 24.1
UB 72.8 39.84 4.37 2.39 1.09 0.60 31.2 56.7
Dogs LB 63.5 27.46 22.9 9.9 0.91 0.40 12.1 30.0
UB 93.0 59.65 33.5 21.5 1.34 0.86 40.3 61.6
bw: body weight;; LB: lower bound; UB: upper bound; P95: 95th percentile.
(a): The contributions from a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL have been corrected for their RPFs (see Section 1.3.1).
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In Tables 18 and 19, exposure estimates (UB mean and 95th percentile) are presented together with
NOAELs/LOAELs for the different farm and companion animal species. Exposure is expressed as a
percentage of the NOAEL in the right-hand columns. When a NOAEL is lacking, the LOAEL is used instead
but provides a less conservative basis for comparison with exposure. Uncertainties affecting the
assessment of exposure, toxicity and risk are listed and evaluated in Section 3.5. The estimates of
exposure to ZEN and the sum of (ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL) are presented in Section 3.3.
Risk characterisation for ZEN alone (Table 18) was based on estimated UB exposure; however, the
difference between UB and LB exposure was small for ZEN alone.
For ZEN alone, for sheep the calculated chronic exposure at the UB mean and UB 95th percentile
were 3 and 16% of the identiﬁed NOAEL, respectively. This NOAEL was based on ovulation rates and
lambing percentages. The Panel concluded that the risk of adverse health effects of feed containing
ZEN was low for sheep
For piglets, the estimated exposure of ZEN at the UB mean and 95th percentile were 9 and 21% of
the NOAEL, respectively. This NOAEL was based on the appearance of the vulva and the uterus weight.
For gilts, the estimated chronic exposure of ZEN at the UB mean and UB 95th percentile were 3 and 8%
of the NOAEL (based on prolonged cycling), respectively. The Panel concluded that the estimated risk for
chronic adverse health effects from feed containing ZEN was low for piglets and gilts.
For poultry (chickens and fattening turkeys), the estimated exposure of ZEN at the UB mean or
the P95th percentile was less than 0.06% of the NOAEL (based on the reduced number of
lymphocytes and the vent swelling). The Panel concluded that the estimated risk for chronic adverse
health effects from feed containing ZEN was extremely low for poultry.
For ﬁsh, a NOAEL was only available for carp and was extrapolated to all ﬁsh species. The
estimated chronic exposure of ZEN at the UB mean and 95th percentile were 6 and 24% of the
NOAEL, respectively. This NOAEL was based on reduced monocytes and granulocytes number,
increased lipid peroxidation in liver and gill and altered metabolic activation. The Panel concluded that
the estimated risk for chronic adverse health effects from feed containing ZEN was low for ﬁsh.
For dogs, only a LOAEL was available. The estimated exposure of ZEN at the UB mean and 95th
percentile were 1 and 3%, respectively, of the LOAEL. This LOAEL was based on myometrium and
endometrium lesions, enlargement and atrophy of uterine glands, blood haematology and
biochemistry. The Panel concluded that the estimated risk for chronic adverse health effects from feed
containing ZEN was low for dogs.
Table 18: Comparison of estimated ZEN exposure levels and NOAELs/LOAELs for different farm and
companion animal species
Estimated
exposure
(lg ZEN/kg bw
per day)(a)
Estimated exposure,
% of NOAEL or LOAEL
NOAEL
(lg ZEN/
kg bw)
LOAEL
(lg ZEN/
kg bw)
P95
(UB)
mean
(UB)
P95 (UB) mean (UB)
Sheep 28 56 4.32 0.89 15.4 3.2
Gilts 40 200 3.17 1.16 7.9 2.9
Piglets 10.4 (NOEL) 17.6 (LOEL) 2.20 0.94 21.1 9
Chicken(b) 7,500 30,000 16.1 4.66 0.22 0.062
Turkeys (fattening)(c) 9,100 19,000 (c) 1.24 (c) 0.014
Fish (carp) 9 18 2.18 0.55 24.2 6.11
Dogs – 25 0.70 0.25 2.8 (LOAEL) 1 (LOAEL)
bw: body weight; ZEN: zearalenone; NOAEL: no observed adverse effect level; LOAEL: lowest observed adverse effect level; UB:
upper bound.
(a): Exposures have been calculated from dietary concentrations expressed on a fresh weight (88% dry matter) basis to make
them comparable with the data from which NOAELS/LOAELS have been derived.
(b): Exposure have been calculated for chicken of the age as reported by Chi et al. (1980a,b) to allow comparison with the
NOAEL
(c): Insufﬁcient samples were provided to allow reliable 95th percentile estimates of exposure to be made.
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Risk characterisation for ZEN and its modiﬁed forms (Table 19) was based on UB exposures.
Because of the high rate of left-censored data for modiﬁed ZEN, the difference between UB and LB
exposures is larger than for ZEN alone. The estimated exposures were compared with the NOAELs/
LOAELs identiﬁed for ZEN, as no reference point could be identiﬁed for the modiﬁed forms.
The Panel noted that no data on levels of a-ZAL, b-ZAL, ZAN, a-ZEL or b-ZEL were provided in
species-speciﬁc compound feeds for poultry (laying hens, fattening chickens and fattening turkeys).
However, considering the very high NOAELs for these species, and the composition of their feed, the
Panel considered the risk of health effects from ZEN and its modiﬁed forms extremely unlikely for
these species.
For sheep, the estimated chronic exposure of ZEN and its modiﬁed forms at the UB mean and UB
95th percentile were 9.3 and 25% of the NOAEL, respectively. The Panel concluded that the risk of
adverse health effects of feed containing ZEN and its modiﬁed forms was low for sheep.
For piglets, the estimated chronic exposure of ZEN and its modiﬁed forms at the UB mean and UB
95th percentile were 47 and 59% of the NOAEL, respectively. For gilts, the estimated chronic
exposure of ZEN and its modiﬁed forms were 8 and 12% of the NOAEL, respectively. The
Panel concluded that the estimated risk for chronic adverse health effect from feed containing ZEN and
its modiﬁed forms was low for piglets and gilts.
For ﬁsh, NOAEL was only available for carp and was extrapolated to all ﬁsh species. The estimated
chronic exposure of ZEN and its modiﬁed forms were 10 and 28% of the NOAEL, respectively. The
Panel concluded that the estimated risk for chronic adverse health effect from feed containing ZEN and
its modiﬁed forms was low for ﬁsh.
For dogs, only a LOAEL was available. For this species, the estimated chronic exposure of ZEN and
its modiﬁed forms were 3 and 5% of the LOAEL, respectively. The Panel concluded that the estimated
risk for chronic adverse health effect from consuming feed containing ZEN and its modiﬁed forms was
low for dog.
The CONTAM Panel noted that this risk characterisation of chronic risks for poultry, sheep, pig, ﬁsh
and dogs should be considered indicative owing to the uncertainties associated to the identiﬁed
reference points (see Section 3.5) and the dietary exposure to the modiﬁed forms of ZEN.
3.5. Uncertainty analysis
Table 20 lists the main sources of uncertainty identiﬁed by the Panel. It includes a qualitative
assessment of whether each source of uncertainty leads to over/underestimation of the resulting risk.
Sections 3.5.1–3.5.3 present in more detail the uncertainties affecting different parts of the risk
assessment.
The impact of the uncertainties in the risk assessment of farm and companion animals is large.
Table 19: Comparison of estimated ZEN + modiﬁed forms (sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL
and b-ZEL) exposure levels and NOAELs/LOAELs for different farm and companion animal
species
Estimated
exposure
(lg ZEN /kg bw
per day)(a)
Estimated exposure,
% of NOAEL or LOAEL
NOAEL
(lg ZEN/kg bw)
LOAEL
(lg ZEN/kg bw)
P95
(UB)
mean
(UB)
P95 (UB) mean (UB)
Sheep 28 56 6.92 2.59 24.7 9.3
Gilts 40 200 4.82 3.16 12.1 7.9
Piglets 10.4 (NOEL) 17.6 (LOEL) 6.16 4.90 59.2 47.1
Fish (carp) 9 18 2.54 0.90 28.2 10
Dogs – 25 1.18 0.76 4.7 (LOAEL) 3 (LOAEL)
bw: body weight; ZEN: zearalenone; NOAEL: no observed adverse effect level; LOAEL: lowest observed adverse effect level; UB:
upper bound.
(a): Exposures have been calculated from dietary concentrations expressed on a fresh weight (88% dry matter) basis to make
them comparable with the data from which NOAELS/LOAELS have been derived and molar potency factors relative to ZEN
were applied for modiﬁed ZEN.
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Table 20: Summary of uncertainties
Source of uncertainty
Parameter
affected(a)
ZEN(b) ZEN+modiﬁed
forms(b)
Direction and
approximate
magnitude of
uncertainty
(+/)(c)
Limitation in analytical identiﬁcation and
quantiﬁcation of zearalenone modiﬁed forms:
lack of calibrants and reference materials for
validation
O N Y 
Not adequate analytical sensitivity for
zearalenone modiﬁed forms.
O N Y 
Little occurrence data for zearalenone modiﬁed
forms in EFSA database, especially for feed
ingredients of animal origin, no data for some
forms, data from 1 or 2 countries for other
compounds.
O N Y 
No data on ZEN glucosides and sulfates in the
EFSA database (in contrast to literature data)
O N Y 
Use of substitution method, UB occurrence data
in the exposure estimations (applies only to the
sum ZEN+modiﬁed forms)
O N Y +
Imputation of missing occurrence data (using
mean of measured data) (applies only to the
sum ZEN+modiﬁed forms)
O N Y +/
Use of RPFs developed for ZEN modiﬁed forms
group HBGV based on experiments in rodents
R N Y +/
Applicability of RPFs to different animal species
with different metabolism
R N Y +
No toxicological/not robust data T some
species
Y +/
Toxicity data with naturally contaminated
material (usually containing other mycotoxins)
T some
species
Y +/
Extrapolation from one ﬁsh species to another
ﬁsh species (to check with species there are and
not)
T some
species
some species +/
Differences between ages, sexes and breed T Y Y +/
Missing information on body weight in toxicity
studies
T Y Y +/
The number of samples were not equally
distributed across all feed groups
O Y Grass Y +/
Effect of variation between countries, between
sampling methods and over time, and
uncertainty about moisture content, on
extrapolation from occurrence data to 95th
percentile for the EU
O Y Y +/
High variability of feedstuffs used and feeding
systems for livestock
C Y Y +/
Example animal diets used to calculate animal
exposure
C Y Y +/
Body weight assumptions C Y Y +/
RPF: relative potency factor; HBGV: health-based guidance value.
(a): C = Feed consumption, O = occurrence, R = RPFs, T = Toxicity.
(b): Y = yes, N = No
(c): + = uncertainty with potential to cause over-estimation of exposure/risk;  = uncertainty with potential to cause under-
estimation of exposure/risk.
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3.5.1. Uncertainty associated with occurrence and exposure
Occurrence
A ﬁnal data set of 17,706 samples was available to estimate dietary exposure to ZEN and its
modiﬁed forms. ZEN occurrence data were provided by 25 Member States, whereas data on the
modiﬁed forms were provided by three Member States only. Therefore, there is large uncertainty on
the possible country-based and year based differences in the levels of ZEN modiﬁed forms in diverse
feed commodities. It is known that mycotoxin accumulation in crops is strongly affected by climate
change. The last harvest seasons have been characterised by an increasing trend of contamination,
due to exceptional climatic conditions. In particular, in 2014 several EU countries obtained a derogation
to MLs for ZEN, DON, and fumonisins in maize. However, data in the EFSA database cover a long
period (2001–2015) and have been collected from different geographic area, thus resulting in a
decrease in the uncertainty.
The analytical results were performed by different laboratories at varying LOQ/LODs. EFSA replaced
left-censored data with UB values based on the reported LOQ which has an impact on the uncertainty
(see Section 2.1). Likewise, the lack of information on the analytical method used to analyse some
feed samples (~ 37%) adds some uncertainty to the levels of ZEN and its modiﬁed forms reported for
some feed commodities.
Feed composition
• Representativeness of feeds analysed: As reported in Table 5, there is a wide discrepancy in
the geographical spread of samples reported (possible over/underestimation).
• Feed data: There were limited or no data available on some key ingredients, e.g. oilseed
meals, fresh or conserved pasture grass. The formulations therefore assume no exposure from
these feeds (possible underestimation).
• Diet formulations: Single diet formulations have been assumed for each species, although as
discussed above (Section 2.2) there are large differences in feeding systems and diet
formulations for livestock and companion animals in the EU (possible over/underestimation).
Feed intakes
• A single level of feed intake has been assumed for each livestock species/companion animal,
but in practice this can vary for a given live weight or level of activity/productivity (possible
over/underestimation).
• Single levels of production or activity have been assumed, but these can vary markedly
resulting in greater or lesser amounts of feed required or consumed (possible over/
underestimation).
Details of the assumptions made for feed intake and diet composition for the different farmed
livestock and companion animals are given in Appendix D.
Exposure assessment
Estimates of exposure to ZEN and its modiﬁed forms have been made using their concentrations in
feeds and the amounts of those feeds consumed. In making these estimates, a number of
assumptions have been made, particularly in respect of the types and amounts of feed consumed
which will contribute to the uncertainty associated with the estimates of exposure. The main areas of
uncertainty/concern relate to the extent to which the feeds reported are representative of feeds used
for livestock and companion animals in the EU, the composition of the diets assumed for each of the
livestock species/companion animals, and the estimates of feed consumed.
The Panel noted the wide range between the LB and UB values reported for the estimates of
exposure. This is particularly the case for the sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL and b-ZEL. The
analytical results used for the exposure assessment were reported by different laboratories with
varying LOQ/LODs. This, together with the large proportion of samples with left-censored data (i.e.
ZEN about 60%, ZAN about 70%, a-ZEL and b-ZEL, and a- and b-ZAL about 100%), is likely to
account for these large differences. Furthermore, for certain feeds (particularly for poultry), no data
were presented for a-ZAL, b-ZAL, ZAN, a-ZEL or b-ZEL. Consequently, while the LB values tends to
underestimate the chronic dietary exposure to ZEN and its modiﬁed forms, the use of UB values tend
to overestimate it (see Section 2.1) and this therefore results in a large uncertainty to the overall
estimates of dietary exposure.
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It should be noted that there is considerable uncertainty in the estimate of exposure for rabbits. Two
feeds, wheat feed and sunﬂower meal, accounted for over 85% of the exposure to ZEN and ZEN +
a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL, yet for these feeds there were limited numbers of samples
(n = 99 and 30, respectively), while 84% and 97% of the data, respectively, were left censored.
3.5.2. Uncertainties on the studies used for evaluation of adverse effects in farm
and companion animals
No toxicological data on ZEN were available for cats. For other animal species such as cattle, goats,
horses, rabbit and mink the toxicological data were too limited to allow the establishment of reference
points for ZEN.
For ﬁsh, the only toxicological data were obtained for carps and therefore have to been
extrapolated to all ﬁsh species.
Similarly, for poultry, toxicological data were only available for chicken and turkey. This contributed
to the overall uncertainty.
For dogs, the experiment was performed on mixed breed animals, only LOAEL was determined and
body weight of the animals was not reported.
For pig, the key study was performed with naturally contaminated maize, containing not only ZEN
but also other mycotoxins. Assigning observed oestrogenic effects to ZEN might be justiﬁed although
interactions with other mycotoxins, notably with DON, cannot be excluded (e.g. Tiemann and D€anicke,
2007; D€oll and D€anicke, 2011).
Except for pigs no data were available on the effect of sex and age on the toxicity of ZEN. For all
the animal species taken into consideration, no data were available on the possible difference of the
different breeds. This contributed to the overall uncertainty.
Concerning the modiﬁed forms of ZEN, the toxicological data were either lacking or very limited. For
the different animal species, it was not possible to identify any reference point for any modiﬁed form of
ZEN.
3.5.3. Other uncertainties: Use of RPFs of the ZEN modiﬁed forms
Potency factors of the modiﬁed forms relative to ZEN (RPFs) were applied to occurrence levels of
the respective ZEN metabolites according to the CONTAM Panel 2016 (see Table 1) (EFSA CONTAM
Panel 2016). The CONTAM Panel noted that these RPFs were based on uterotrophic effects measured
for ZEN and its modiﬁed forms in a rodent experiment and thereby not considering other oestrogenic
effects and other endpoints. Furthermore, applying these RPFs derived from rodents to different farm
and companion animal species does not consider the species differences in the toxicokinetics and
toxicodynamics (animal species with different pattern of oestrogen receptors and metabolism).
4. Conclusions
Zearalenone is a phenolic resorcylic acid lactone mycotoxin produced by several Fusarium species,
particularly F. graminearum. It can be modiﬁed in plants, fungi and animals by phase I and phase II
metabolism. Modiﬁed forms of ZEN occurring in feed include its reduced phase I metabolites (i.e. a-
and b-ZEL, a- and b-ZAL, ZAN) and its phase II conjugates, such as those conjugated with glucose,
sulfate and glucuronic acid. a-ZAL, one of the phase I metabolites of ZEN, is used as a growth
promoter in non-EU countries under the name of Zeranol. It is banned in Europe, and therefore it is
included in ofﬁcial control plans.
Methods of analysis
• Analytical methods for ZEN and its modiﬁed forms in feed are well-established. However, while
methods reported in the scientiﬁc literature are widely based on the more sensitive LC–MS/MS,
most of the routine analyses are still performed by LC-FLD or LC-UV.
• Calibrants for ZEN conjugates and reference materials for phase I and phase II modiﬁed forms
are not commercially available.
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Hazard identiﬁcation and characterisation
Toxicokinetics in farm and companion animals
Zearalenone
• Wide interspecies differences in ZEN absorption, distribution, metabolism and excretion have
been documented.
• Rumen, enteric, hepatic end extrahepatic ZEN metabolism has been reported; the nature and
the amount of the generated metabolites may affect the species-sensitivity to the toxin.
• Reductive biotransformations largely prevail; the main ZEN metabolites are a-ZAL, b-ZAL, with
only very limited amounts of a-ZEL, b-ZEL, and other reductive metabolites being produced;
reduced metabolites retain or increase the oestrogenic potency of the parent compound.
• Based on the levels measured in biological ﬂuids of ZEN treated animals, the a-derivatives
seem to prevail in pigs, dogs, and turkeys while the b-derivatives appear to be more abundant
in cattle, goats, horses, broiler chickens and laying hens.
• CYP-mediated aromatic or aliphatic hydroxylation also occurs, but information in farm and
companion animals is very limited.
• In orally exposed animals, ZEN and its metabolites are rapidly absorbed, distributed to several
organs and quickly excreted mainly via the biliary route as glucuronides; an active
enterohepatic circulation has been demonstrated.
• Excretion in milk and eggs has been documented for ZEN and its metabolites.
Ruminants
• There is scant information on the toxicokinetics of ZEN in cattle; rumen microbes extensively
metabolise ZEN to a-ZEL and b-ZEL, the latter being predominant also in biological ﬂuids
• Little is known on the toxicokinetics of ZEN in sheep; ZEN is almost completely biotransformed
by ovine rumen ﬂuid to a-ZEL and b-ZEL at similar proportions and both metabolites are
present in urine as both free and conjugated forms
• No studies have been identiﬁed on ZEN administration to goats by the oral route.
Pigs
• In pigs, the generation of a-ZEL largely outweigh that of b-ZEL and other reductive
metabolites which are recovered, along with ZEN in blood, urine, and bile mostly in their
glucuronidated form.
Poultry
• In poultry, ZEN is characterised by a low oral bioavailability and a rapid elimination.
• b-ZEL was largely predominant over a-ZEL in broiler chickens and laying hens, while turkey
poults tended to biotransform ZEN more extensively and synthesise a relatively higher amount
of a-ZEL; in all cases glucuronidation was the main conjugation reaction.
Horse
• a-ZEL and b-ZEL are the main ZEN metabolites in the horse, the latter being predominantly
formed over a-ZEL under in vivo conditions.
Farmed Rabbit
• Little is known about the toxicokinetics of ZEN in rabbits; ZEN, a-ZEL and b-ZEL were detected
in colonic chyme, faeces, bile and urine of rabbits orally dosed with ZEN.
Fish
• There is scant information concerning ZEN toxicokinetics in ﬁsh.
• In rainbow trout, there is evidence of a prevalent generation of b-ZEL versus a-ZEL, while the
reverse seems to occur in carp.
Farmed mink
• No data on the toxicokinetics of ZEN and modiﬁed forms could be identiﬁed for farmed mink.
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Companion animals
• No information could be identiﬁed for cats.
• In orally exposed dogs, measurable blood levels of ZEN, a- and b-ZEL were detected with a
clear prevalence of the a- over the b-derivative (up to 100%).
ZEN modiﬁed forms
• Little is known about the metabolic fate of modiﬁed forms, except for a-ZAL, which is used
legally as a growth promoter in some non-EU countries under the name of zeranol.
• In all species, a-ZAL is oxidised to ZAN and isomerised to b-ZAL; the parent compound and the
metabolites are mainly glucuronidated.
• In pigs, plant modiﬁed forms (ZEN14Glc, ZEN16Glc and ZEN14Sulf) are most likely hydrolysed
in the gastrointestinal tract and thus contribute to ZEN overall toxicity.
Mode of action
• The main biological activity of ZEN is its oestrogenic activity, i.e. the ability to act similar to the
endogenous steroidal sex hormone 17-b-oestradiol. ZEN binds and activates oestrogenic
receptors, and has a stronger afﬁnity to ER-a than to ER-b.
• ZEN and its modiﬁed forms differ considerably in their oestrogenic activity. Based on their
uterotrophic activity assessed in rodents, ZEN and its modiﬁed forms are ranked as follows:
a-ZEL > a-ZAL > ZEN  ZAN  b-ZAL > b-ZEL.
• ZEN can activate the PXR and increase the transcription of a number of genes, including
several CYPs.
Adverse effects and identiﬁcation of reference points for risk characterisation in farm and
companion animals for ZEN
Ruminants
• Cattle appear to be more resistant to the adverse effects of ZEN than other farm animals
because they biotransform ZEN more into b-ZEL than a-ZEL.
• Limited adverse effects were observed in cattle at exposure levels of 48–1,456 lg/kg bw per
day. However, due to limitations in the study, neither a NOAEL nor LOAEL could be established.
• Based on ovulation rates and lambing percentages, a LOAEL of 56 lg ZEN/kg bw per day and
a NOAEL 28 lg ZEN/kg bw per day was established for sheep.
• No data were available for deriving reference points for risk characterisation for goats.
Pigs
• Pigs are generally regarded as being a very sensitive species to ZEN, the most sensitive being
prepubertal female piglets.
• Based on the appearance of the vulva and the uterus weight, a NOEL of 10.4 lg ZEN/kg bw
per day was established for piglets.
• For sexually mature female pigs, a NOAEL of 40 lg/kg bw per day was identiﬁed, based on
prolonged cycling.
Poultry
• Poultry responds to the presence of ZEN in feed at rather high dietary concentrations and can
generally be regarded as resistant.
• Based on decreased number of lymphocytes and the vent swelling, NOAELs of 7,500 and
9,100 lg/kg bw per day were identiﬁed for chickens and turkeys, respectively.
• For other poultry species and categories, data are scarce. Therefore, LOAELs/NOAELs could
not be derived.
Horses
• The only available study performed with the puriﬁed mycotoxin (11–13 lg ZEN kg bw per day
for 8–10 days) did not allow to derive a NOAEL or a LOAEL due to poor experimental design
and the lack of a control group.
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Farmed Rabbit
• No oestrogenic effect at 100 lg/kg bw were observed. However, at 10 lg/kg bw per day a
transient increase of catecholamine was observed.
• No NOAEL or LOAEL could be established for farmed rabbits.
Fish
• Very limited toxicity data are available for ﬁsh for ZEN.
• The CONTAM Panel estimated a NOAEL for carp of 0.3 mg/kg feed to correspond to 9 lg/kg
bw per day. It was based on changes in monocytes and granulocytes number, lipid
peroxidation in liver and gill and alterations of metabolic activation.
• No effect level to characterise the hazard of ZEN could be established for other ﬁsh species.
Companion animals
• Dogs are considered sensitive to ZEN. No NOAEL could be established for dogs. Based on
myometrium and endometrium lesions, enlargement and atrophy of uterine glands, blood
haematology and biochemistry, a LOAEL of 25 lg ZEN/kg bw per day has been estimated for
mature bitches.
• No data could be identiﬁed concerning the effects of ZEN in cats.
Farmed Mink
• Only studies performed with high ZEN dosages of 10 or 20 mg/kg feed (corresponding to
about 1,000 or 2,000 lg ZEN / kg bw per day) are available.
• Overt oestrogenic effects were detected already at the lowest tested dose; therefore, the
available studies were not suitable for deriving reference point of hazard characterisation.
Adverse effects and identiﬁcation of reference points for risk characterisation in farm and
companion animals for ZEN modiﬁed forms
• Very few experiments investigated the adverse effect of the modiﬁed form of ZEN on livestock
species, horses, ﬁsh and dogs and none of them were suitable to derive a NOAEL or LOAEL.
Occurrence in Feed
• The dietary exposure was estimated using a ﬁnal data set of 17,706 analytical results. Data were
representing most of the feed commodities with potential presence of ZEN. The percentage of
left-censored data reported (results below limit of detection and/or limit of quantiﬁcation) was
high (ZEN about 60%, ZAN about 70%, a-ZEL and b-ZEL, and a- and b-ZAL up to 100%).
• Samples for ZEN were collected between 2001 and 2015 in 25 different European countries,
whereas samples on the modiﬁed forms mostly from between 2013 and 2015 in only three
Member States.
• Apart from ‘Cereal grains, their products and by-products’ and ‘Compound feed’ only a limited
number of quantiﬁed data were available for other feed groups, i.e. forages, land animal
products, legume seeds, minerals, oil seeds and tubers. The highest number of reported
samples for ZEN was available for ‘Cereal grains, their products and by-products’ (~67%) and
in particular ‘Wheat’ (n = 6,499). Other well represented feed groups that were well
represented were ‘Complementary/Complete feed’ (n = 2,625), ‘Maize and corn’ (n = 2,048)
and ‘Barley’ (n = 1,596). Although an important ingredient in commercial rabbit diets, no data
were reported for Lucerne meal.
• The occurrence assessment for ZEN reported in the literature is consistent with data in the
EFSA database. Concerning the occurrence of modiﬁed forms, phase II conjugated forms have
often been reported in the recent literature, whereas no data have been received by EFSA.
• The co-occurrence of ZEN and its phase I and phase II modiﬁed is mainly reported in cereals
and products thereof.
• While milling may lead to a redistribution of ZEN and its modiﬁed forms in the ﬁnal fractions with
a possible enrichment in middlings, there is no evidence of signiﬁcant degradation by processing.
Use of RPFs for the ZEN modiﬁed forms
• RPFs of the modiﬁed forms relative to ZEN, ranging from 0.2 to 60, were applied to occurrence
levels of the respective ZEN metabolites according to CONTAM Panel 2016. The CONTAM
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Panel noted that these RPFs were based on uterotrophic effects measured for ZEN and its
modiﬁed forms in rodent experiments. However, the application of these RPFs derived from
rodents to different farm and companion animal species does not take into account the species
differences in the toxicokinetics and toxicodynamics.
Farm and companion animal exposure to ZEN and its modiﬁed forms
• Exposure to ZEN and its modiﬁed forms is primarily from consumption of contaminated cereal
grains and cereal by-products. Except for forage maize (and maize silage produced from it)
and cereal straw, levels in forages are generally low.
Exposure to ZEN
• The mean lowest LB to highest UB exposures of dairy cows and beef cattle to ZEN ranged
from 0.06 to 5.1 lg/kg bw per day, and the P95 exposures ranged from 0.30 to 32.9 lg/kg
bw per day.
• For sheep and goats, the calculated lowest LB to highest UB mean exposures to ZEN were
0.18 and 1.78 lg/kg bw per day, respectively, while at the 95th percentile the range was from
0.27 (LB) to 10.8 (UB) lg/kg bw per day.
• The calculated mean LB and UB exposures for pigs were 0.81 and 1.35 lg/kg bw/day,
respectively, while the 95th percentile exposures ranged from 2.50 (LB) to 7.88 (UB) lg/kg bw
per day, respectively.
• For poultry, the calculated mean exposure ranged from 0.74 (LB) to 3.64 (UB) lg/kg bw per day.
The equivalent range for the 95th percentile estimates of exposure was 3.46 and 12.7 lg/kg bw
per day, respectively.
• For horses, the calculated LB and UB mean exposure estimates to ZEN were 0.18 and 0.89 lg/kg
bw per day, respectively, while for the 95th percentile the range LB–UB was 0.35–3.69 lg/kg bw
per day.
• For farmed salmonids and carp,, the calculated mean LB and UB exposures ranged from 0.08
to 0.50 lg/kg bw per day, respectively. At the 95th percentile, LB and UB estimates of
exposure were 0.49 and 1.78 lg/kg bw per day, respectively.
• The calculated mean exposure for farmed rabbits ranged from 0.76 (LB) to 1.11 (UB) lg/kg
bw per day, while the equivalent range for the 95th percentile was from 0.85 to 1.35 lg/kg bw
per day.
• The mean calculated daily exposure for farmed mink ranged from 0.31 (LB) to 0.33 (UB) lg/kg
bw per day, while the equivalent range for the 95th percentile was from 1.40 to 1.41 lg/kg bw
per day.
• For companion animals (cats and dogs), the calculated LB and UB mean exposure to ZEN
ranged from 0.22 to 0.33 lg/kg bw per day, respectively, while at the 95th percentile the
range was from 0.75 (LB) to 0.80 (UB) lg/kg bw per day.
Farm and companion animal exposure to the sum of ZEN, a-ZAL, b-ZAL, ZAN, a-ZEL and
b-ZEL
• There was considerable variation between livestock groups in the percentage of the total
exposure (ZEN + a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL) that was accounted for by the sum
of the modiﬁed forms (a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL).
• For many species, notably poultry, ZEN accounted for the total exposure (100%) because of
lack of data of ZEN modiﬁed forms.
• At the LB exposure, the modiﬁed forms accounted for 0 to approximately 39% of the total
exposure at both the mean and 95th percentile for cattle, goat, sheep, horses, pigs, ﬁsh,
rabbits, cats, dogs and mink.
• At the UB exposure, the modiﬁed forms accounted for 50% or more of the total exposure,
both at the mean and 95th percentile for dairy cows, beef cattle, lactating sheep, horses,
weaned pigs and rabbits. More than half of the UB mean exposure for fattening pigs, lactating
sows, cats and dogs was from the modiﬁed forms, but was < 50% at the 95th percentile.
• The Panel noted that estimating the occurrence and exposure with such a high number of left-
censored data leads to a very high uncertainty.
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Farm and companion animal health risk characterisation
• The risk characterisation of exposure to ZEN is evaluated taking into consideration the
comparison between the exposure of ZEN alone, and the identiﬁed NOAELs/LOAELs for chronic
adverse effects.
• The risk characterisation of exposure to ZEN and its modiﬁed forms is evaluated based on the
comparison between the exposure of ZEN and its modiﬁed forms (sum of ZEN, a-ZAL, b-ZAL,
ZAN, a-ZEL and b-ZEL corrected for molar RPFs, and the identiﬁed NOAELs/LOAELs for chronic
adverse effects of ZEN as well as the uncertainty analysis.
• For cattle, horses, rabbit, duck, goats, mink and cats, the health risk from the exposure
to ZEN and to ZEN and its modiﬁed forms could not be assessed as no NOAEL or LOAEL have
been identiﬁed.
• For poultry, the risk of adverse health effect of feed containing ZEN was considered extremely
low.
• For pigs (gilt and piglets), sheep, dog and ﬁsh, the risk of adverse health effect of feed
containing ZEN was considered low.
• The same conclusions apply to the sum of ZEN and its modiﬁed forms.
5. Recommendations
• More data are needed on the occurrence of modiﬁed forms of ZEN in feed.
• Calibrants and reference materials are needed for the development of properly validated and
sensitive routine analytical methods for ZEN modiﬁed forms.
• Highly sensitive analytical methods should be designed for the most potent modiﬁed form a-
ZEL.
• Modiﬁed forms of ZEN, especially the more potent a-ZEL, should be included in ofﬁcial
monitoring plans to gather more data on the occurrence on ZEN modiﬁed forms in feed.
• Well-designed studies are needed for livestock species, particularly for cattle, horses, rabbits,
poultry, companion animals and mink to study toxicokinetics and toxicity of ZEN to reduce the
uncertainties in the animal risk assessment.
• Information is needed for livestock species, ﬁsh, companion animals and mink on toxicokinetics
and toxicity of ZEN and its modiﬁed forms to perform the animal risk assessment.
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Abbreviations
ADME absorption, distribution, metabolism and excretion
AhR aryl hydrocarbon receptor
ALP alkaline phosphatase
ALT alanine aminotransferase
Apo apolipoprotein
AST aspartate aminotransferase
bw body weight
cmax peak concentrations
CAR constitutive androstane receptor
CAS Chemical Abstracts Service
CONTAM Panel EFSA Panel on Contaminants in the Food Chain
CYP cytochrome P450
COMT catechol-O-methyltransferase
DON deoxynivalenol
DM dry matter
E2 17b-oestradiol
EIA enzyme immunoassay
ELISA enzyme-linked immunosorbent assay
ERs oestrogen receptors
Glc glucoside
GC gas chromatography
GGT gamma-glutamyl transferase
hAR human androgen receptor
Hb haemoglobin
HDL-C high-density lipoprotein cholesterol
HPLC high-performance liquid chromatography
HPLC-FLD high-performance liquid chromatography–ﬂuorescence detection
HPLC–MS/MS high-performance liquid chromatography–tandem mass spectrometry
HPTLC high-performance thin-layer chromatography
HSD hydroxysteroid dehydrogenase
i.m. intramuscular
i.p intraperitoneal
i.v. intravenous
LB lower bound
LC liquid chromatography
LC–MS/MS liquid chromatography–tandem mass spectrometry
LC-FLD liquid chromatography-ﬂuorescence detector
LC-UV liquid chromatography-ultraviolet detector
LDH lactate dehydrogenase
LDL-C low-density lipoprotein cholesterol
log Kow log partition coefﬁcient between octanol and water
LOD limit of detection
LOQ limit of quantiﬁcation
LOAEL lowest observed adverse effect level
LOEL lowest observed effect level
MCH mean cell haemoglobin
MCV mean cell volume
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m.p. melting point
MS mass spectrometry, mass spectrum
NDV Newcastle disease virus
NOAEL no observed adverse effect level
NOEL no observed effect level
NOAEL no observed adverse effect level
PCNA proliferating cell nuclear antigen
p.o. per os
PXR pregnane X receptor
RAL b-resorcylic acid lactone
ROS reactive oxygen species
RPF relative potency factor
P4 progesterone
SPE solid-phase extraction
Sulf Sulphate
SULT sulfotransferase
TC total cholesterol
TG thyroglobulin
TDI tolerable daily intake
tmax peak time
t1/2 terminal half-life
t" el terminal half-life elimination
UB upper bound
UGT uridine diphosphate glucuronosyltransferase
WG working group
WHO World Health Organization
ZAL zearalanol
ZAN zearalanone
ZEN zearalenone
ZEN14Glc zearalenone-14-glucoside
ZEN16Glc zearalenone-16-glucoside
ZENSulf zearalenone sulfate (Position yet to be deﬁned)
ZEN14Sulf zen-14-sulfate
a-ZAL a-zearalanol
a-ZEL a-zearalenol
b-ZAL b-zearalanol
b-ZEL b-zearalenol
b-ZEL14Glc b-zearalenol-14-glucoside
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Appendix A – Chemical information on zearalenone and modiﬁed forms
Common
name
Abbreviation Formula MW Occurrence Structure
Parent
compound
Zearalenone ZEN C18H22O5 318 Microorganisms
Phase I
metabolites
a-Zearalenol a-ZEL C18H24O5 320 Plants,
microorganisms,
animals
b-Zearalenol b-ZEL C18H24O5 320 Plants,
microorganisms,
animals
Zearalanone ZAN C18H24O5 320 Plants,
microorganisms,
animals
a-Zearalanol* a-ZAL C18H26O5 322 Plants,
microorganisms,
animals
b-Zearalanol b-ZAL C18H26O5 322 Plants,
microorganisms,
animals
Phase II
metabolites
Zearalenone-
14-glucoside
ZEN14Glc C24H32O10 480 Plants,
microorganisms
Zearalenone-
16-glucoside
ZEN16Glc C24H32O10 480 Plants,
microorganisms
a-Zearalenol-
14-glucoside
aZEL14Glc C24H34O10 482 Plants,
microorganisms
b-Zearalenol-
14-glucoside
bZEL14Glc C24H34O10 482 Plants,
microorganisms
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Common
name
Abbreviation Formula MW Occurrence Structure
Zearalenone-
14-sulfate
ZEN14Sulf C18H22O8S 398 Plants,
microorganisms
a-Zearalenol-
sulfate
a-ZELSulf C18H24O8S 400 Plants,
microorganisms
MW: molecular weight.
*: a-Zearalanol (e.g. Ralgro®) maybe used as a growth promoter in food producing species in non EU-countries.
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Appendix B – Identiﬁcation and selection of evidence relevant for the risk
assessment of zearalenone and its modiﬁed forms in feed
B.1. Search for scientiﬁc literature
B.2. Exclusion criteria for abstracts
The titles and abstracts of these references were screened to identify the relevant papers. Papers
on the following subjects were excluded:
• Papers on other mycotoxins, test substance not zearalenone or their modiﬁed forms.
• Papers in non EU languages, with no English abstract.
• Studies on occurrence in food.
• Papers on adverse effects in humans.
• Papers on human dietary exposure.
• Meeting abstracts with no scientiﬁc paper published, letter to the editor, extended abstracts
and conference proceedings.
Table B.1: Search terms and information source for literature search on zearalenone
Chemistry and analysis
Search terms (zearal*) AND (chemistry OR analysis OR determination OR detection OR identiﬁcation OR
formation OR GC OR “GC-MS” OR HPLC OR” LC-MS” OR “ICP-MS”)
Metabolism, Kinetics
Search terms (zearal*) AND (toxicokinetic* OR “absorption” OR distribution OR metabolism OR “excretion OR
elimination OR bioconcentration OR biotransformation OR “half-life” OR “half-lives” OR modelling
OR “carry-over” OR transfer)
Toxicity
Search terms (zearal*) AND (toxicity OR toxi* OR acute OR subacute OR subchronic OR chronic OR mutagen*
OR carcino* OR genotox* OR reprotox* OR nephrotox* OR neurotox* OR hepatotox* OR
immunotox* OR haemotox* OR hematotox* OR haematotox* OR cytotox* OR “develop* toxicity”
OR thyroid OR endocri* OR uter* OR “endocrine” OR OR estrogen OR oestrogen OR poisoning OR
“incidental poisoning” OR rat OR mouse OR “lab animal” OR animal* OR “case studies”)
Occurrence and exposure
Search terms (zearal*) AND (“feed occur”* OR feed OR feedstuffs OR “feed-stuffs” OR “feed occurrence” OR
grains OR barley OR wheat OR maize OR oat OR rice OR rye OR spelt OR “compound feed” OR
seeds OR “complete feed” OR “animal exposure” OR “feed intake”)
Animal species
Search terms (zearal*)AND (Livestock OR “farm animals” OR Ruminants OR Cattle OR cows OR heifer OR
bovine OR Sheep OR ovine OR goats OR swine OR pigs OR sow OR “lactating sow” OR piglet OR
gilts OR poultry OR chickens OR hen OR turkeys OR ducks OR Quail OR “guinea-fowl” OR Rabbits
OR Fishes OR Trout OR Salmon OR zebraﬁsh OR Horses OR herd or equine OR mare OR Pets OR
Cats OR Dogs OR bitch OR mink)
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Appendix C – EFSA guidance documents applied for the risk assessment
• EFSA (European Food Safety Authority), 2005. Opinion of the Scientiﬁc Committee on a
request from EFSA related to a harmonised approach for risk assessment of substances which
are both genotoxic and carcinogenic. EFSA Journal 2005;3(10):282, 31 pp. https://doi.org/
10.2903/j.efsa.2005.282
• EFSA (European Food Safety Authority), 2006. Guidance of the Scientiﬁc Committee on a
request from EFSA related to uncertainties in Dietary Exposure Assessment. EFSA Journal
2006;4(5):438, 54 pp. https://doi.org/10.2903/j.efsa.2006.438
• EFSA (European Food Safety Authority), 2009a. Guidance of the Scientiﬁc Committee on use of
the benchmark dose approach in risk assessment. EFSA Journal 2009;7(6):1150, 72 pp.
https://doi.org/10.2903/j.efsa.2009.1150
• EFSA (European Food Safety Authority), 2009b. Guidance of the Scientiﬁc Committee on
transparency in the scientiﬁc aspects of risk assessments carried out by EFSA. Part 2: General
principles. EFSA Journal 2009;7(5):1051, 22 pp. https://doi.org/10.2903/j.efsa.2009.1051
• EFSA (European Food Safety Authority), 2010. Management of left-censored data in dietary
exposure assessment of chemical substances. EFSA Journal 2010;8(3):1557, 96 pp. https://doi.
org/10.2903/j.efsa.2010.1557
• EFSA (European Food Safety Authority), 2011a. Use of BMDS and PROAST software packages
by EFSA Scientiﬁc Panels and Units for applying the Benchmark Dose (BMD) approach risk
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Appendix D – Feed intakes and diet composition (livestock)
To estimate exposure to zearalenone and its modiﬁed forms, information on both the amount of
feed consumed and the concentration of these compounds in the feed is required. This Appendix gives
details of the feed intakes, live weights and diet compositions for different livestock, ﬁsh and
companion animals used as the basis to estimate exposures. These are based on published guidelines
on nutrition and feeding (e.g. Caraba~no and Piquer, 1998; NRC 2000, 2007a,b, Leeson and Summers,
2008, McDonald et al., 2011; EFSA FEEDAP Panel, 2012; OECD, 2013) and information provided by
European feed manufacturers. They are therefore estimates of the Panel on Contaminants in the Food
Chain (CONTAM Panel), but are in agreement with common practice. In Appendix E the concentrations
of zearalenone and its modiﬁed forms in feeds used to estimate exposure are presented.
D.1. Feed intakes
D.1.1. Cattle, sheep, goats and horses
Dairy cows
The amounts of feed given to lactating dairy cows varies according to the amount and quality of
forages and other feeds available, the milk yield and the size of the cow. In this Opinion, it is assumed
that non-forage feeds are fed at the rate of 0.3 kg/kg of milk produced (Nix, 2010). Exposures to
zearalenone and the sum of its modiﬁed forms have been estimated for a 650-kg dairy cow, with a
milk yield of 40 kg/day, reﬂecting a relatively high milk yield. Assumptions on the amounts of forages
and non-forage feed are given in Table D.1.
Beef cattle
There are a wide variety of beef production and husbandry systems in Europe. They may be
categorised broadly as forage-based or cereal-based systems, although combinations of these systems
are commonly found. In this opinion, four feeding systems are considered, in which the forages are
(1) grass hay (2) maize silage and (3) cereal straw with, in each case, appropriate supplementation
with non-forage feed materials. A fourth system, namely ‘cereal beef’, is also considered. For exposure
estimates, live weights of 300 or 400 kg, and feed intakes of between 6.6 and 10 kg dry matter
(DM)/day have been assumed, depending on the feeding regime, based on guidelines published by
EBLEX (2015, 2016), and details are given in Table D.1.
Sheep and goats
A large number of breeds and systems of management have been developed for sheep and goats
to suit the land, climate and husbandry conditions in the EU. As for other ruminants, forages may be
the only feeds used after weaning (NRC, 2007a). Common exceptions to this are pregnant and
lactating animals, whose feed is usually supplemented with non-forage feeds or commercial compound
(complementary) feeds (AFRC, 1993; NRC, 2007a). In this Opinion, exposure estimates have been
made for lactating sheep and goats. The CONTAM Panel has used a daily dry matter intake of 2.8 kg
for an 80-kg lactating sheep feeding twin lambs to estimate the exposures. For lactating goats, the
CONTAM Panel has used daily dry matter intakes of 3.3 kg for a 60-kg goat for milking (4 kg milk/day).
No estimates of exposure have been made for fattening sheep and goats. For these livestock, fresh or
conserved forages are frequently the sole feed, and levels of zearalenone and modiﬁed forms in these
feeds are generally low or not reported. Furthermore, no data have been provided for complementary
feeds for fattening sheep and goats to allow exposure in those situations where forages are not the
sole feed.
Horses
Horses are non-ruminant herbivores. They generally consume 2–3.5% of their body weight in feed
(dry matter) each day, of which a minimum of 50% should be as forage (pasture or hay) (NRC,
2007b). Mature horses with minimal activity can be fed forage alone, but for growing and active
horses supplementary feeding with cereal grains, cereal by-products (e.g. oats, barley, and wheat
bran) and vegetable proteins is necessary. The CONTAM Panel has estimated two exposure scenarios
for a 450-kg horse, with a daily intake of 9 kg DM/day; in the ﬁrst, it is assumed that fresh grass is the
forage, and therefore makes no contribution to zearalenone exposure, while in the second scenario
grass hay is the forage (Table D.1).
Zearalenone and its modiﬁed forms in feed
www.efsa.europa.eu/efsajournal 95 EFSA Journal 2017;15(7):4851
D.1.2. Non-ruminant animals
Pigs
Although there is a considerable range of pig production systems in Europe, exposure estimates
have been made for piglets (pig starter), ﬁnishing pigs, lactating sows (using feed intakes proposed by
EFSA FEEDAP Panel, 2012) and gilts (Table D.2).
Poultry
The CONTAM Panel applied the live weights and feed intakes reported for fattening chickens
(broilers), laying hens and turkeys proposed by EFSA FEEDAP Panel (2012) and for ducks by Leeson
and Summers (2008) (Table D.2)
Farmed ﬁsh (salmonids and carp)
Commercially reared species include Atlantic salmon, rainbow trout, sea bass, sea bream, cod,
halibut, tuna, eel and turbot. In this Scientiﬁc Opinion, exposures to zearalenone and its modiﬁed
forms have been made for farmed salmon and carp. Details of the body weights and feed intakes used
are given in Table D.2.
Table D.1: Live weights, growth rate/productivity, dry matter intake for cattle, sheep, goats and
horses, and the proportions of the diet as non-forage
Species
Live
weight
(kg)
Growth rate
or productivity
Dry matter
intake
(kg/day)
% of diet as
non-forage
feed
Reference
Dairy cows, lactating 650 40 kg milk/day 20.7 40 OECD (2013)
Fattening cattle: beef(a) 400 1 kg/day 9.6 15 AFRC (1993)
Fattening cattle: maize silage-based
ration
300 1.4 kg/day 6.6 25 Browne et al.
(2004)
Fattening cattle: cereal straw-based
diet
300 0.9 kg/day 8.0 68 EBLEX (2016)
Sheep: lactating 80 Feeding twin
lambs
2.8 50 OECD (2013)
Goats: milking 60 6 kg milk/day 3.4 65 NRC (2007a)
Horses 450 Moderate activity 9.0 50 NRC (2007b)
(a): Housed castrate cattle, medium maturing breed.
(b): Months 2–3 of lactation.
Table D.2: Live weights and feed intake for pigs, poultry and ﬁsh (EFSA FEEDAP Panel, 2012) and
ducks (Leeson and Summers, 2008)
Species
Live
weight
(kg)
Feed intake
(kg dry
matter/day)
Reference
Pigs: starter 20 1.0 EFSA FEEDAP Panel (2012)
Pigs: ﬁnishing 100 3.0 EFSA FEEDAP Panel (2012)
Pigs: gilts 50 2.0 NRC (2012)
Pigs: lactating sows 200 6.0 EFSA FEEDAP Panel (2012)
Poultry: broilers(a) 2 0.12 EFSA FEEDAP Panel (2012)
Poultry: laying hens 2 0.12 EFSA FEEDAP Panel (2012)
Turkeys: fattening turkeys 12 0.40 EFSA FEEDAP Panel (2012)
Ducks: fattening ducks 3 0.14 Leeson and Summers (2008)
Salmonids 2 0.04 EFSA FEEDAP Panel (2012)
Carp 1 0.02 Schultz et al. (2012)
(a): Fattening chickens.
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Rabbits
Feed intakes of 65–80 g/kg body weight (bw) per day have been reported (Caraba~no and Piquer,
1998). For the exposure estimates, the CONTAM Panel have assumed a live weight of 2 kg, and a daily
feed intake of 75 g/kg bw (derived from Caraba~no and Piquer, 1998).
Farmed mink
For estimating exposure, the CONTAM Panel have assumed a live weight of 2.07 kg for a male mink
at pelting, and with a feed intake of 227 g/day (75 g dry matter) (NRC, 1982).
Companion animals: Dogs and cats
The amount of food consumed is largely a function of the mature weight of the animal, level of
activity, physiological status (e.g. pregnancy or lactation) and the energy content of the diet. In this
Scientiﬁc Opinion, the CONTAM Panel assumed body weights (kg) and feed intakes (g dry matter/day)
for dogs and cats were 25/360 and 4/60, respectively (derived from NRC, 2006).
D.2. Diet composition
Many livestock in the European countries are fed proprietary commercial compound feeds. Where
sufﬁcient data have been provided on species-speciﬁc compound feeds, estimates of exposure have
been made using these data together with estimated intakes given in Appendix D.1. Where data on
proprietary compound feeds were not available, or were available but in insufﬁcient numbers,
estimates of exposure have been made using dietary inclusion rates of feed materials given in this
section.
D.2.1. Cattle, sheep, goats and horses
For most ruminants and horses, forages (either fresh or conserved) are important ingredients in
their diet, but they are normally supplemented with non-forage feeds such as cereals, cereal
by-products, oilseed meals and by-products of human food production. These may be fed either as
individual feeds, mixtures of feed materials or as species-speciﬁc complementary feeds in the form of
compound feeds. In some situations, however, forages may represent the total diet.
Fresh (grazed) grass or grass silage are the principal forages for ruminants and horses in the EU.
As reported elsewhere in this Opinion (Section 3.3), zearalenone and its modiﬁed forms have not been
reported in these feeds, and therefore, it has been assumed that where they are fed they make no
contribution to exposure. For other forages, however, notably grass hay, maize silage and cereal straw,
the presence of zearalenone has been reported. Therefore, two estimates of exposure have been
reported for ruminants and horses, the ﬁrst of which assumes no exposure from forages (i.e. the main
forages are fresh grass and/or grass silage). Exposures have also been estimated for diets in which
grass hay, maize silage or cereal straw are the forage.
For lactating dairy cows and fattening beef cattle, data for species-speciﬁc compound feeds were
provided (Table 7) and therefore these were used to estimate exposure to ZEN in these diets. AFSSA
(2009) have provided example intakes of dairy cows fed maize silage supplemented with maize grain
and soybean meal, while example diets of beef cattle on maize silage or cereal straw-based diets are
taken from EBLEX (2005, 2015, 2016), and these are given in Table D.3.
For lactating sheep and goats, levels of zearalenone and its modiﬁed forms in species-speciﬁc
compound feed data were available and therefore these have been used to estimate exposure.
Horses are non-ruminant herbivores, and consequently their diet should contain a minimum of 50%
forages. While mature horses with minimal activity can be fed forage alone (NRC, 2007b), for growing
and active horses supplementary feeding with cereal grains, cereal by-products (e.g. oats, barley, and
wheat bran) and vegetable proteins is necessary. Although oats are the preferred cereal for many
horse owners, other cereal grains and cereal by-products are also routinely used. In the absence of
sufﬁcient data on levels of zearalenone and an its modiﬁed forms in complementary feeds for horses,
the CONTAM Panel has The CONTAM Panel has estimated the exposure for a 450-kg horse, with a
daily intake of 9 kg DM/day, of which half is in the form of grass hay and where cereal grains, their
products and by-products represent 82% of the non-forage component of the daily ration (Table D.5).
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D.2.2. Pigs and poultry
Sufﬁcient data for species-speciﬁc compound feeds or pigs, and for most categories of poultry
(fattening chickens and turkeys, and for laying hens), were provided for zearalenone (Appendix D) and
have been used to estimate exposure. No data were provided for a-ZAL, b-ZAL, ZAN, a-ZEL or b-ZEL
in compound feeds for laying hens, fattening hens and fattening turkeys, and therefore, no estimates
of exposure to ZEN plus the modiﬁed forms have been made for these poultry. No compound feed
data were available speciﬁcally for gilts, and therefore the occurrence data for fattening pigs have
been used to estimate exposure.
In common with other poultry, ducks have limited ability to digest ﬁbre,16 and therefore, cereal
grains form the major part of their diets. In Europe, wheat, maize and barley are most commonly
used, with rye, sorghum triticale and oats used less widely. Other ingredients include cereal by-
products and vegetable proteins, supplemented with minerals, trace elements and vitamins (Leeson
and Summers, 2008; McDonald et al., 2011). An example diet used in estimating exposure by ducks to
Zearalenone and its modiﬁed forms is given in Table D.5.
D.2.3. Rabbits
Rabbits are usually fed a pelleted diet (in the form of complete feedingstuffs) consisting of dried
forages, cereals and vegetable proteins supplemented with minerals, vitamins and trace elements.
Lebas and Renouf (2009) reviewed diet formulations used in experimental studies: in 58 diets, cereals
and cereal by-products (mostly wheat bran) cereals, cereal by-products (mostly wheat bran) and
oilseed meals (mostly soybean meal and sunﬂower meal) were 18–20%, 18–20% and 16%,
respectively. Dried lucerne is a particularly important ingredient in some diets, and has been included
at levels of up to 65% (Lebas and Renof, 2009). No data on levels of zearalenone in lucerne meal
were available to EFSA, and therefore, this feed has not been included in the example diet used to
estimate exposure. However, since zearalenone occurs predominantly in cereals, the lack of data for
lucerne meal is unlikely to result in a major underestimation of exposure, while its inclusion may have
resulted in a lower estimate of exposure. In this Scientiﬁc Opinion, the feed ingredients used in a
Table D.3: Feed intakes of high yielding lactating dairy cows (40 L/day) and beef cattle fed diets
based on different forages with non-forage feeds adjusted for milk yield, and beef cattle)
Species
Quantities of feed consumed
(kg dry matter/day)
Reference
Forage
Maize
grain
Soybean
meal
Barley
grain
Rapeseed
meal
Lactating dairy cows: maize
silage-based diet
15.0 9.5 2.8 – – AFSSA (2009)
Fattening beef cattle: maize
silage-based diet
4.9 – – – 1.5 EBLEX (2015)
Beef cattle: cereal straw-based
diet
2.5 – – 4.1 1.4 EBLEX (2016)
Beef cattle: “Cereal beef” 1.5 – – 5.5 1.5 EBLEX (2005)
Table D.4: Assumed diet composition (non-forage feed) for horses
Feed materials(a) Horses
Oats (%) 40
Beans (%) 10
Wheat feed (%) 30
Oat feed (%) 12
Molasses (%) 5
Minerals, vitamins etc. (%) 3
(a): See Commission Regulation (EU) No 575/2011 of June 2011 for full description.15
15 Commission Regulation (EU) No 575/2011 of June 2011 on the Catalogue of feed materials OJ L 159, 17.6.2011, p. 25–65.
16 An exception to this is geese, which can live entirely on grass and similar forage.
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typical French commercial rabbit compound, as provided by T. Gidenne (Personal communication,
2011) have been used, details of which are given in Table D.5.
D.2.4. Farmed ﬁsh (salmonids and carp)
Traditionally, the principal raw materials used for the manufacture of ﬁsh feeds in Europe have
been ﬁshmeal and ﬁsh oils, and although alternative sources of oil and protein (e.g. soybean meals
and vegetable oils) are increasingly being used ﬁsh-derived feeds still remain the major ingredients.
For many ﬁsh species, digestion of complex carbohydrates and the metabolic utilisation of the
absorbed glucose are low, reﬂecting the scarcity of carbohydrates in the aquatic environment
(Guillaume et al., 2001). Instead, ﬁsh obtain much of their energy from protein in the diet. Where
carbohydrates are used, they generally require some form of pretreatment (e.g. cooking, ﬂaking or
toasting).
Berntssen et al. (2010) provided details of the composition of a diet for growing salmonids, and the
CONTAM Panel used this feed formulation to estimate the exposures (Table D.5).
In contrast, studies with the common carp (Cyprinus carpio) have demonstrated greater intestinal
amylase activity than in carnivorous ﬁsh, which accounts for the better utilisation of carbohydrates by
these ﬁsh. The optimum level of carbohydrates appears to be 30–40% (FAO, Aquaculture Feed and
Fertiliser Resources Information System17), which allows for higher levels of cereals than in diets for
salmonids. The CONTAM Panel have adopted the ingredients of commercial compound feeds for carp
reported by Schultz et al. (2012) to estimate exposure to ZEN and its modiﬁed compounds.
D.2.5. Farmed mink
Mink are carnivorous animals and are fed high protein diets consisting mainly of meat and meat by-
products. Commercially manufactured mink feed consists largely of ﬁsh and land animal by-products,
with lesser amounts of cereals and cereal by-products, and supplemented with mineral/vitamin
premixtures. Mink are fed diets high in protein, although their nutritional requirements vary according
to the animal’s physiological stage (e.g. gestating, lactating, growing) and climatic conditions,
particularly temperature. The proportions of cereal grains, their products and by-products used in
estimating the exposure are given in Table D.5.
D.2.6. Companion animals (Cats and dogs)
Most small companion animals derive their nutritional needs from processed food, and in 2010 EU
annual sales of pet food products was approximately 8.3 million tonnes.18 Although a wide range of
ingredients is used in commercial diets, most dog and cat diets contain at least some animal protein.
Other ingredients include cereals (predominantly wheat, rice or maize), cereal by-products, vegetable
proteins and by-products of human food production.
The European Pet Food Industry Federation (FEDIAF) has provided information on typical inclusion
levels of cereals, cereal by-products and other feed materials in dry cat and dog food.19 In the
absence of sufﬁcient data on species-speciﬁc manufactured complete feedingstuffs, the CONTAM
Panel has used example diets based on information provided by FEDIAF (details given in Table D.5).
However, these should be regarded as indicative only, since actual ingredients will vary depending both
on the availability of feed materials and the nutrient requirements of the animals.
17 Available online: http://www.fao.org/fishery/affris/en/
18 Available online: www.Fedif.org
19 FEDIAF, Personal communication by email, May 2016.
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Table D.5: Estimated example diet composition (%) for fattening ducks, farmed rabbits, farmed
ﬁsh, farmed mink and companion animals (cats and dogs)
Feed materials Ducks Rabbits
Farmed ﬁsh
Farmed mink(b)
Companion
animals
Salmonids Carp Cats Dogs
Wheat 45 ni 13.2 24 6 10 10
Barley 15 18 ni 1 ni ni
Maize ni ni ni 10 6 5 6
Oats ni ni ni ni ni 1 0.5
Soybean meal 28 ni 12.3 32.4 ni 8 4
Rapeseed meal ni ni ni 12.5 ni ni ni
Maize gluten meal ni ni 11.5 ni ni 17 15
Sunﬂower meal ni 20 ni ni ni ni ni
Lucerne meal 5 19 ni ni ni ni ni
Beans(a) ni 10 ni ni ni 1 2
Wheat feed 2 16 ni ni ni 12 20
Sugar beet pulp(a) ni 12 ni ni ni ni ni
Fishmeal(a) ni ni 30.5 6.7 36 6 0.5
Meat meal(a) ni ni ni ni 40 38 40
Molasses(a) ni ni ni ni ni ni ni
Fish and vegetable oils(a) 3 ni 31.9 2.3 8 ni Ni
Others feeds (unspeciﬁed)(a) ni 2 ni 1 ni ni ni
Minerals, vitamins etc(a) 2 3 0.6 3.6 3 2.0 2.0
ni: not included in the diet formulations.
(a): No data on ZEN concentrations available, and therefore, the contribution to ZEN exposure is assumed to be zero.
(b): Based on data translated from Finnish to English provided by the Finnish Fur Breeders Association in 2015, www.profur.fi
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Appendix E – Mean and P95 LB and UB concentrations of ZEN and the sum
of ZEN + a-ZAL + b-ZAL + ZAN + a-ZEL + b-ZEL (with molar RPFs applied) in
feed materials and species-speciﬁc compound feeds used to estimate
exposures for farmed livestock and companion animals(a)
Feed n
ZEN
Sum of ZEN + a-ZAL + b-ZAL + ZAN
+ a-ZEL + b-ZEL
(with RPFs applied)
Mean(c) P95(c),(d) Mean(c) P95(c),(d)
LB UB LB UB LB UB LB UB
Wheat 6,177 24 27 92 94 24 28 92 98
Barley 1,586 12 17 23 40 12 63 23 46
Oats 779 12 16 55 61 12 70 55 110
Maize 2,046 116 120 547 547 116 127 547 553
Soybean meal 14 8 25 – – 8 25 – –
Sunﬂower meal 30 1 12 – – 1 153 – –
Wheatfeed 99 49 58 46 46 89 240 86 227
Oatfeed 72 1 6 0 8 1 6 0 8
Forages
Maize silage 59 138 140 – – 138 142 – –
Grass hay 31 64 66 – – 64 83 – –
Cereal straw 41 0 11 – – 0 139 – –
Dairy: high yielding 379 16 20 63 63 16 110 63 154
Fattening beef cattle 72 17 24 84 84 17 111 84 171
Lactating sheep 78 16 19 83 83 16 102 83 166
Lactating goats 28 10 13 – – 10 13. – –
Pig starter 345 16 21 50 50 16 111 50 140
Growing/fattening pigs 443 40 45 108 108 40 120 108 183
Lactating sow 97 36 42 263 263 36 116 263 337
Fattening chickens(b) 129 35 41 143 143 – – – –
Laying hens(b) 98 55 61 211 211 – – – –
Turkeys for fattening(b) 27 27 42 – – – – – –
ZEN: zearalenone; ZAL: zearalanol; ZAN: zearalanone; ZEL: zearalenol; N: number of samples; LB: lower bound; UB: upper
bound; P95: 95th percentile; RPF: relative potency factor.
(a): Expressed on a dry matter basis.
(b): No data on levels of a-ZAL, b-ZAL, ZAN, a-ZEL or b-ZEL were provided for compound feeds for these poultry.
(c): Values were rounded to the nearest whole number (0 decimal places).
(d): The 95th percentile with less than 60 observations may not be statistically robust (EFSA, 2011b). Those estimates were not
included in this table.
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Appendix F – LOD and LOQs of the concentrations (lg/kg whole-weight) of zearalenone and its modiﬁed forms in
feed samples classiﬁed according to the Catalogue of feed materials speciﬁed in Commission Regulation (EU)
No 68/201314
Feed category
Abbreviation
LOD LOQ
Mean Min Max Mean Min Max
Cereal grains, their products
and by-products
Barley Barley, unspeciﬁed a-ZAL 1.8 0 6.7 41.9 20 50
b-ZAL 1.8 0 6.7 41.9 20 50
ZAN 2.9 0 33.3 37.4 10 100
a-ZEL 0 0 0 50 50 50
b-ZEL 0 0 0 10 10 10
ZEN 2.6 0 38.3 7.0 1 115
Barley middlings a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZAN 5 5 5 10 10 10
ZEN 3.3 3.3 3.3 10 10 10
Barley protein feed a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 3.3 3.3 10 10 10
Malt ZEN 7.7 7.7 7.7 24 23 25
Malt rootlets ZAN 5 5 5 10 10 10
Buckwheat Buckwheat a-ZAL 0 0 0 50 50 50
b-ZAL 0 0 0 50 50 50
ZAN 0 0 0 50 50 50
a-ZEL 0 0 0 50 50 50
b-ZEL 0 0 0 10 10 10
ZEN 3.2 0 6.7 21 4 50
Cereal grains,
their products and
by-products
Cereal grains, their
products
and by-products
a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZAN 5.3 5 15 10.1 10 15
ZEN 31.6 2 66.7 94.6 5 200
Grains as crops Other grains ZEN 3 3 3 9 9 9
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Feed category
Abbreviation
LOD LOQ
Mean Min Max Mean Min Max
Maize and Corn Maize and Corn a-ZAL 6.67 6.67 6.67 20 20 20
b-ZAL 6.67 6.67 6.67 20 20 20
ZAN 5 5 5 10 10 10
ZEN 7.9 0.0 38.3 13.8 0.1 115
Millet Millet a-ZAL 0 0 0 50 50 50
b-ZAL 0 0 0 50 50 50
ZAN 4 0 5 18 10 50
a-ZEL 0 0 0 50 50 50
b-ZEL 0 0 0 10 10 10
ZEN 0 0 0 50 50 50
Mixed grains Brewers’ grains ZEN 10.6 3.3 25 31.7 10 75
Distillers’ dark grains;
[Distillers’ dried grains
and solubles]
ZAN 5 5 5 10 10 10
Distillers’ dried
grains
ZEN 20 20 20 23.3 10 50
Mixed grains,
unspeciﬁed
ZEN 5.3 0.0 20 14.6 0.03 50
Oats Oat feed ZEN 1.7 1.67 3.33 5.1 5 10
Oat ﬂour (Feed) ZEN 0.3 0.3 0.3 0.9 0.9 0.9
Oat groats (Feed) a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 3.3 3.3 10 10 10
Oats, unspeciﬁed a-ZAL 1.4 0 6.7 43.6 20 50
b-ZAL 1.4 0 6.7 43.6 20 50
ZAN 0.4 0 5 46.7 10 50
a-ZEL 0 0 0 50 50 50
b-ZEL 0 0 0 10 10 10
ZEN 1.9 0 38.3 4.7 1 115
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Feed category
Abbreviation
LOD LOQ
Mean Min Max Mean Min Max
Rice, broken Rice middlings ZAN 5 5 5 10 10 10
Rice, broken a-ZAL 0 0 0 50 50 50
b-ZAL 0 0 0 50 50 50
ZAN 0 0 0 50 50 50
a-ZEL 0 0 0 50 50 50
b-ZEL 0 0 0 10 10 10
ZEN 1.4 0 10 37.7 5 50
Rice, milled a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 3.3 3.3 10 10 10
Rye Rye a-ZAL 0 0 0 50 50 50
b-ZAL 0 0 0 50 50 50
ZAN 0 0 0 50 50 50
a-ZEL 0 0 0 50 50 50
b-ZEL 0 0 0 10 10 10
ZEN 4.5 0 38.3 7.6 0.1 115
Rye middlings ZAN 5 5 5 10 10 10
Sorghum; [Milo] Sorghum; [Milo] ZAN 5 5 5 10 10 10
ZEN 3 3 3 9 9 9
Spelt Spelt ZAN 5 5 5 10 10 10
ZEN 5.1 5 6.7 6.6 5 20
Triticale Triticale a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.6 2 20 8.31 5 50
Zearalenone and its modiﬁed forms in feed
www.efsa.europa.eu/efsajournal 104 EFSA Journal 2017;15(7):4851
Feed category
Abbreviation
LOD LOQ
Mean Min Max Mean Min Max
Wheat Malting wheat
screenings
ZEN . . . 25 25 25
Vital wheat gluten ZEN . . . 10 10 10
Wheat, unspeciﬁed a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZAN 6.0 5 15 10.5 10 15
ZEN 3.7 0.3 50 7.3 0.1 150
Wheat bran a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZAN 5 5 5 10 10 10
ZEN 3.8 3 20 10.8 9 50
Wheat feed a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZAN 5 5 5 10 10 10
ZEN 3.7 2 20 10.7 8 50
Wheat germ ZAN 5 5 5 10 10 10
Wheat gluten ZAN 5 5 5 10 10 10
ZEN 7.8 3.3 10 10 10 10
Wheat middlings ZAN 5 5 5 10 10 10
ZEN 9.9 3 16.7 9.5 5 50
Compound feed Complementary/
Complete feed
Breeding pigs a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.67 20 20 20
ZEN 6.5 2 20 16.0 7.5 50
Calves a-ZAL 6.7 6.67 6.67 20 20 20
b-ZAL 6.7 6.67 6.67 20 20 20
ZEN 5.9 3 10 17.8 9 30
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Feed category
Abbreviation
LOD LOQ
Mean Min Max Mean Min Max
Complementary feed
(incomplete diet)
a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZAN 5 5 5 10 10 10
ZEN 14.3 3.3 38.3 41.1 10 115
Complete feed ZAN 5 5 5 10 10 10
ZEN 14.8 0.0 16.7 44.2 0.03 50
Dairy cows a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 5.7 0.0 20 15.4 0.03 50
Fattening calves ZEN 8.1 3 16.7 13.4 9 50
Fattening cattle a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 7.1 3.3 20 15.2 7.5 50
Fattening chickens ZEN 6.8 0.3 30 18.4 1 90
Fattening ducks/
Complete feed
ZEN 4.3 3.3 10 12.9 10 30
Fattening geese/
Complementary feed
ZEN 10 10 10 30 30 30
Fattening geese/
Complete feed
ZEN 3.3 3.3 3.3 10 10 10
Fattening rabbits ZEN 5.6 3.3 20 15 10 50
Fattening sheep ZEN 4 4 4 10 10 10
Fattening turkeys/
Complete feed
ZEN 13.1 3.3 20 34.23 10 60
Fish/Complete feed ZEN 3.3 3.3 3.3 10 10 10
Growing/fattening pigs a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 7.0 0.0 38.3 17.1 0.0 115
Horses ZEN 21.1 3.3 50 56.7 10 150
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Feed category
Abbreviation
LOD LOQ
Mean Min Max Mean Min Max
Lactating/dairy goats/
Complete feed
ZEN 5 5 5 15 15 15
Lactating/dairy sheep a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 4.9 3.3 5 14.7 10 15
Lambs a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 5.4 3.3 10 15 10 30
Laying hens ZEN 7.4 0.3 20 18.3 1 50
Pet food, birds a-ZAL 6.7 6.67 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 3.3 3.3 10 10 10
Pet food, cats/Complete
feed
ZEN 3.3 3.3 3.3 10 10 10
Pet food, dogs ZEN 3.1 2 3.3 9.8 9 10
Poultry (starter diets) a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 2 3.3 9.9 5 10
Unspeciﬁed
Complementary/
Complete feed
ZEN 3.0 2 5 8.7 5 10
Weaning pigs a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 4.98 3 16.7 14.1 7 50
Compound feed Compound feed a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZAN 24.2 15 33.3 57.5 15 100
ZEN 5.8 3.33 50 10.3 10 50
Fish, other aquatic animals and
products derived thereof
Fish Fish meal ZEN 20 20 20 50 50 50
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Feed category
Abbreviation
LOD LOQ
Mean Min Max Mean Min Max
Forages and roughage, and
products derived thereof
Cereals straw Cereal straw, treated a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 3.3 3.3 10 10 10
Cereals straw, unspeciﬁed a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.4 3.33 6 10.1 10 15
Forage meal;
[Grass meal];
[Green meal]
Forage meal; [Grass meal];
[Green meal]
ZEN 50 50 50 50 50 50
Forages and roughage,
and products
derived thereof
Forages and roughage, and
products derived thereof
ZEN 19.3 0.3 66.7 57.3 1 200
Grass, ﬁeld dried, [Hay] Grass, ﬁeld dried, [Hay] a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 5.9 2 20 16.7 10 50
Grass, herbs, legume plants,
[green forage]
ZEN 20 20 20 50 50 50
Lucerne; [Alfalfa] Lucerne meal; [Alfalfa meal] ZEN 2 2 2 10 10 10
Lucerne, high temperature
dried; [Alfalfa, high
temperature dried]
ZEN 10 10 10 30 30 30
Maize silage Maize silage a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 17.0 2 20 42.7 5 50
Land animal products and
products derived thereof
Processed animal protein Processed animal protein ZEN 2 2 2 10 10 10
Legume seeds and products
derived thereof
Carob, dried Carob pods, dried ZEN 10 10 10 10 10 10
Peas Peas a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 3.3 3.3 10 10 10
Sweet lupins Sweet lupins ZEN 3 3 3 9 9 9
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Feed category
Abbreviation
LOD LOQ
Mean Min Max Mean Min Max
Legumes, nuts and oilseeds Other seeds Other seeds a-ZAL 0 0 0 46 40 50
b-ZAL 0 0 0 46 40 50
ZAN 0 0 0 38 20 50
a-ZEL 0 0 0 46 40 50
b-ZEL 0 0 0 10 10 10
ZEN 0 0 0 38 20 50
Minerals and products derived
thereof
Minerals and products
derived thereof
Minerals and products
derived thereof
ZEN 7.3 2 10 16.7 10 30
Miscellaneous Miscellaneous Miscellaneous ZEN 1 1 1 3 3 3
Products from the bakery
and pasta industry
Feed beer a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 3.3 3.3 10 10 10
Plants by-products from
spirits production
ZEN 3 3 3 9 9 9
Products from the bakery
and pasta industry
ZEN 11.5 3 20 29.5 9 50
Oil seeds, oil fruits, and
products derived thereof
Cotton seed Cotton seed ZEN 66.7 66.7 66.7 200 200 200
Oil seeds, oil fruits, and
products derived thereof
Oil seeds, oil fruits, and
products derived thereof
ZEN 10 10 10 10 10 10
Palm kernel expeller Palm kernel expeller ZEN 10 10 10 10 10 10
Rape seed Rape seed, unspeciﬁed a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 3.3 3.3 10 10 10
Rape seed meal a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 5.7 3.3 8 15 10 20
Rape seed, expeller a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 22.2 3.3 38.3 50 10 115
Safﬂower seed Safﬂower seed meal,
partially decorticated
ZEN 10 10 10 10 10 10
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Feed category
Abbreviation
LOD LOQ
Mean Min Max Mean Min Max
Sunﬂower seed Sunﬂower seed,
unspeciﬁed
a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.5 3.3 10 10 10 10
Sunﬂower seed expeller a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.9 3.3 20 11.4 10 50
Sunﬂower seed meal a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 6.7 3.3 20 18 10 50
Toasted soya (beans) Soya (bean) expeller a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 3.3 3.3 3.3 10 10 10
Soya (bean) meal ZEN 18.6 5 20 46.8 15 50
Soya (bean) meal, dehulled ZEN 20 20 20 50 50 50
Soya beans, extruded ZEN 4 2 5 13.3 10 15
Toasted soya (beans) a-ZAL 6.7 6.7 6.7 20 20 20
b-ZAL 6.7 6.7 6.7 20 20 20
ZEN 7.5 3.3 10 10 10 10
Tubers, roots, and products
derived thereof
Sugar beet (Sugar) beet molasses ZEN 10 10 10 10 10 10
Dried (sugar) beet pulp,
molasses
ZEN 5 5 5 10 10 10
LOD: limit of detection; LOQ: limit of quantiﬁcation; ZEN: zearalenone; ZAL: zearalanol; ZAN: zearalanone; ZEL: zearalenol.
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Appendix G – Mean, median, 75th and 95th percentile concentrations (lg/kg whole-weight) in feed samples
classiﬁed according to the Catalogue of feed materials speciﬁed in Commission Regulation (EU) No 68/201314
uncorrected for molar RPFs
Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Cereal grains,
their products
and by-products
Barley Barley, unspeciﬁed a-ZAL 26 100 0 42 0 50 0 50 – –
b-ZAL 26 100 0 42 0 50 0 50 – –
ZAN 38 82 6 37 0 50 0 50 – –
a-ZEL 19 100 0 50 0 50 0 50 – –
b-ZEL 19 100 0 10 0 10 0 10 – –
ZEN 1586 71 11 15 0 5 5 9 20 35
Barley bran ZEN 2 0 4,391 4,391 4,391 4,391 8,750 8,750 – –
Barley middlings a-ZAL 1 100 0 20 0 20 0 20 – –
b-ZAL 1 100 0 20 0 20 0 20 – –
ZAN 2 100 0 10 0 10 0 10 – –
ZEN 1 100 0 10 0 10 0 10 – –
Barley protein feed a-ZAL 1 100 0 20 0 20 0 20 – –
b-ZAL 1 100 0 20 0 20 0 20 – –
ZEN 1 100 0 10 0 10 0 10 – –
Malt ZEN 2 100 0 24 0 24 0 25 – –
Malt rootlets ZAN 2 50 20 25 20 25 41 41 – –
ZEN 4 0 13 13 13 13 20 20 – –
Buckwheat Buckwheat a-ZAL 1 100 0 50 0 50 0 50 – –
b-ZAL 1 100 0 50 0 50 0 50 – –
ZAN 1 100 0 50 0 50 0 50 – –
a-ZEL 1 100 0 50 0 50 0 50 – –
b-ZEL 1 100 0 10 0 10 0 10 – –
ZEN 4 100 0 21 0 15 0 35 – –
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Cereal grains, their
products
and by-products
Cereal grains, their
products and by-
products
a-ZAL 12 100 0 19 0 19 0 19 – –
b-ZAL 12 92 2 19 0 19 0 19 – –
ZAN 49 76 13 21 0 10 0 10 – –
ZEN 164 79 28 103 0 50 0 200 82 200
Grains as crops Other grains ZEN 1 100 0 3 0 3 0 3 – –
Maize_&_Corn Maize screenings ZEN 1 0 18 18 18 18 18 18 – –
Maize and Corn,
unspeciﬁed
a-ZAL 114 100 0 18 0 18 0 18 0 18
b-ZAL 114 100 0 18 0 18 0 18 0 18
ZAN 35 43 68 72 15 15 51 51 – –
ZEN 2,046 31 102 105 24 25 97 98 481 481
Millet Millet a-ZAL 1 100 0 50 0 50 0 50 – –
b-ZAL 1 100 0 50 0 50 0 50 – –
ZAN 6 83 5 20 0 10 0 32 – –
a-ZEL 1 100 0 50 0 50 0 50 – –
b-ZEL 1 100 0 10 0 10 0 10 – –
ZEN 1 100 0 50 0 50 0 50 – –
Mixed grains Brewers’ grains ZEN 3 100 0 15 0 10 0 25 – –
Distillers’ dark grains;
[Distillers’ dried grains
and solubles]
ZAN 24 8 64 65 49 49 86 86 – –
ZEN 1 0 2,400 2,400 2,400 2,400 2,400 2,400 – –
Distillers’ dried grains ZEN 10 30 14 18 19 19 19 20 – –
Grain ﬂour ZEN 1 0 11 11 11 11 11 11 – –
Mixed grains,
unspeciﬁed
ZEN 32 81 4 13 0 10 0 11 – –
Oats Oat feed ZEN 72 96 1 6 0 5 0 5 0 7
Oat ﬂour (Feed) ZEN 1 100 0 0 0 0 0 0 – –
Oat groats (Feed) a-ZAL 1 100 0 20 0 20 0 20 – –
b-ZAL 1 100 0 20 0 20 0 20 – –
ZEN 1 100 0 10 0 10 0 10 – –
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Oats, unspeciﬁed a-ZAL 14 100 0 44 0 50 0 50 – –
b-ZAL 14 100 0 44 0 50 0 50 – –
ZAN 13 92 2 45 0 50 0 50 – –
a-ZEL 11 100 0 50 0 50 0 50 – –
b-ZEL 11 100 0 10 0 10 0 10 – –
ZEN 779 78 10 14 0 3 0 8 48 53
Rice, broken Rice bran ZEN 1 0 128 128 128 128 128 128 – –
Rice middlings ZAN 1 100 0 10 0 10 0 10 – –
Rice, broken,
unspeciﬁed
a-ZAL 108 100 0 50 0 50 0 50 0 50
b-ZAL 108 100 0 50 0 50 0 50 0 50
ZAN 108 100 0 50 0 50 0 50 0 50
a-ZEL 108 100 0 50 0 50 0 50 0 50
b-ZEL 108 100 0 10 0 10 0 10 0 10
ZEN 152 98 0 37 0 50 0 50 0 50
Rice, milled a-ZAL 1 100 0 21 0 21 0 21 – –
b-ZAL 1 100 0 21 0 21 0 21 – –
ZEN 1 100 0 10 0 10 0 10 – –
Rye Rye, unspeciﬁed a-ZAL 9 100 0 50 0 50 0 50 – –
b-ZAL 9 100 0 50 0 50 0 50 – –
ZAN 9 100 0 50 0 50 0 50 – –
a-ZEL 9 100 0 50 0 50 0 50 – –
b-ZEL 9 100 0 10 0 10 0 10 – –
ZEN 312 90 2 9 0 5 0 5 7 26
Rye bran (Feed) ZEN 1 0 110 110 110 110 110 110 – –
Rye middlings ZAN 1 100 0 10 0 10 0 10 – –
Sorghum; [Milo] Sorghum; [Milo] ZAN 2 50 16 21 16 21 32 32 – –
ZEN 3 33 151 152 14 14 440 440 – –
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Spelt Spelt ZAN 4 75 6 13 0 10 12 17 – –
ZEN 33 85 3 8 0 5 0 10 – –
Triticale Triticale a-ZAL 2 100 0 20 0 20 0 20 – –
b-ZAL 2 100 0 20 0 20 0 20 – –
ZEN 67 72 17 21 0 6 8 13 22 22
Wheat Malting wheat
screenings
ZEN 2 100 0 25 0 25 0 25 – –
Vital wheat gluten ZEN 5 60 273 279 0 10 15 15 – –
Wheat, unspeciﬁed a-ZAL 12 100 0 20 0 20 0 20 – –
b-ZAL 12 100 0 20 0 20 0 20 – –
ZAN 40 53 44 50 0 11 25 25 – –
ZEN 6177 55 21 24 0 5 8 12 81 82
Wheat bran (Feed) a-ZAL 89 100 0 20 0 20 0 20 0 20
b-ZAL 89 100 0 20 0 20 0 20 0 20
ZAN 6 67 9 16 0 10 25 25 – –
ZEN 111 86 4 12 0 10 0 10 28 30
Wheat feed a-ZAL 65 98 4 24 0 20 0 20 0 20
b-ZAL 65 98 2 21 0 20 0 20 0 20
ZAN 6 50 10 15 5 10 25 25 – –
ZEN 99 84 43 51 0 10 0 10 40 40
Wheat germ (Feed) ZAN 1 100 0 10 0 10 0 10 – –
Wheat gluten feed ZAN 2 50 5 10 5 10 10 10 – –
ZEN 3 100 0 10 0 10 0 10 – –
Wheat middlings ZAN 3 67 17 23 0 10 50 50 – –
ZEN 102 50 18 22 3 10 33 34 65 65
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Compound feed Complementary/
Complete feed
Breeding pigs a-ZAL 2 100 0 11 0 11 0 13 – –
b-ZAL 2 100 0 11 0 11 0 13 – –
ZEN 97 48 32 37 3 15 25 30 231 231
Calves a-ZAL 4 100 0 13 0 13 0 13 – –
b-ZAL 4 100 0 13 0 13 0 13 – –
ZEN 12 42 100 105 17 25 90 90 – –
Complementary feed
(incomplete diet)
a-ZAL 1 100 0 8 0 8 0 8 – –
b-ZAL 1 100 0 8 0 8 0 8 – –
ZAN 131 22 19 20 9 9 22 22 75 75
ZEN 248 64 44 66 0 49 1 50 264 264
Complete feed ZAN 172 27 26 28 14 14 29 29 84 84
ZEN 224 57 57 81 0 50 3 50 335 335
Dairy cows a-ZAL 53 100 0 13 0 13 0 13 – –
b-ZAL 53 100 0 13 0 13 0 13 – –
ZEN 379 48 14 18 0 7 16 20 56 56
Fattening calves ZEN 127 39 28 32 15 16 35 35 86 86
Fattening cattle a-ZAL 15 100 0 13 0 13 0 13 – –
b-ZAL 15 100 0 13 0 13 0 13 – –
ZEN 72 69 15 21 0 8 2 13 74 74
Fattening chickens ZEN 129 37 31 36 7 18 31 34 126 126
Fattening ducks/
Complete feed
ZEN 7 100 0 10 0 10 0 10 – –
Fattening geese/
Complementary feed
ZEN 1 100 0 30 0 30 0 30 – –
Fattening geese/
Complete feed
ZEN 5 60 34 40 0 10 50 50 – –
Fattening rabbits ZEN 14 57 1,081 1,087 0 10 20 21 – –
Fattening sheep ZEN 7 57 5 11 0 10 12 12 – –
Fattening turkeys/
Complete feed
ZEN 27 48 24 37 4 20 20 50 – –
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Fish/Complete feed ZEN 1 100 0 10 0 10 0 10 – –
Fur animals/Complete
feed
ZEN 1 0 140 140 140 140 140 140 – –
Goat (kids) (weaning
diets)/
Complementary feed
ZEN 2 0 59 59 59 59 108 108 – –
Growing/fattening pigs a-ZAL 4 100 0 11 0 11 0 13 – –
b-ZAL 4 100 0 11 0 11 0 13 – –
ZEN 443 41 35 40 7 13 26 27 95 95
Horses ZEN 7 43 16 40 10 20 29 54 – –
Lactating/dairy goats/
Complete feed
ZEN 28 64 8 12 0 5 11 11 – –
Lactating/dairy sheep a-ZAL 4 100 0 12 0 13 0 13 – –
b-ZAL 4 100 0 12 0 13 0 13 – –
ZEN 78 59 14 17 0 5 14 14 73 73
Lambs a-ZAL 1 100 0 8 0 8 0 8 – –
b-ZAL 1 100 0 8 0 8 0 8 – –
ZEN 12 67 20 26 0 10 36 36 – –
Laying hens ZEN 98 47 48 53 1 10 34 34 186 186
Pet food, birds a-ZAL 1 100 0 13 0 13 0 13 – –
b-ZAL 1 100 0 13 0 13 0 13 – –
ZEN 15 7 15 15 20 20 20 20 – –
Pet food, cats/Complete
feed
ZEN 4 50 19 24 12 17 38 38 – –
Pet food, dogs ZEN 7 86 4 10 0 10 0 10 – –
Poultry (starter diets) a-ZAL 52 100 0 13 0 13 0 13 – –
b-ZAL 52 100 0 13 0 13 0 13 – –
ZEN 132 46 31 35 10 10 38 38 125 125
Rabbits/Complete feed ZEN 1 0 2 2 2 2 2 2 – –
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Unspeciﬁed
Complementary/
Complete feed
ZEN 102 34 51 54 15 15 36 36 145 145
Weaning pigs a-ZAL 42 100 0 13 0 13 0 13 – –
b-ZAL 42 100 0 13 0 13 0 13 – –
ZEN 345 63 14 19 0 7 12 15 44 44
Compound feed Compound feed a-ZAL 106 100 0 20 0 20 0 20 0 20
b-ZAL 106 100 0 20 0 20 0 20 0 20
ZAN 3 67 5 43 0 15 15 100 – –
ZEN 201 69 17 24 0 10 11 12 77 77
Fish, other
aquatic animals
and products
derived thereof
Fish Fish meal ZEN 1 100 0 50 0 50 0 50 – –
Forages and
roughage, and
products
derived thereof
Cereals straw Cereal straw, treated a-ZAL 1 100 0 19 0 19 0 19 – –
b-ZAL 1 100 0 19 0 19 0 19 – –
ZEN 1 100 0 10 0 10 0 10 – –
Cereals straw a-ZAL 40 100 0 19 0 19 0 19 – –
b-ZAL 40 100 0 19 0 19 0 19 – –
ZEN 41 100 0 10 0 10 0 10 – –
Forage meal;
[Grass meal];
[Green meal]
Forage meal;
[Grass meal];
[Green meal]
ZEN 4 75 43 80 0 50 85 110 – –
Forages and
roughage, and
products derived
thereof
Forages and roughage,
and products
derived thereof
ZEN 11 73 68 108 0 15 1 200 – –
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Grass, ﬁeld dried,
[Hay]
Grass, ﬁeld dried, [Hay] a-ZAL 5 100 0 16 0 16 0 16 – –
b-ZAL 5 100 0 16 0 16 0 16 – –
ZEN 31 19 57 58 20 20 20 20 – –
Grass, herbs, legume
plants, [green forage]
ZEN 16 6 18 19 20 20 20 20 – –
Lucerne; [Alfalfa] Lucerne ﬁeld dried;
[Alfalfa ﬁeld dried]
ZEN 1 0 16 16 16 16 16 16 – –
Lucerne meal;
[Alfalfa meal]
ZEN 2 50 450 451 450 451 900 900 – –
Lucerne, high
temperature dried;
[Alfalfa, high
temperature dried]
ZEN 2 50 10 15 10 15 20 20 – –
Maize silage Maize silage a-ZAL 1 100 0 10 0 10 0 10 – –
b-ZAL 1 100 0 10 0 10 0 10 – –
ZEN 59 29 121 124 20 20 75 75 937 937
Land animal
products and
products
derived thereof
Animal by-products Animal by-products ZEN 1 0 20 20 20 20 20 20 – –
Processed animal
protein
Processed animal
protein
ZEN 1 100 0 2 0 2 0 2 – –
Legume seeds
and products
derived thereof
Carob, dried Carob pods, dried ZEN 1 100 0 10 0 10 0 10 – –
Horse beans Horse beans ZEN 1 0 20 20 20 20 20 20 – –
Peas Peas a-ZAL 1 100 0 19 0 19 0 19 – –
b-ZAL 1 100 0 19 0 19 0 19 – –
ZEN 1 100 0 10 0 10 0 10 – –
Sweet lupins Sweet lupins ZEN 1 100 0 3 0 3 0 3 – –
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Legumes, nuts
and oilseeds
Other seeds Other seeds a-ZAL 5 100 0 46 0 50 0 50 – –
b-ZAL 5 100 0 46 0 50 0 50 – –
ZAN 5 100 0 38 0 50 0 50 – –
a-ZEL 5 100 0 46 0 50 0 50 – –
b-ZEL 5 100 0 10 0 10 0 10 – –
ZEN 5 100 0 38 0 50 0 50 – –
Minerals and
products
derived thereof
Calcium carbonate;
[Limestone]
Calcium carbonate;
[Limestone]
ZEN 1 0 100 100 100 100 100 100 – –
Minerals and
products derived
thereof
Minerals and products
derived thereof
ZEN 4 75 1 7 0 8 3 10 – –
Miscellaneous Miscellaneous Miscellaneous ZEN 1 100 0 3 0 3 0 3 – –
Products from the
bakery and pasta
industry
Feed beer a-ZAL 1 100 0 16 0 16 0 16 – –
b-ZAL 1 100 0 16 0 16 0 16 – –
ZEN 1 100 0 8 0 8 0 8 – –
Plants by-products from
spirits production
ZEN 12 8 222 222 105 105 303 303 – –
Products from the
bakery and pasta
industry
ZEN 4 100 0 9 0 9 0 16 – –
Oil seeds, oil
fruits, and
products
derived thereof
Cocoa husks Cocoa husks ZEN 2 0 85 85 85 85 150 150 – –
Cotton seed Cotton seed ZEN 5 40 9 89 5 20 20 200 – –
Niger seed Niger seed ZEN 1 0 5 5 5 5 5 5 – –
Oil seeds, oil fruits,
and products
derived thereof
Oil seeds, oil fruits,
and products derived
thereof
ZEN 1 100 0 10 0 10 0 10 – –
Palm kernel expeller Palm kernel expeller ZEN 1 100 0 10 0 10 0 10 – –
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Rape seed Rape seed a-ZAL 1 100 0 20 0 20 0 20 – –
b-ZAL 1 100 0 20 0 20 0 20 – –
ZEN 4 75 5 12 0 10 10 15 – –
Rape seed meal a-ZAL 1 100 0 20 0 20 0 20 – –
b-ZAL 1 100 0 20 0 20 0 20 – –
ZEN 8 25 11 15 13 20 20 20 – –
Rape seed, expeller a-ZAL 1 100 0 20 0 20 0 20 – –
b-ZAL 1 100 0 20 0 20 0 20 – –
ZEN 5 60 5 35 0 20 5 25 – –
Safﬂower seed Safﬂower seed meal,
partially decorticated
ZEN 1 100 0 10 0 10 0 10 – –
Sunﬂower seed Sunﬂower seed,
unspeciﬁed
a-ZAL 42 100 0 21 0 21 0 21 – –
b-ZAL 42 100 0 21 0 21 0 21 – –
ZEN 47 91 74 83 0 10 0 10 – –
Sunﬂower seed expeller a-ZAL 29 100 0 21 0 21 0 21 – –
b-ZAL 29 100 0 21 0 21 0 21 – –
ZEN 30 97 1 11 0 10 0 10 – –
Sunﬂower seed meal a-ZAL 4 100 0 21 0 21 0 21 – –
b-ZAL 4 100 0 21 0 21 0 21 – –
ZEN 6 83 3 14 0 10 0 20 – –
Sunﬂower seed meal,
dehulled
ZEN 2 0 20 20 20 20 20 20 – –
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Feed category Abbreviation N
% Left
Censored
Mean
(lg/kg)(a)
Median
(lg/kg)(a)
P75
(lg/kg)(a)
P95
(lg/kg)(a),(b)
LB UB LB UB LB UB LB UB
Toasted soya
(beans)
Soya (bean) expeller a-ZAL 5 100 0 20 0 20 0 20 – –
b-ZAL 5 100 0 20 0 20 0 20 – –
ZEN 7 57 36 41 0 10 64 64 – –
Soya (bean) meal ZEN 14 79 7 22 0 20 0 20 – –
Soya (bean) meal,
dehulled
ZEN 5 20 13 17 20 20 20 20 – –
Soya (bean) protein
concentrate
ZEN 1 0 20 20 20 20 20 20 – –
Soya beans, extruded ZEN 3 100 0 11 0 15 0 15 – –
Toasted soya (beans),
unspeciﬁed
a-ZAL 3 100 0 20 0 20 0 20 – –
b-ZAL 3 100 0 20 0 20 0 20 – –
Oil seeds, oil
fruits, and
products
derived thereof
Toasted soya
(beans)
Toasted soya (beans) ZEN 8 100 0 10 0 10 0 10 – –
Other seeds and
fruits, and
products
derived thereof
Buckwheat Buckwheat ZEN 1 0 65 65 65 65 65 65 – –
Fruit kernels Fruit pulp, dried ZEN 1 0 20 20 20 20 20 20 – –
Perilla seed Perilla seed ZEN 1 0 14 14 14 14 14 14 – –
Tubers, roots,
and products
derived thereof
Sugar beet (Sugar) beet molasses ZEN 1 100 0 10 0 10 0 10 – –
Dried (sugar) beet pulp ZEN 1 0 20 20 20 20 20 20 – –
Dried (sugar) beet pulp,
molasses
ZEN 1 100 0 10 0 10 0 10 – –
Sugar beet, unspeciﬁed ZEN 1 0 153 153 153 153 153 153 – –
ZEN: zearalenone; ZAL: zearalanol; ZAN: zearalanone; ZEL: zearalenol; N: number of samples; LB: lower bound; UB: upper bound; P75/P95: 75th/95th percentile; RPF: relative potency factor.
(a): The 95th percentile with less than 60 observations may not be statistically robust (EFSA, 2011b). Those estimates were not included in this table.
(b): Values were rounded to the nearest whole number (0 decimal places).
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Appendix H – Effects of the oral zearalenone (ZEN) administration to
female dogs
Effects/parameters
lg ZEN/kg bw/100 days
N/group = 3; age 3 years
bw: unknown
Reference
lg ZEN/kg bw/42 days
N/group = 10; Age
70 days bw 8 Kg
Reference
Blood cells and
biochemistry
0 25 50 0 50 75
WBC 10.7 14.1* 13.9 Gajezcka
et al. (2007)
ND ND ND
RBC 6.5 6.5 6.4 Gajezcka
et al. (2007)
ND ND ND
Total cholesterol 2.1 2.4 1.4 Gajezcka
et al. (2007)
ND ND ND
MCV 72.4 70.0 78.9 Gajezcka
et al. (2007)
ND ND ND
MCH 1.56 1.51* 1.46 Gajezcka
et al. (2007)
ND ND ND
Hb 10.1 9.7* 9.2 Gajezcka
et al. (2007)
ND ND ND
Plasma bilirubin 52.8 63.0* 88.0* Gajezcka
et al. (2007)
ND ND ND
Plasma AST 12.2 1.83* 2.57* Gajezcka
et al. (2007)
ND ND ND
Plasma ALT 30.0 24.0* 25.0* Gajezcka
et al. (2007)
ND ND ND
Serum 17b-
estradiol (pg/mL)
NS NS Gajezcka
et al.(2008b)
4.6 14.66* 21.58* Gajezcka
(2013)
Gajezcka
et al. (2013)
Serum
progesterone
(ng/mL)
< 1 ↑5–15# ↑up to
25##
Gajezcka
et al.
(2008b)
0.16 0.14 0.13* Gajezcka
(2013)
Gajezcka
et al. (2013)
Uterus
Weight (horns);
length (body)
ND ND ND +* +* Stopa et al.
(2014)
Histological lesions – + + Gajezcka
et al. (2008a)
+ + Stopa et al.
(2014)
PCNA positive cells + – – – – Gajezcka
et al. (2008a)
ND ND ND
Ultrastructural
changes
– + ++ Gajezcka
et al. (2008c)
ND ND ND
Ovaries
Histological lesions ND + ++ Gajezcka
et al. (2008a)
+ ++ Gajezcka
(2013)
Ultrastructural
changes
+ ++ ND ND ND
ER b
(immunochemistry)
ND ND ND +++ ↓+/++ ↓+ Gajezcka
(2012)
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Effects/parameters
lg ZEN/kg bw/100 days
N/group = 3; age 3 years
bw: unknown
Reference
lg ZEN/kg bw/42 days
N/group = 10; Age
70 days bw 8 Kg
Reference
CYPscc
(aromatase) mRNA
ND ND ND NS NS
3b-HSD mRNA ND ND ND NS + 400%
over
control
Gajezcka
et al.
(2011b)
ALT: alanine aminotransferase; AST: aspartate aminotransferase; ER: oestrogen receptor; Hb: haemoglobin; PCNA: proliferating
cell nuclear antigen; MCV: mean cell volume; MCH: mean cell haemoglobin; HSD: hydroxysteroid dehydrogenase; NS: not
statistically signiﬁcant different from the control; ND: not determined; #limited to the ﬁrst part of the trial; ##limited to or
mainly in the second part of the trial; +/ = present/absent.
*p < 0.05 or less vs controls.
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